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 ABSTRACT 
CARDIAC REGENERATIVE MEDICINE:  
INSIGHTS FROM HEALTHY AND DISEASED ENGINEERED TISSUES 
 
by 
Pamela Grace Hitscherich 
Cardiovascular disease remains the leading cause of mortality in the United States. 
Current tissue engineering approaches have fallen short of promoting fully functional 
cardiovascular cells and the post-myocardial infarction microenvironment is still not well 
understood. These gaps in knowledge are addressed in this dissertation through the 
development of in vitro engineered cardiac tissues using electroactive materials to 
enhance the differentiation of pluripotent stem cell derived cardiomyocytes and through 
the development of in vitro myocardial inflammation models dedicated to understanding 
cardiomyocytes and macrophages interactions.  
Specifically, piezoelectric poly (vinylidene fluoride-trifluoroethylene) (PVDF-
TrFE) supports the attachment and survival of mouse embryonic stem cell derived 
cardiomyocytes (mES-CM) and endothelial cells (mES-EC). Characterization of mES-
CM confirms expression of classical cardiac specific marker such as cTnT and Cx43, as 
well as efficient calcium handling properties when cultured on PVDF-TrFE including 
response to ryanodine receptor and β-adrenergic stimulation. MES-EC also retain their 
ability to uptake low density lipoprotein when cultured on PVDF-TrFE scaffolds and 
express classical endothelial cell specific markers such as eNOS and PECAM-1. 
Additionally, a novel graphene composite scaffold (PCL+G) exhibiting even 
distribution of graphene particles within the matrix allowing miniscule amounts of 
graphene to increase conductivity is developed and characterized. MES-CM seeded on 
conductive PCL+G scaffolds attach well and begin migrating into the scaffold matrix. 
They exhibit well-registered sarcomeres, express cardiac specific markers such as cTnT, 
MHC and Cx43 and spontaneous beat for up to two weeks. MES-CM on PCL+G 
scaffolds can be electrically paced and respond to ryanodine receptor and β-adrenergic 
stimulation. The combination of highly aligned fiber orientation and the presence of 
graphene promoted significantly improve calcium cycling efficiency by a fractional 
release of over 40%.  
Finally, in vitro myocardial inflammation models are developed to examine both 
direct and indirect co-culture of mES-CM with polarized macrophage subpopulations 
present in the post-myocardial infarction (MI) microenvironment. Direct co-culture with 
macrophage subsets cause significant changes in mES-CM calcium handling function, 
especially in store operated calcium entry (SOCE). Additionally, a macrophage secreted 
matricellular protein osteopontin (OPN) is also found to affect mES-CM SOCE response 
at concentrations similar to plasma levels in patients post-MI. A pathway connecting 
OPN to SOCE response through ERK1/2 activation is analyzed through indirect co-
culture with macrophage conditioned media and found to be affected by OPN inhibition, 
suggesting this pathway is involved with calcium homeostasis in the post-MI 
microenvironment, specifically in the pro-healing, anti-inflammatory phase.  
Taken together, the presented results expand the current state of research in 
cardiac regenerative medicine by demonstrating the potential of two electroactive 
biomaterials for the formation of functional cardiac tissues and by illuminating a novel 
target involved in changes in cardiomyocytes calcium homeostasis during post-MI 
healing through an in vitro engineered diseased model.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 The Heart and Cardiovascular Disease 
Cardiac muscle, or the myocardium, is a complex tissue with a highly organized 
extracellular matrix. Collagen fibers throughout the thickness of the tissue are highly 
aligned which allows for organization of cardiac cells for efficient, coordinated and 
functional pumping of the heart 1.  Numerous cell types are present in the heart including 
cardiomyocytes, the functional and contractile cells of the heart, fibroblasts, 
macrophages, endothelial cells and smooth muscle cells. Cardiac fibroblasts have long 
been considered to be the most abundant cell type in the myocardium, although recent 
findings suggest that fibroblasts make up only about 15% of nonmyocytes in the heart 2. 
Fibroblasts form a 3D network between cells and tissue layers and are involved in 
electrical signaling.  The vascular network, composed of endothelial cells, is estimated to 
be within 2-3 µm of any cardiomyocytes in the heart 3,4, with endothelial cells being the 
most abundant nonmyocyte cell type in the myocardium 2. Complex paracrine 
interactions between endothelial cells and cardiomyocytes are important in both the 
healthy and diseased tissue 3,4. Very recently, it has also been demonstrated that resident 
cardiac macrophages contribute to healthy and steady state cardiac function as they 
facilitate electrical signal propagation in the AV node through intricate interactions with 
cardiomyocytes via connexin43 gap junctions 5.  
Cardiovascular disease, including heart attack or myocardial infarction (MI), is 
the leading cause of disability and death in the Western world. Every 40 seconds 
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someone in the United States will suffer a heart attack, amounting to almost 800,000 per 
year 6. Twenty percent of heart attacks are silent, or unknown to the patient while over 
25% of heart attacks are recurrences 6. The risk factors associated with MI include high 
age, smoking and sex, as men are more likely to suffer heart attack, and comorbidities 
such as high blood pressure, high cholesterol and diabetes 7.  
MI is caused by a blockage of the vasculature in the heart leading to ischemia, 
which results in a large-scale loss of cardiac muscle tissue. Hence, cardiac regenerative 
medicine has focused on  both cell-based 8 and engineered tissue strategies 9 to replace or 
repair damaged or dead tissue. The most recent clinical trial examining autologous stem 
cell therapy for treatment post-MI in the United States is PreSERVE-AMI, a randomized, 
double-blind and placebo controlled Phase II clinical trial 10,11. PreSERVE-AMI 
examined the safety and efficacy of intracoronary injection of autologous bone marrow-
derived stem cells. These specific endothelial progenitor cells, characterized by CD34 
expression (CD34+), migrate from the bone marrow to the site of injury through the 
circulation and promote neovascularization and tissue regeneration. The initial Phase I 
trial including 31 patients had found dose dependent improvement in myocardial 
perfusion12 but improvements in ejection fraction, scar size or perfusion were not 
demonstrated in PreSERVE-AMI study including 161 patients 11. Although CD34+ cells 
were found to be safe, offering encouragement for continued examination of CD34+ cell-
based therapy, they do not offer any re-muscularization of the infarcted tissue.  
To complement this strategy, it is imperative to understand the post-MI 
microenvironment in which cell-based therapies will be deployed. The first stage of 
healing post-MI is inflammation 13. It is critical to better understand how macrophages 
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influence the inflammatory response post-MI, as the prolonging of inflammation is 
associated with detrimental remodeling and function 14. Initial damage to the myocardium 
is followed by extensive tissue remodeling, which leads to structural changes and 
functional alterations causing a decrease in cardiac pump performance. In order to 
develop successful therapies for post-MI regeneration, numerous components of the 
tissue in vivo need to be carefully considered 15.  
 
1.2 Cardiac Tissue Engineering  
1.2.1 Therapeutic Cell Sources  
The number of cardiomyocytes in a human left ventricle is estimated at up to four billion 
16-18. MI is thought to cause the death of nearly one billion 16,17. The heart is inherently 
unable to replace the loss of these cells, as adult cardiomyocytes have very limited ability 
to proliferate 19-22. Hence, it is imperative to find a reliable cell source for the replacement 
of lost cardiomyocytes. An ideal cell source for cardiac regenerative medicine would 
have high proliferative capacity, to replace the large-scale loss of cells, and should have 
the ability to differentiate into functional cells that can integrate into the myocardial 
tissue.  
Different cell populations have been explored for their potential for cardiac 
regeneration 23.  One cell type of interest is adult stem cells, including mesenchymal stem 
cells (MSC) and resident cardiac stem cells (CSC). CSC are a recently discovered 
population of cells, small in number and highly heterogeneous, present in the adult 
myocardium that can be extracted and expended in vitro 9,24-26. A clinical trial exploring 
CSC demonstrated encouraging results 27-29. However much is still unknown about CSC 
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and their place in the adult heart and further exploration is necessary.  
MSC can be isolated from multiple sources including the bone marrow and 
adipose tissue 30 31. MSC have been demonstrated to differentiate into osteogenic, 
adipogenic, chondrogenic and cardiac cell types under the correct set of stimuli 32,33 30,34. 
MSC were considered immune privileged, or able to be allogeneically transplanted 
without immune rejection 35, however more recently, data demonstrates that allogeneic 
MCS can cause an immune response 36. MSC are known to secrete factors that promote 
angiogenesis and stem cell recruitment, prevent apoptosis and contribute to matrix 
remodeling 37,38 39. MSC transplantation has demonstrated improved heart function in 
animal models of acute myocardial injury 40-42. Localization of MSC to the site of cardiac 
injury and improved cardiac function were demonstrated in patients with heart failure 43-
49. However, MSC populations are highly heterogeneous, depending on their tissue of 
origin, so it is difficult to fully understand their potential 50. It is also unclear whether 
MSC can differentiate into functional cardiomyocytes or conversely, induce 
dedifferentiation and proliferation of endogenous cardiomyocytes 51,52. Because of this, it 
has been proposed that improvements in heart function after MSC transplantation are 
related to secretion of paracrine factors that augment the inflammatory response 53-55. 
Therefore, the safety of long-term MSC use and its mechanistic effects for cardiac repair 
remain to be elucidated.  
Pluripotent stem cells, including embryonic (ESC) and induced pluripotent stem 
(iPSC) cells, have also been explored for regenerative medicine applications. They offer 
unlimited proliferative ability and have been successfully differentiated toward the 
cardiac lineage to generate stem cell derived cardiomyocytes 56. Pluripotent stem cell 
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differentiation follows a well-defined developmental lineage through mesoderm 
induction as shown in Figure 1.1.  Mesodermal cells differentiate into cardiac progenitor 
cells exhibiting specific gene markers such as GATA4 and Nkx2.5. Cardiac progenitors 
then further differentiate into immature cardiomyocytes expressing genes associated with 
the contractile apparatus such as myosin heavy chain β and cardiac troponin T 57,58. The 
goal of differentiation is for the cells to ultimately mature into adult cardiomyocytes 
exhibiting similar mature cardiomyocyte structure, phenotype and function as seen in the 
isolated, adult myocyte in Figure 1.1.  
Induced pluripotent stem cells (iPSC) add an additional step to the differentiation, 
as they require first the reprogramming of an adult cell type back to a pluripotent stem 
cell like cells. The generation of iPSC was seen as a turning point in stem cell research, 
as it generates a pluripotent stem cell type without the ethical concerns associated with 
ESC and the potential for autologous sourcing 59. However, the initial method of 
reprogramming using viral vectors posed some risks 60-62. Because of this, other methods 
have been developed including the using of Cre-loxP sites and treatment with small 
molecules such as reversine and mir-302 63-67. 
  
6 
Figure 1.1 Stages of cardiomyogenesis from pluripotent stem cells to mature 
cardiomyocytes demonstrates changes in cell size, organization, morphology, gene 
and protein expression (Scale bar = 100 µm).  
Source: Hitscherich, P. & Lee, E.J. in Tissue Engineering for Artificial Organs Vol. 2  (ed Anwarul 
Hasan)  (2017). 
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Differentiation protocols for ESC and iPSC have included the formation of 
embryoid bodies via hanging drops for mouse derived cells as well as microwell 
centrifugation or micropatterning for human derived cells 68-71. Monolayer culture with 
treatment of activin A and BMP4, treatment with ECM proteins or even co-culture with 
other cell types, such as END-2 or OP9 cells have been shown to generate differentiated 
cardiomyocytes from ESC and iPSC 72-75. Animal models have demonstrated great 
success in ESC and iPSC-derived cardiomyocytes survival and integration into host 
tissues, including in nonhuman primates, where ESC-derived cardiomyocytes were 
shown to not only integrate, but also electrically couple with the host tissue 72,76-84. 
However, pluripotent stem cell derived populations remain immature post differentiation 
displaying heterogeneous phenotype and asynchronous contraction 85.  
 Immaturity limits the clinical potential of pluripotent stem cell derived 
cardiomyocytes, as functional maturity is required for excitation-contraction coupling and 
proper host integration to reduce the risk of secondary side effects such as arrhythmia or 
even teratoma formation 56. Because of this, current clinical trials examining cell 
injection or transplantation for the replacement of lost cardiomyocytes post-MI have only 
been performed with adult autologous cell sources, most in an undifferentiated state, and 
have offered only moderate, if any, improvements due to large scale cell death as well as 
migration away from the injury site 86. Hence, a more mature pluripotent stem cell 
derived cardiomyocyte population is essential.   
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1.2.2 Biomaterials 
Structural cues are important for tissue organization and function. In the myocardium, the 
highly organized and anisotropic extracellular matrix 87 is essential for the functional 
efficiency of the heart and should be considered in cardiac tissue engineering approaches 
88.  Specifically, electrical signal propagation is enhanced along the direction of cellular 
alignment due to the formation of gap junctions. During diseased states when the native 
myocardial architecture and organization is disturbed, there is increased risk for 
arrhythmia 88.  
 One class of biomaterial of interest in cardiac tissue engineering is hydrogels. 
Hydrogels are highly tunable in their chemical, mechanical and physical properties and 
can form 3 dimensional culture environment of various shapes and sizes 89. They can be 
composed of natural proteins such as collagen or fibrin. Collagen type I is a highly 
biocompatible, biodegradable material that is present in high degree in most tissues of the 
body, including the heart 90-93. Fibrin or collagen combined with Matrigel can be 
embedded with cardiac cells to form functional cardiac tissues 90,94-98. These tissues can 
then be implanted and have caused functional improvements in rat MI models 99-101. 
Synthetic materials, such as poly(ethylene glycol) (PEG) have also been explored and 
found to foster differentiation of pluripotent stem cell derived cardiomyocytes 102,103. 
Injectable hydrogels are a newer class of materials that have immense potential for tissue 
engineering applications as they reduce the risk associated with large, invasive 
procedures 104,105. Poly(N-isopropylacrylamide) (PNIPAAM) can form an injectable 
hydrogel that has been shown to support myocardial contractility by decreasing left 
ventricular wall stress and promoting angiogenesis and cell migration 106. Cell embedded 
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injectable hydrogels have also been explored. Very recently, Hitscherich et al. examined 
the potential for self-assembling peptide hydrogels for use with ESC 107. Peptide 
hydrogels can be tailored to include specific sequences based upon the application of 
interest and exhibit thixotropic behavior by liquefying under shear stress but retaining 
shape at rest 107. Although they have been characterized for dental 108, immune 109 and 
hind-limb ischemia 110,111 applications, their potential for cardiac tissue engineering 
application remains to be seen.  
Preformed scaffolds are another method for cardiac tissue engineering 88,112,113. 
Anisotropic and aligned scaffolds can be generated using fibrous polymers, which can 
provide structural and mechanical guidance to seeded cells to form cardiac tissue in vitro. 
Common polymers used for tissue engineering applications are inherently insulative and 
may impede the propagation of electrical signals between cells, increasing the risk of 
arrhythmia 114. For electroactive tissues such as the myocardium, electroactive materials 
might better recapitulate the native myocardial environment.   
 Since native cardiomyocytes in vivo are subjected to constant electrical signals, a 
number of research groups have developed external electrical stimulation protocols to 
promote the function and differentiation of cardiomyocytes. Studies have shown 
enhanced cell-cell coupling and tissue organization as well as improved 
electrophysiological and calcium-handling properties in stem cell derived cardiomyocytes 
exposed to electrical stimulation 115,116. Piezoelectric materials such as poly (vinylidene 
fluoride-trifluoroethylene) (PVDF-TrFE) generate electrical voltage in response to even 
minute mechanical deformation allowing for electrical stimulation independent of 
external sources 117-120. These surface charge changes have been shown to affect protein 
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adsorption as well as cellular adhesion and activity 121-123. The potential for PVDF-TrFE 
in cardiovascular applications has yet to be determined. Additionally, conductive 
scaffolds have been shown to enhance cell-cell communication, organization and 
transmission of electrical potentials that result in increased cardiac marker expression, 
conduction velocity and beating frequency 114,124,125. Studies have also demonstrated 
improved differentiation and enhanced function of pluripotent stem cell derived 
cardiomyocytes on other 3D conductive scaffolds 114,126,127. 2D films and composite 
materials of graphene, a highly conductive carbon derivative, have been shown to be 
highly biocompatible with adult and pluripotent stem cells as well as primary 
cardiomyocytes 128-134. This is in contrast to concerns of cytotoxicity with some of the 
current conductive hybrid scaffolds limiting their clinical relevance 114,135-137. However, 
the functional maturity of these cells and translation of graphene into 3D tissues has yet 
to be explored.  
 
1.3 Cardiac Inflammation 
The post-MI microenvironment is very complex. Lack of oxygen and nutrients causes 
downstream hypoxia and massive amounts of cell death, igniting both an innate and 
adaptive immune response. Inflammation plays a crucial role in the pathogenesis of MI 
injury and considered to be instrumental in determining whether healing will be 
constructive or maladaptive 14,138,139.  
Following MI, macrophages are among the key cells activated during the initial 
phases of the host response and mediate inflammation 14,140.  Pro-inflammatory or 
classically activated M1 phenotype macrophages are initially responsible for removing 
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necrotic cardiomyocytes and fibroblasts along with apoptotic neutrophils that have 
responded before them 141. As healing continues, polarization shifts toward the anti-
inflammatory or alternatively activated M2 phenotype 142. It remains unknown what 
mechanism underlies the polarization shift, but the resolution of inflammation is critical 
to healing. In fact, a prolonged inflammatory response is associated with dysfunctional 
matrix deposition, scar formation and heightened cardiomyocytes apoptosis 14.  
Despite their critical role in the healing process post-MI, specific interaction 
between macrophages and surviving resident cardiomyocytes is not known. Additionally, 
how the inflammatory microenvironment post-MI could affect potential cellular based 
therapies is also unknown. In recent studies, survival and apoptosis of murine embryonic 
and adult cardiomyocytes was explored in co-culture with isolated murine macrophages. 
Cells were examined under normoxic and hypoxic conditions for up to 24 hours to 
explore the role of CB2 receptor in inflammation after MI 143. In addition, Trial et al. 
examined the effect of macrophages activated by fibronectin fragments on the survival of 
primary rat cardiomyocytes and demonstrated that stimulated macrophages protect 
cardiomyocytes from apoptosis 144. The most recent study by Ai et al. utilized 
microfluidic channels to co-culture macrophages with H9c2 myoblasts for up to 3 days 
145. Macrophages polarized by lipopolysaccharides (LPS) into a pro-inflammatory 
phenotype promoted myocyte apoptosis through mitochondrial damage. These studies are 
limited however, as none of them examined any phenotypic or functional measures to 
evaluate the effect of macrophage co-culture. Since in vivo exploration is too complex to 
tease out direct cellular interactions, a controlled in vitro model examining macrophage 
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phenotype specific effects on cardiomyocyte function would aid in the understanding of 
the post-MI microenvironment.  
  
1.4 Significance and Aims 
This dissertation aims to develop fully functional engineered cardiac tissues as well as to 
better understand the environmental niche for efficient therapy for cardiac regeneration. 
This is achieved through developing in vitro models of healthy cardiac tissue and 
diseased condition following these specific aims: 
• Aim 1: To explore the potential of electroactive scaffolds for the generation of in 
vitro cardiac tissue 
 
• Aim 2: To develop an in vitro myocardial inflammation model for a better 
understanding of the post-MI microenvironment 
 
In Chapter 2 the potential of a piezoelectric biomaterial to form in vitro 
cardiovascular tissues is investigated 146. Cardiomyocytes are electroactive cells 147 and 
electrical stimulation has been considered to promote differentiation and functional 
maturity of cardiomyocytes in vitro. Since piezoelectric materials generate electrical 
charge in response to mechanical deformation, this feature is especially attractive for 
cardiac cells that contract. The cytocompatibility and function of mouse embryonic stem 
cell-derived cardiomyocytes and endothelial cells are investigated.  
In Chapter 3 the benefits and limitation of a conductive, graphene containing 
biomaterials for the generation of in vitro cardiac tissues is explored 148. Highly 
conductive materials are especially attractive for cardiac applications, as cardiomyocytes 
exist in an electrically and mechanically dynamic microenvironment in the heart. In fact, 
the electro-conductive networks within the myocardium control the contractile behavior 
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of cardiac cells. Other conductive materials such as carbon nanotubes have shown 
promise in the promotion of pluripotent stem cell-derived cardiomyocyte maturation. 
However, their application is limited due to problems with biocompatibility. Hence, the 
creation of a highly biocompatible scaffold material with conductive networks for the 
creation of functional cardiac tissues is examined. 
What is currently lacking and poorly understood are the implications of the highly 
complex inflammatory response that occurs after myocardial infarction. No existing 
models investigate the effects of myocardial inflammation on the function of 
cardiomyocytes. How specific interaction between cardiomyocytes and activated 
inflammatory cells, such as macrophages, affect myocardial function is also unknown. 
In Chapter 4, two myocardial inflammation models are created to examine the 
interactions between cardiomyocytes and different polarized macrophage subpopulations. 
This chapter describes specifically how macrophages affect mouse embryonic stem cell-
derived cardiomyocyte calcium-handling function. It is important to understand how 
polarized macrophages affect cardiomyocyte function in order to determine potential 
therapeutic targets for the improvement of cell-based therapies and post-MI cardiac 
function.  
Chapter 5 includes a summary of the studies with discussion on limitations and 
future directions for the generation of functional in vitro cardiac tissues and myocardial 
inflammation models.  
Together, the work in this dissertation contributes to the current knowledge in 
cardiac regenerative medicine by demonstrating the potential of two electroactive 
biomaterials for the formation of functional cardiac tissues and by illuminating a novel 
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target involved in cardiomyocytes calcium (Ca2+) homeostasis during post-MI healing 
through an in vitro engineered disease model.  
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CHAPTER 2 
PIEZOELECTRIC SCAFFOLD FOR CARDIAC TISSUE ENGINEERING 
 
2.1 Introduction 
Cardiovascular disease (CVD) remains one of the leading causes of death and disability 
in the western world 149. Since the myocardium has a limited ability to regenerate after 
injury, cardiac tissue engineering has emerged as a promising approach to repair or 
replace damaged tissue in the heart. Several groups have explored various types of 
biomaterials including hydrogels 95,150, fibrous scaffolds 151,152 and cell-mediated 
biomaterials 153,154 to construct three-dimensional (3D) cardiac tissues. In addition, 
different cell sources have been explored for cardiac tissue engineering including 
pluripotent stem cells, with infinite proliferative capacity and the ability to differentiate 
into cardiac cells. Studies have demonstrated differentiation of human embryonic and 
induced pluripotent stem cells into cardiomyocytes 56,74,155 and the differentiation 
methods have been extensively reviewed elsewhere 71. However, one of the remaining 
challenges with pluripotent stem cell derived cardiomyocytes is their immature 
phenotype post differentiation 85.  
Native cardiomyocytes undergo continuous mechanical stretching and electrical 
signaling in vivo. As cardiomyocytes are electroactive cells 147, electrical stimulation has 
been considered to promote differentiation and functional maturity of cardiomyocytes in 
vitro. Radisic et al. demonstrated enhanced excitation-contraction coupling and 
ultrastructural organization in electrically stimulated neonatal ventricular myocytes 116. 
Another study demonstrated that electrical stimulation promoted mature 
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electrophysiological and calcium-handling properties for both human embryonic and 
induced pluripotent stem cell derived cardiomyocytes 115. Enhanced ultrastructural 
organization and alignment as well as decreased expression of fetal cardiac genes, such as 
α-myosin heavy chain and atrial natriuretic peptide have been demonstrated.  
In addition to external electrical stimulation, electrical stimulation through the use 
of piezoelectric material may be beneficial in inducing functional improvements of 
cardiomyocytes. Recently, poly (vinylidene) fluoride (PVDF) and its copolymer poly 
(vinylidene fluoride-trifluoroethylene) (PVDF-TrFE), both exhibiting piezoelectric 
characteristics, have been explored as potential scaffold materials for tissue engineering 
applications. Piezoelectric scaffolds possess the intrinsic property of producing an 
electrical voltage in response to mechanical deformation without the need for external 
power sources or electrodes 117-120. While the feasibility of PVDF-TrFE scaffolds for 
bone and neural cell studies have recently been demonstrated, the effect of PVDF-TrFE 
scaffolds on cardiovascular cells has not yet been explored. Thus, this study describes the 
viability, phenotype, and function of both mouse embryonic stem (mES) cell derived 
cardiomyocytes (mES-CM) and endothelial cells (mES-EC) on PVDF-TrFE scaffolds to 
determine the feasibility of PVDF-TrFE scaffolds for cardiovascular tissue engineering 
applications.  
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2.2 Methods 
 
2.2.1   Mouse Embryonic Stem (mES) Cell Culture and Differentiation 
A stable cardiac troponinT-eGFP mES cell line (generous gift from Dr. Yibing Qyang at 
Yale University) was used. MES cells were cultured on a mouse embryonic fibroblast 
(Global Stem, MD) feeder layer for 2 days in a DMEM medium supplemented with 15% 
knockout serum replacement, 1% NEAA, sodium-pyruvate, penicillin/streptomycin 
(Gibco, NY), 2-mercaptoethanol (Sigma Aldrich, MO) and leukemia inhibiting factor 
(LIF, 5ng/mL). To differentiate mES cells into cardiomyocytes, mES cells were 
transferred to and cultured in a feeder-free condition with IMDM medium supplemented 
with 15% knockout serum replacement, 1% penicillin/streptomycin (GIBCO, NY),  
Figure 2.1 Schematic of mES-CM differentiation via hanging drop method. 
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Thioglycerol (Sigma Aldrich, MO) and LIF (5ng/mL) for 2 days. Embryoid bodies (EBs) 
were then formed by a hanging drop method, as described previously 68. After 2 days, 
EBs were collected in a differentiation medium containing IMDM medium supplemented 
with 15% fetal bovine serum, L-glutamine (GIBCO, NY), ascorbic acid and thioglycerol 
(Sigma Aldrich, MO) and cultured for 8-9 additional days. Spontaneously contracting 
and GFP positive cells were yielded starting as early as differentiation day 6-7. MES-CM 
were purified on day 10-11 of differentiation using a discontinuous Percoll (GE 
Healthcare) separation technique 57,156,157. Purity of mES-CM was assessed by fluorescent 
imaging by counting the number of GFP positive cells to the total number of cells post-
purification. A schematic of mES-CM differentiation can be seen in Figure 2.1. 
 
2.2.2   Endothelial Cell Culture 
Endothelial cells (EC) were derived from mES cells as previously described 158. MES-
ECs were cultured in MCDB complete endothelial growth medium containing 10% FBS, 
1% penicillin-streptomycin and Endogro (VEC Technologies, NY) in 0.1% gelatin 
(Sigma Aldrich, MO) coated flasks. Fresh culture medium was exchanged every 2 days. 
MES-ECs were passaged when they reached 80% confluency using 0.25% trypsin-EDTA 
(Gibco, NY). MES-ECs of passage 6 to 11 were used in this study.  
 
2.2.3   Fabrication and Characterization of PVDF-TrFE Scaffolds 
Electrospun PVDF-TrFE scaffolds having aligned fibers were fabricated and 
characterized as previously described 119,159. Briefly, PVDF-TrFE (65/35) (Solvay 
Solexis, Inc.) was dissolved in methyl ethyl ketone and electrospun using a fast rotating 
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drum to collect aligned fibers. Scaffolds were annealed via heating at 135°C for 96 hours 
followed by cooling in ice water. The annealed and aligned PVDF-TrFE scaffolds 
exhibited an elastic modulus of 359.77±143.26 MPa and an ultimate tensile strength of 
21.42±9.62 MPa along the fiber axis 119. The average fiber diameter of 575±139 nm and 
the average fiber alignments of 89%±10% were obtained by analyzing scanning electron 
micrographs using ImageJ, as previously described 159. For fiber alignment, a line was 
drawn perpendicular to the major axis of fibers and angular difference among the fibers 
was calculated. The average alignment was calculated by using the following equation: 
 
                                            Alignment = (!"°!!"#$%!& !"##$%$&'$)!"°  (2.1) 
 
2.2.4   Cell Seeding onto Scaffolds 
Scaffolds of 0.5 cm x 0.5 cm (Figure 2.2A) with thickness ranging from 0.1 to 0.25 mm 
thickness were UV sterilized followed by preconditioning in 20% FBS containing culture 
medium overnight. Scaffolds were then left to dry for 30 minutes prior to cell seeding. 
MES-CM or mES-EC were seeded onto pre-treated scaffolds at a density of 8x106 
cells/cm2 and were left to attach for 2.5 hours before additional culture medium was 
added. MES-CM seeded scaffolds were cultured in the differentiation medium as 
described above, and mES-EC were cultured in MCDB complete medium for 6 days 
prior to characterization. Both cell types on 2D culture dishes served as controls.  
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2.2.5   Cell Viability 
A LIVE/DEAD Viability/Cytotoxicity kit (Life Technologies, NY) was used to 
determine viability of cells on scaffolds after 3 and 6 days of culture. Briefly, scaffolds 
were rinsed with warm PBS and then stained with 0.2 M ethidium homodimer and 0.005 
M calcein for 30 minutes at 37 °C. Immunofluorescent images were obtained using a  
confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, NJ) and the ratio of 
live/dead cells to the total number of cells was analyzed using ImageJ software. 
 
2.2.6   Immunofluorescence Imaging 
The use of a stable cardiac troponinT-eGFP mES cell line allowed examination of cardiac 
troponin T expression by mES-CM during culture. GFP expression of mES-CM was 
Figure 2.2 (A) Macroscopic image of PVDF-TrFE scaffold used for cell seeding, 
Scale bar = 1 mm/tick mark.  (B) Scanning electron microscope image of a PVDF-
TrFE scaffold with aligned fibers. Arrows indicate principle fiber axis. 
Source: Hitscherich, P. et al. The Effect of PVDF-TrFE Scaffolds on Stem Cell Derived Cardiovascular 
Cells. Biotechnol. Bioeng. 113, 1577-85, (2016). 	
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visualized using a confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, 
NJ).  
 
2.2.7   F-actin Imaging 
For the visualization of sarcomeres, samples including mES-CM seeded scaffolds and 2D 
control cells were fixed overnight using 4% formaldehyde (Sigma Aldrich, MO) after 6 
days of culture.  Samples were stained for F-actin using Rhodamine-conjugated 
phalloidin (1:20, Life Technologies, NY) for 2 hours at room temperature and were 
counter-stained with DAPI to visualize nuclei.  
 
2.2.8   Low Density Lipoprotein Assay 
To determine the phenotype of mES-EC on the scaffolds, low-density lipoprotein (LDL, 
Alfa Aesar, MA) uptake was performed. Scaffolds were incubated with a 1:10 dilution of 
LDL to culture medium for 4 hours at 37 °C and 5% CO2 and then washed twice with 
culture medium before imaging with a confocal fluorescence microscope (IX81 DSU, 
Olympus, Somerset, NJ).  
 
2.2.9   Western Blot Analysis 
After 6 days of culture, cell lysates of scaffolds and controls were prepared using a lysis 
buffer containing RIPA buffer, 1% Triton X100 (Boston BioProducts, MA) and 1% 
protease inhibitor (Sigma Aldrich, MO). Samples were then diluted 1:1 in Laemmli SDS 
buffer (Bio-rad, CA) with 5% 2-mercaptoethanol (Sigma Aldrich, MO). Primary 
antibodies used for mES-CM samples were mouse anti-cardiac troponin T (cTnT, 1:1000, 
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Abcam, MA), rabbit anti-connexin43 (Cx43, 1:3000, Abcam, MA) and mouse anti-heavy 
chain cardiac myosin (MHC, 1:1000, Abcam, MA). Primary antibodies used for mES-EC 
samples were rabbit anti-endothelial nitric oxide synthase (eNOS, 1:200, Santa Cruz 
Biotechnology, TX), rabbit anti-ephrin type B receptor 4 (EphB4, 1:500, Santa Cruz 
Biotechnology, TX), mouse anti-thrombomodulin (TM, 1:500, Abcam, MA), rabbit anti-
Notch1 (1:500, Santa Cruz Biotechnology, TX) and rabbit anti-platelet endothelial cell 
adhesion molecule (PECAM1, 1:200, Santa Cruz Biotechnology, TX). Mouse anti-β-
actin (1:2000, Sigma Aldrich, MO) was used as a loading control. Secondary antibodies 
used were goat anti-rabbit (1:2000, Santa Cruz Biotechnology, TX) and goat anti-mouse 
(1:2000, Santa Cruz Biotechnology, TX). Fresh fetal rat heart homogenates, mES cell 
lysates and 2D plated mES-CM lysates served as controls for mES-CM samples. Rat 
aortic endothelial cell (RAEC) lysate, mES cell lysate and 2D cultured mES-EC lysates 
served as controls for mES-EC samples. For quantitative analysis, protein bands were 
normalized to the loading control, β-actin, and analyzed using densitometry  (ImageJ). 
 
2.2.10   Evaluation of Calcium-Handling 
After 6 days of culture, 2D mES-CM and scaffold samples were digested to a single cell 
suspension via collagenase (0.1 g/mL, Roche, NJ) and accutase (GIBCO, NY) treatment 
for single cell calcium-handling analysis. Digested cells were reseeded onto collagen-
coated (50 µg/mL collagen, BD Biosciences, CA) glass bottom dishes overnight. 
Intracellular Ca2+ transients were examined as previously described 160,161. Briefly, 
samples were incubated at room temperature with Rhod-2AM (4 µM) for 30 minutes, 
followed by a 20 minutes washout (for AM cleavage) in normal Tyrode’s solution. 
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Samples were then placed in a heated chamber (35˚C) with a fluorescent inverted 
microscope (Nikon Eclipse TE200) with an Andor Ixon Charge-Coupled device (CCD) 
camera (Andor Technology, at 50 frames/s, 512 x 180 pixels). The intensity of 
fluorescence from spontaneously contracting cells was recorded and normalized to the 
basal diastolic fluorescence levels. Cells were electrically stimulated to examine their 
response to electrical pacing at 0.5, 1 and 2 Hz frequencies (4.5 ms duration, 150 V, 
Grass S48 Stimulator, Grass Medical Instruments, West Warwick, RI). In addition, cells 
were treated with 10 mM caffeine, a ryanodine receptor agonist, to investigate 
sarcoplasmic reticulum Ca2+ content and fractional Ca2+ release. Cell response to β-
adrenergic stimulation was also examined with the treatment of 1µM isoproterenol. 
 
2.2.11   Statistical Analysis 
Results are presented as mean ± SEM. Statistical analysis of cell viability and beating 
frequency was performed with an independent-samples t-test. Statistical analysis of 
protein expression of mES-CM and mES-EC as well as functional properties of mES-CM 
in 2D and on PVDF-TrFE scaffolds were analyzed via independent-samples t-test, or the 
nonparametric alternative, Mann-Whitney U Test. Statistical significance was accepted 
for p<0.05. 
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2.3 Results 
2.3.1   Characterization of mES-CM in 2D 
Through a previously described method 68, mES-CM were successfully derived from 
mES cells. Spontaneously contracting cells were yielded as early as 6 days into the 
differentiation process. Since a stable mES cTnT-eGFP cell line was used, differentiated 
cardiomyocytes expressing cTnT gene exhibited extensive GFP expression (Figure 
2.3A). Higher expression of GFP was observed with more days in culture. The average 
beating frequency of purified mES-CM was 1.14 ± 0.12 Hz on day 6 of culture. Figure 
2.3B demonstrates that mES-CM exhibit well-registered sarcomeres as shown by F-actin 
staining. Moreover, they express classical cardiac specific markers such as MHC, cTnT, 
and gap junction protein Cx43 as demonstrated by western blot analysis (Figure 2.3C). 
As expected, there was a significant increase in the expression of both cTnT and MHC in 
mES-CM compared to mES (p < 0.05). Cx43 expression was not significantly different, 
as mES cells are known to express Cx43 in their undifferentiated state as well 162. 
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Figure 2.3 (A) Expression of cTnT-eGFP by mES-CM in 2D culture, Scale bar=20 
µm. (B) Well-registered sarcomeres were demonstrated in mES-CM in 2D culture. F-
actin in red and DAPI stained nuclei in blue, Scale bar=10 µm. (C) Quantitative 
analysis of protein expression of Cx43, MHC and cTnT by mES and mES-CM 
cultured in 2D. MES-CM expressed significantly higher amounts of cTnT and MHC 
(p<0.05), however similar Cx43 expression was shown, n=4, mean± SEM. (D) MES-
CM response to exogenous electrical pacing at 0.5, 1 and 2 Hz, respectively.  
Source: Hitscherich, P. et al. The Effect of PVDF-TrFE Scaffolds on Stem Cell Derived Cardiovascular 
Cells. Biotechnol. Bioeng. 113, 1577-85, (2016). 	
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To examine contractile and electrophysiological performance of mES-CM, 
intracellular Ca2+ transients were measured from single cells. The digestion of 2D 
cultured mES-CM was necessary to provide consistent treatment as the cells cultured on 
the scaffolds. Digested cells adhered well and initiated spontaneous contraction within 24 
hours. MES-CM also responded to external electrical pacing at varying frequencies such 
as 0.5, 1 and 2 Hz frequencies (Figure 2.3D).  
 
2.3.2   Characterization of mES-CM on PVDF-TrFE Scaffolds 
Purified mES-CM were seeded onto PVDF-TrFE scaffolds at a density of 8 x 106 cells 
per cm2 to achieve complete and consistent coverage of cells on the scaffolds. Cells 
required a minimum of 2 hours to attach to preconditioned scaffolds. Within 24-48 hours 
post seeding, cells were not only fully adhered, but also initiated spontaneous contraction. 
Live/dead assay revealed that most of the cells remain viable on the scaffolds exhibiting 
99.90 % viability on day 3 (Figure 2.4A) and 99.70 % viability on day 6 with no 
significant changes. MES-CM became highly aligned in the direction of the fiber 
alignment and GFP expression was evident throughout the culture period, as shown in 
Figure 2.4B. Strong expression of GFP indicates high expression of cTnT by mES-CM. 
Cells exhibited spontaneous contractions after 3-4 days of culture resulting in 
synchronous contraction of entire scaffolds, which can be detected under the microscope. 
Beating frequency of mES-CM on scaffolds was approximately 1.49 ± 0.19 Hz, which 
was similar to that of 2D cultured mES-CM after 6 days of culture. Confocal fluorescent 
microscopy of mES-CM seeded scaffolds revealed a homogeneous distribution of highly 
aligned mES-CM with well-developed myofilaments having registered sarcomeres 
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Figure 2.4 Characterization of mES-CM on annealed and aligned PVDF-TrFE scaffolds. (A) Over 99.9% cell viability was 
evident on day 3 of culture. Live cells stained green with calcein and dead cells stained red with ethidium homodimer, Scale 
bar=50 µm. (B) Strong cTnT-eGFP expression is shown on day 6, Scale bar=20 µm. (C) Immunofluorescent analysis revealed 
highly aligned actin filaments with well-registered sarcomeres. F-actin in red and DAPI stained nuclei in blue, Scale bar=10 
µm. (D) Quantitative analysis of protein expression of Cx43, MHC and cTnT in mES-CM cultured on PVDF-TrFE scaffolds 
(n=4,) compared to mES-CM cultured in 2D (n=10), mean ± SEM. No significant difference was found among groups. Arrows 
indicate principle fiber axis.  
Source: Hitscherich, P. et al. The Effect of PVDF-TrFE Scaffolds on Stem Cell Derived Cardiovascular Cells. Biotechnol. Bioeng. 113, 1577-85, (2016). 	
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(Figure 2.4C). MES-CM on scaffolds also expressed cardiac specific markers such as 
cTnT, MHC and Cx43. No statistical difference was found in the MHC and cTnT 
expression, but expression by mES-CM cultured on PVDF-TrFE scaffolds appeared 
higher than in 2D, while Cx43 expression was significantly higher in mES-CM cultured 
in 2D (Figure 2.4D, p<0.05).  
To compare the contractile and electrophysiological performance of mES-CM seeded 
on PVDF-TrFE scaffolds with mES-CM cultured in 2D, intracellular Ca2+ transients were 
measured on digested single cells. Digested cells adhered well to collagen-coated dishes 
and spontaneously contracted within 24 hours. The amplitude and morphology/duration of 
the Ca2+ transients, fractional Ca2+ release, and response to β-adrenergic stimulation using 1 
µM isoproterenol were compared with 2D mES-CM. MES-CM cultured on scaffolds 
responded to pacing at 0.5, 1 and 2 Hz frequencies, similar to mES-CM cultured in 2D. 
The average Ca2+ transient amplitude, which indicates the amount of Ca2+ release and 
uptake within the cytoplasm, trended higher than mES-CM cultured in 2D (0.20 ± 0.01 
vs. 0.29 ± 0.05). The average time to 50% of that peak amplitude (T50) for mES-CM 
cultured on PVDF-TrFE scaffolds was significantly longer (p<0.05) than that of mES-
CM cultured in 2D (143.17 ± 21.67 ms vs. 220.30 ± 39.19 ms). To assess the functional 
capacity of the sarcoplasmic reticulum (SR), 10 mM caffeine was added to the cells. 
Treatment with caffeine resulted in complete Ca2+ release from the SR, indicating 
functional SR calcium-handling properties and ryanodine receptor (RyRs) function, as 
shown in Figure 2.5A and 4B. The average amplitude and T50 of caffeine-induced Ca2+ 
release was 0.84 ± 0.07 and 1819.03 ± 427.85 ms, respectively for mES-CM cultured in 
2D.  
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Figure 2.5 (A, B) Representative traces demonstrating Ca2+ transients and caffeine-induced SR Ca2+ release of 
mES-CM cultured in 2D and on PVDF-TrFE scaffolds, respectively. The Ca2+ transients were induced by electrical 
field stimulation at 0.5 Hz. (C) Comparison of fractional release of mES-CM cultured in 2D (n=20) vs. on PVDF-
TrFE scaffolds (n=10). No significant difference was found between culture conditions. (D, E) Representative traces 
demonstrating the effect of β-adrenergic stimulation via treatment with isoproterenol on spontaneous Ca2+ transients. 
(F) Comparison of spontaneous frequency increase associated with β-adrenergic stimulation of mES-CM cultured in 
2D (n=5) vs. on PVDF-TrFE scaffolds (n=4), mean± SEM. 
Source: Hitscherich, P. et al. The Effect of PVDF-TrFE Scaffolds on Stem Cell Derived Cardiovascular Cells. Biotechnol. Bioeng. 113, 
1577-85, (2016). 	
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Similar results were seen for mES-CM cultured on PVDF-TrFE scaffolds, having an 
amplitude of 1.02 ± 0.15 and T50 of 1141.99 ± 261.83 ms. The average fractional release, 
which demonstrates the amount of Ca2+ released per transient versus total Ca2+ content 
trended higher in mES-CM cultured on scaffolds than mES-CM in 2D (26.34 ± 2.27% vs. 
29.47 ± 4.89%), as seen in Figure 2.5C. Moreover, the addition of 1 µM of isoproterenol, 
a β-adrenergic agonist, led to increased amplitude and frequency of Ca2+ transients by 
both mES-CM in 2D culture (Figure 2.5D) and on scaffolds (Figure 2.5E). The frequency 
was increased by approximately 42% and 88% for mES-CM cultured in 2D and on 
scaffolds, respectively (Figure 2.5F), indicating that mES-CM respond to β-adrenergic 
stimulation. 
 
2.3.3   Characterization of mES-EC on PVDF-TrFE Scaffolds 
To assess the biocompatibility of PVDF-TrFE scaffolds with vascular cells, mES-EC 
were seeded at the same density as mES-CM. Cells adhered well to preconditioned 
scaffolds within the first 2 hours of seeding and remained highly viable for 6 days as 
shown with viability assay (Figure 2.6A). No significant decrease in the number of viable 
cells were observed on day 6 compared to day 3 as samples from both days exhibited 
over 99.9 % viability. MES-EC cultured on scaffolds demonstrated an uptake of LDL, an 
indicator of mature mES-EC phenotype (Figure 2.6B). In addition, western blotting 
densitometry analysis showed high expression of endothelial cell markers including 
PECAM1, eNOS, and Notch1, similar to that of mES-EC cultured in 2D, further 
confirming the maintenance of EC phenotype on the PVDF-TrFE scaffolds (Figure 
2.6C). 
	31	
 
 
Figure 2.6 (A) Live/dead staining of mES-EC on PVDF-TrFE showing over 99.9% 
viability after day 3. Live cells stained green with calcein and dead stained red with 
ethidium homodimer, Scale bar=50 µm (B) LDL uptake by mES-EC cultured on 
PVDF-TrFE scaffolds shown in red after 6 days in culture, Scale bar=50 µm (C) 
Quantitative analysis of protein expression of eNOS, EphB4, Notch-1, PECAM-1 and 
TM in mES-EC cultured in 2D or on PVDF-TrFE scaffolds. No significant difference 
was found between groups, n=3 for EphB4, all other groups n=4.  Arrows indicate 
principle fiber axis.  
Source: Hitscherich, P. et al. The Effect of PVDF-TrFE Scaffolds on Stem Cell Derived Cardiovascular 
Cells. Biotechnol. Bioeng. 113, 1577-85, (2016). 
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2.4 Discussion 
This study describes the structural and functional properties of cardiovascular cells 
derived from mouse embryonic stem cells on PVDF-TrFE scaffolds. Electroactive, 
piezoelectric scaffolds have the intrinsic property of producing an electrical voltage in 
response to a mechanical deformation without the need for external power sources or 
electrodes 117. Since cardiomyocytes exist in an electrically and mechanically dynamic 
and complex microenvironment in the heart and the contractile behavior of cardiac cells 
is controlled by the electro-conductive networks within the cardiac tissue 163, the unique 
features of electroactive materials are especially attractive for cardiovascular tissue 
engineering applications. In addition, the piezoelectric properties of the scaffold that 
results in changes in surface charge have the potential to affect protein adsorption, 
cellular adhesion and cellular activity 121-123, which may affect differentiation of stem cell 
derived cardiovascular cells. 
 In this study, a mouse embryonic stem cell line was characterized in a peptide 
hydrogel to demonstrate its potential to differentiate into all 3 germ layers. Specifically, 
cardiomyocytes and vascular endothelial cells derived from mouse embryonic stem cells 
were cultured on PVDF-TrFE scaffold for the first time. MES-CM were successfully 
derived using a differentiation protocol which does not require any supplemental growth 
factors added to the culture, but yet yields a high differentiation efficacy 68. Moreover, 
our cardiac troponinT-eGFP mES cells allow us to sort GFP+ cardiomyocytes expressing 
cardiac troponin T and thereby give us an advantage of obtaining a high-purity 
cardiomyocyte population. MES-EC were also successfully derived as described in our 
previous study 158.  
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Our results show that PVDF-TrFE scaffolds support the attachment and survival 
of both cardiovascular cell types. Both mES-CM and mES-EC adhered well to the 
scaffolds with negligible numbers of apoptotic cells during 6 days of culture, without 
requiring additional surface coating.  MES-CM spread and aligned along with the fibers 
resulting in a highly aligned cardiac tissue. PVDF-TrFE scaffold also support the 
contractile behavior of mES-CM as cells initiate spontaneous contraction as early as 24 
hours post-seeding and becomes more evident with longer cultures. MES-CM on PVDF-
TrFE exhibited well-registered sarcomeres demonstrating the presences of a functional 
contractile unit.  The average beating frequency of mES-CM in 2D culture and on PVDF-
TrFE scaffolds is similar to that of previous studies using mES-CM 164,165 as well as 
human iPSC-derived cardiomyocytes 166. Moreover, cells on the scaffolds showed 
increased expression of both cTnT and MHC compared to that of 2D cultured mES-CM, 
although they were not statistically different. The expression of sarcomeric proteins such 
as cTnT and MHC provides basic assessment of contractile function of mES-CM. MES-
CM also express the gap junction protein Cx43 on PVDV-TrFE scaffolds, indicating 
communication between adjacent cells for proper propagation of electrical signals within 
the tissue 167. Since it has previously been reported that long term in vitro culture is 
required to obtain fully matured stem cell-derived cardiomyocytes 168, it is plausible that 
longer term culture may be required to see the changes in the expression of proteins in 
our samples.  
To further characterize the function, calcium-handling properties of mES-CM 
were examined. Functional handling of Ca2+ is one of the most widely characterized 
parameters in stem cell-derived cardiomyocytes, which is necessary for cardiomyocytes 
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excitation contraction coupling and integration into host tissue 169,170. A common method 
of obtaining calcium-handling properties is through a single cell analysis, which requires 
digestion of intact tissues into single cell preparation. To maintain the consistency 
between samples, both mES-CM in 2D culture and mES-CM on scaffolds were digested 
and re-seeded onto glass bottom dishes for analysis. MES-CM in both 2D and on 
scaffolds exhibited similar Ca2+ transient morphology and amplitude. However, transient 
duration, as expressed by T50, was significantly longer for mES-CM cultured on scaffolds 
compared to mES-CM cultured in 2D. It is possible that culture on PVDF-TrFE scaffolds 
increases phospholamban production by mES-CM, which would inhibit SERCA and 
slow the reuptake of free Ca2+ ions as shown in canine skeletal muscle with constant low 
frequency stimulation 171. In addition, caffeine-induced Ca2+ release by mES-CM 
suggests that these cells have functional SR release through the RyRs, which is essential 
for normal Ca2+-induced Ca2+ release and excitation contraction coupling 169,172. The 
trend of increasing fractional Ca2+ release, demonstrated by mES-CM cultured on 
scaffolds compared to mES-CM cultured in 2D suggests that a longer culture period on 
PVDF-TrFE scaffolds may promote fractional Ca2+ release that is similar to native 
cardiomyocytes. It is shown that the physiological fractional Ca2+ release of adult left 
ventricular rat cardiomyocytes is between 60-70% 173. The increase in spontaneous 
contraction frequency in both mES-CM cultured in 2D and on PVDF-TrFE, with the 
treatment of isoproterenol, also suggests that these cells exhibit positive chronotropic 
responses to β-adrenergic stimulation, which is a hallmark of adult cardiomyocytes 58,98.  
 Similar to mES-CM, mES-EC remained highly viable and expressed classical 
endothelial makers such as eNOS, PECAM1 and TM on scaffolds. This demonstrates that 
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the PVDF-TrFE scaffolds support and maintain the phenotype of endothelial cells, which 
is known to be often altered in in vitro cultures 174. Interestingly, mES-EC on scaffolds 
trended higher expression of Notch1, a common arterial marker, compared to 2D culture, 
suggesting that culture on PVDF-TrFE may also support arterial specialization 175. Since 
Notch1 and Notch signaling are important for functional vascular development and 
vascular integrity, this increase in expression may potentially aid in the development of 
neovascularization. Further studies however are needed to examine the effects of Notch1 
on endothelial cell differentiations as well as the signaling mechanisms involved with 
angiogenesis 176. Moreover, mES-EC cultured on scaffolds retaining their ability to 
uptake LDL, a known characteristic of mature endothelial cells, further confirms the 
compatibility of PVDF-TrFE scaffold for vascular endothelial cell culture.  
Given the increasing interest in electroactive materials for tissue engineering, 
piezoelectric PVDF-TrFE scaffolds provide a promising option for developing more 
advanced cardiovascular tissue constructs. However, they may require exogenous 
stimulation in order to achieve their full potential. Further studies of interest would be 
implantation into a mouse MI model to determine whether PVDF-TrFE fosters tissue 
integration. Scaffold would also be under constant mechanical stimulation due to the 
beating of the host heart, which could aid in further differentiation of mES-CM through 
the piezoelectric activity of the scaffold. PVDF is also a non-biodegradable material 177, 
which may be desirable for load bearing applications, but may limit its potential in soft 
tissue related applications as it increases the chances of an immune response and hence, 
different electroactive materials should also be explored.   
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CHAPTER 3 
A CONDUCTIVE SCAFFOLD FOR CARDIAC TISSUE ENGINEERING 
 
3.1 Introduction 
Various biocompatible polymers, including poly-glycerol sebacate 178,179, collagen 95, and 
poly-caprolactone (PCL) 180 have widely been explored as candidate materials for 
engineered cardiac tissues. However, their inherent insulative properties may impede 
electrical signal propagation for electro-active cell types 114.  
Conductive nanomaterials such as carbon nanotubes (CNTs) and graphene with 
unique electrical 136,181, mechanical, and thermal properties 182 have recently emerged as 
promising candidates for various biomedical applications including functional engineered 
tissue growth 183,184. The highly conductive feature of graphene and CNTs is especially 
attractive for cardiomyocyte culture since cardiomyocytes exist in an electrically and 
mechanically dynamic microenvironment in the heart where the contractile behavior of 
cardiac cells is controlled by the electro-conductive networks within the myocardium 163.  
Recent studies have demonstrated the potential of scaffolds composed of 
conductive polymers as well as conductive composite scaffolds and hydrogels with 
embedded conductive particles 114,124,125. Specifically, CNTs have been shown to increase 
spontaneous beating rate and conduction velocity of neonatal cardiac cells promoting 
their electrophysiological properties 114,126,127,185-187. However, the application of pristine 
CNTs for tissue engineering has been limited due to its cytotoxicity. In vitro studies have 
demonstrated that CNTs promote cell apoptosis through multiple mechanisms including 
mitochondrial 188,189 and lysosomal damage 190. CNTs have also been implicated in the 
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formation of reactive oxygen species indicative of oxidative stress, which can damage 
proteins and alter gene expression 191. Decreased proliferation and necrosis of various cell 
types has also been demonstrated after exposure to CNTs 192. A previous in vivo study 
performed by Yamaguchi et al. demonstrated sustained pro-inflammatory response to 
CNTs resulting in changes in liver size, shape and fibrous deposits on other internal 
organs 193. CNT exposure has been linked to blood clots and heart disease in humans as 
well 194. It is suggested that the biocompatibility of pristine CNTs may be enhanced 
through functionalization, although this would alter their unique electrical properties 
195,196.  
Another conductive material, graphene, has also been explored for cell and tissue 
application. 2D forms of graphene, such as in coated slides or films, have been explored 
for cardiomyogenic differentiation of a few cell types including human pluripotent stem 
cells 128,197 and mesenchymal stem cells 130. It is also shown that graphene particles mixed 
within embryoid bodies enhanced spontaneous cardiomyocyte differentiation 198. Sayyer 
et al. created a 3D composite scaffold (rGO-PCL) using reduced graphene oxide and 
poly(caprolactone) via precipitation techniques, demonstrating viability and proliferation 
of L929 fibroblasts and C2C12 myoblasts after 2 days of culture 131. Similarly, Murray et 
al. demonstrated attachment and proliferation of L929 fibroblasts on rGO-PCL composite 
scaffolds formed via microwave assisted polymerization 199. These fabrication 
techniques, however, do not allow for specific organization of fiber orientation.   
Here, nanofibrous scaffolds fabricated using poly(caprolactone) and graphene by 
electrospinning technique have been characterized for their feasibility and potential for 
cardiac tissue engineering application 148. Scaffolds with as little as 0.01% graphene 
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demonstrated increased volume conductivity and an even distribution of graphene 
particles.  Graphene particles provided local conductive sites within the PCL matrix, 
which enabled application of external electrical stimulation throughout the scaffold using 
a custom point stimulation device. To determine the biocompatibility and feasibility of 
graphene containing scaffolds, mouse embryonic stem cell-derived cardiomyocytes were 
used.  The viability, phenotype, and function of embryonic stem cell derived 
cardiomyocytes cultured on 3D graphene-containing scaffolds were examined. Unlike 
CNTs that exhibit cytotoxicity, graphene-containing scaffolds provided a biocompatible 
niche for stem cell-derived cardiomyocytes. Moreover, enhanced functional calcium-
handling properties of cardiomyocytes on graphene-containing scaffolds was 
demonstrated, which suggests the potential of these electroactive scaffolds as next 
generation engineered cardiac tissue for cardiac repair.  
 
3.2 Methods 
3.2.1 Scaffold Fabrication 
Poly(caprolactone) (PCL) pellets (Sigma Aldrich, St. Louis, MO) were dissolved in 
acetone solvent and stirred at 60oC until a clear solution was achieved. For composite 
scaffolds, graphene (G) particles (Cheap Tubes Inc., Cambridgeport, VT) were then 
dispersed within the PCL solution via sonication for 1hr at room temperature. 15% PCL 
scaffolds with 0.01% graphene (PCL+G) were prepared via electrospinning to achieve 
randomly oriented fibers as well as highly aligned fiber orientation (17 kV, 15 cm, 1.5 
mL/hr) as previously described 200.  
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3.2.2  Scaffold Characterization 
3.2.2.1  Scanning Electron Microscopy. The morphological characterization of 
nanofibers and visualization of graphene nanoparticles was performed using scanning 
electron microscopy (SEM). The scaffold samples were gold sputter coated for 50 s at 45 
mA (Desk V, Denton Vacuum, Moorestown, NJ) before SEM imaging (Quanta 250 FEG, 
FEI, Hillsboro, OR).  
 
3.2.2.2  Electrochemical Impedance Spectroscopy. Electrochemical impedance 
spectroscopy was used to determine the distribution of graphene particle within the PCL 
scaffold matrix containing varying concentrations of graphene (0.01 – 0.5 %).  A 10 mV 
AC field at a frequency of 100 Hz with a working distance at a constant 5 cm was applied 
to the scaffolds (eDaq, Colorado Springs, CO).  
 
3.2.2.3  Conductivity Measurements. For volume conductivity, the electrical 
volume resistivity of PCL and PCL+G (0.005 – 0.05%) scaffolds was measured using an 
electrometer (Keithley 6517B, Beaverton, OR) 201. An alternating polarity resistivity test 
was used to reduce noise due to background currents.  Conductivity was calculated as an 
inverse of resistivity.  
Local conductivity of PCL+G scaffolds of varying graphene concentrations (0.01 
and 0.5%) was measured using a custom-built point electrical stimulator. Scaffolds were 
loaded into a custom-built electrical stimulation chamber (Figure 2a).  A localized 
electrical stimulation (5 V, 1Hz, BW: 10 ms) was applied to the scaffold via a stimulating 
electrode (tungsten, A-M Systems, Carlsborg, WA). Signal propagation was recorded via 
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another tungsten electrode (A-M Systems, Carlsborg, WA), which is controlled by a 
micromanipulator (World Precision Instruments, Sarasota, FL). Specifically, points along 
the length of the scaffold in 1 mm increments were probed, first along the center line of 
the scaffold (Level 1) then 1 mm above (Level 2) and 1 mm below (Level 3) the center 
line. The voltage difference across the reference resistor, in series with the scaffold was 
recorded using an oscilloscope (Agilent Technologies, Santa Clara, CA).  
 
3.2.3 Mouse Embryonic Stem (mES) Cell Culture and Differentiation  
A stable cardiac troponinT-eGFP mES cell line (generous gift from Dr. Yibing Qyang at 
Yale University) was used. MES cells were cultured on a mouse embryonic fibroblast 
(Global Stem, MD) feeder layer for 2 days in a DMEM medium supplemented with 15% 
knockout serum replacement, 1% NEAA, sodium-pyruvate, penicillin/streptomycin 
(Gibco, NY), 2-mercaptoethanol (Sigma Aldrich, MO) and leukemia inhibiting factor 
(LIF, 5ng/mL). To differentiate mES cells into cardiomyocytes, mES cells were 
transferred to and cultured in a feeder-free condition with IMDM medium supplemented 
with 15% knockout serum replacement, 1% penicillin/streptomycin (GIBCO, NY), 1-
Thioglycerol (Sigma Aldrich, MO) and LIF (5ng/mL) for 2 days. Embryoid bodies (EBs) 
were then formed by a hanging drop method, as described previously 68. After 2 days, 
EBs were collected in a differentiation medium containing IMDM medium supplemented 
with 15% fetal bovine serum, L-glutamine (GIBCO, NY), ascorbic acid and thioglycerol 
(Sigma Aldrich, MO) and cultured for 8-9 additional days. Spontaneously contracting 
and GFP positive cells were yielded starting as early as differentiation day 6-7. MES-CM 
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were purified on day 10-11 of differentiation using a discontinuous Percoll (GE 
Healthcare) separation technique 57,156,157. 
 
3.2.4 Cell Seeding onto Scaffolds  
Scaffolds (0.5 cm x 0.5 cm) were UV sterilized followed by overnight preconditioning in 
20% FBS containing differentiation medium. Scaffolds were dried for 30 minutes prior to 
cell seeding. MES-CM were seeded onto pre-treated scaffolds at a density of 8x106 
cells/cm2 for 2.5 hours before additional culture medium was added.  PCL scaffolds 
without graphene were used as a 3D control while cells cultured on culture dishes served 
as a 2D control. MES-CM seeded scaffolds were cultured for 6 or 14 days in the 
differentiation medium for further characterization.  
 
3.2.5   Cell Viability 
A LIVE/DEAD Viability/Cytotoxicity kit (Life Technologies, NY) was used to 
determine viability of cells on scaffolds after 7 days of culture as previously described 
146.  Briefly, scaffolds were rinsed with warm PBS and then stained with 0.2 M ethidium 
homodimer and 0.005 M calcein for 30 minutes at 37 °C. Immunofluorescent images 
were obtained using a confocal fluorescence microscope (IX81 DSU, Olympus, 
Somerset, NJ) and the ratio of live/dead cells to the total number of cells was analyzed 
using ImageJ software. 
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3.2.6   Immunofluorescence Imaging 
The use of a stable cardiac troponinT-eGFP mES cell line allowed examination of cardiac 
troponin T expression by mES-CM during culture. GFP expression of mES-CM was 
visualized using a confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, 
NJ).  
 
3.2.7   F-actin Imaging 
For the visualization of sarcomeres, samples including mES-CM seeded scaffolds and 2D 
control cells were fixed overnight using 4% formaldehyde (Sigma Aldrich, MO) after 6 
days of culture.  Samples were stained for F-actin using Rhodamine-conjugated 
phalloidin (1:20, Life Technologies, NY) for 2 hours at room temperature and were 
counter-stained with DAPI to visualize nuclei.  
 
3.2.8 Western Blot Analysis 
After 6 or 14 days of culture, cell lysates from scaffolds and controls were prepared for 
western blot as previously described 146. Primary antibodies used for mES-CM samples 
were mouse anti-cardiac troponin T (cTnT, 1:1000, Abcam, Cambridge, MA, ab8295), 
rabbit anti-connexin43 (Cx43, 1:3000, Abcam, Cambridge, MA, ab11370) and mouse 
anti-heavy chain cardiac myosin (MHC, 1:1000, Abcam, Cambridge, MA, ab15). Mouse 
anti-β-actin (1:2000, Sigma Aldrich, St. Louis, MO, A1978) was used as a loading 
control. Secondary antibodies used were goat anti-rabbit (1:2000, Santa Cruz 
Biotechnology, Dallas, TX, SC-2004) and goat anti-mouse (1:2000, Santa Cruz 
Biotechnology, Dallas, TX, SC-2005).  
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3.2.9 SEM of mES-CM Seeded PCL+G Scaffolds  
MES-CM seeded PCL+G tissues were fixed in 2% glutaraldehyde (Fisher Scientific, 
Hanover Park, IL) for 24 hours, rinsed 3 times in phosphate buffered saline and 
dehydrated in varying concentrations of ethanol (Sigma Aldrich, St. Louis, MO). 
Samples were then critical point dried in a Samdri-790 (Tousimis, Rockville, MD) 
followed by sputter coating with gold palladium (Quorum 15-T, Quorum Technologies, 
Laughton, England). SEM images were taken using a Leo 1530 vp SEM (Leo Electron 
Microscopy Ltd, Cambridge, England).  
 
3.2.10 Evaluation of Calcium-Handling Properties 
After 6 days of culture, 2D mES-CM and mES-CM cultured on PCL and PCL+G 
scaffolds were digested to a single cell suspension via collagenase (0.1 g/mL, Roche, 
Nutley, NJ) and accutase (Gibco, Grand Island, NY) treatment, as previously described 
146. Digested cells were reseeded onto collagen-coated (50 µg/mL collagen, BD 
Biosciences, San Jose, CA) glass bottom dishes overnight. To examine intracellular Ca2+ 
transients, samples were incubated with Rhod-2AM (4 µM, Invitrogen, Carlsbad, CA) for 
30 minutes at room temperature, followed by a 20-minute washout (for AM cleavage) in 
normal Tyrode’s solution. Samples were then placed in a heated chamber (35˚C) 
mounted on a fluorescent inverted microscope (Nikon Eclipse TE200, Mellville, NY) 
with an Andor Ixon Charge-Coupled device (CCD) camera (50 frames/s, 512 x 180 
pixels, Andor Technology, Concord, MA) as previously described 160,161. The intensity of 
fluorescence from spontaneously contracting cells was recorded and normalized to the 
basal diastolic fluorescence levels. Cells were electrically stimulated to examine their 
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response to electrical pacing at 0.5, 1 and 2 Hz frequencies (4.5 ms duration, 150 V, 
Grass S48 Stimulator, Grass Medical Instruments, West Warwick, RI). In addition, cells 
were treated with 10 mM caffeine to investigate sarcoplasmic reticulum Ca2+ content and 
fractional Ca2+ release. Cell response to β-adrenergic stimulation was also examined with 
the treatment of 1µM isoproterenol.  
 
3.2.11 Statistical Analysis  
Results are presented as mean ± SEM or individual data points. Statistical analysis was 
performed in SPSS (Version 24, IBM) using a two-tailed independent samples t-test, one- 
way ANOVA or their nonparametric counterpart, followed by Bonferroni post hoc tests, 
where appropriate. Statistical significance was accepted for p*<0.05 for omnibus tests 
and adjusted for post-hoc tests. A sample size of at least n=5 was used for all cell studies 
to allow for statistical examination of the data.  
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Figure 3.1 (A) Impedance analysis of 15% PCL and 15% PCL+G scaffolds with 
varying concentrations of graphene demonstrated a decrease in impedance with an 
increase in graphene concentration. (B) Volume conductivity of random PCL scaffolds 
with varying concentrations of graphene from 0 – 0.05% demonstrated higher 
conductivity with higher graphene concentrations. (C) XRD analysis revealed the 
presence of graphene within PCL+G scaffolds by an additional large, sharp peak along 
with the two characteristic crystalline PCL peaks at 21.37° and 23.73. Inset showed 
the peak at 29.23° demonstrating the presence of graphitic carbon. 
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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3.3 Results 
3.3.1 Fabrication and Characterization of Graphene Nanocomposite (PCL+G) 
Scaffolds 
3D electroactive nanofibrous scaffolds were successfully fabricated by electrospinning 
graphene dispersed PCL solutions as previously described 200. Scaffolds were prepared 
either with randomly oriented fibers or highly aligned fibers with (0.005 – 0.5%) and 
without graphene. To determine the distribution of graphene nanoparticles within the 
PCL matrix, electrochemical impedance spectroscopy was performed. Results revealed 
that as the graphene concentrations increased, the impedance of the scaffold decreased, 
indicating an even distribution of graphene particles within the scaffolds (Figure 3.1A). 
Resistivity measurements confirmed that the conductivity, which is the inverse of 
resistivity, increased with increased graphene concentrations as shown in Figure 3.1B. 
Moreover, XRD analysis displayed an additional sharp peak at 29.23° in PCL+G 
compared to that of PCL scaffold representing graphitic carbon further confirming the 
presence of graphene within the scaffold (Figure 3.1C). 
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Figure 3.2 (A) Representative SEM image of aligned 15% PCL+G (0.01%) scaffold. Scale bar =10 µm. High magnification 
SEM images of 15% PCL+G scaffold (0.01% graphene) displayed (B) graphene particles within the matrix indicated by 
arrows, scale bar = 4 µm and (C) the edge of graphene particles on a fiber indicated by arrows, scale bar = 1 µm.  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue Engineering. J. Biomed. Mater. Res. A 106 2923-2933, 
(2018). 
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To further characterize the scaffolds, SEM images were used. A representative 
SEM image of aligned PCL+G scaffolds is shown in Figure 3.2A. The average scaffold 
thickness was measured at 64.88 ± 18.20 µm and 83.67 ± 25.31 µm for PCL and PCL+G 
scaffolds, respectively. The average inter-fiber spacing of PCL scaffolds (2483.60 ± 
250.72 nm) was similar to that of PCL+G scaffolds (3365.50 ± 666.51 nm). The average 
fiber diameter of random PCL and PCL+G scaffolds were 431.96 ± 85.39 nm and 694.13 
± 82.46 nm, respectively. The average inter-fiber spacing of aligned PCL and PCL+G 
scaffolds were 5408.95 ± 1004.41 nm and 2905.30 ± 784.58 nm, respectively. The 
average fiber diameter for aligned PCL (932.40 ± 104.95 nm) was similar to that of 
aligned PCL+G scaffolds (994.79 ± 66.10 nm).  Using SEM with higher magnification, 
graphene particles within the PCL matrix were visualized with the average thickness of 
graphene particles measuring 70 ± 2.64 nm (Figure 3.2B and C).  
 
3.3.2 Application of Local Electrical Stimulation  
To determine whether external electrical stimulation can be applied to PCL+G scaffolds, 
an electrical stimulation device was custom-built to provide localized, point stimulation 
(Figure 3.3A).  Unlike field stimulation, which uses the conductance of liquids to 
stimulate an entire tissue or cell sheet simultaneously, point electrical stimulation allowed 
for controlled and localized stimulation at a site of the material in contact with the 
stimulating electrode. The electrical signal is then propagated throughout the rest of the 
scaffold based upon their properties. As the stimulating electrode made contact at one 
edge of the scaffolds, a recording electrode was moved to different locations on the 
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Figure 3.3 (A) Schematic of a custom-built electrical stimulation setup. (B) Scaffold impedance decreased with an 
increased graphene concentration. Small changes in impedance were demonstrated highlighting local changes in graphene 
distribution throughout the scaffold matrix. Level 1: along the centerline of the scaffold, Level 2: 1 mm above the 
centerline and Level 3: 1 mm below the centerline of the scaffold. 
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue Engineering. J. Biomed. Mater. Res. A 106 2923-
2933, (2018). 
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scaffold and a voltage drop could be measured across the reference resistor. The voltage 
drops were then converted to a scaffold impedance value assuming constant input current 
and voltage to the circuit. Results demonstrated decreased impedance with higher 
concentrations of graphene (Figure 3.3B), consistent with the results from 
electrochemical impedance spectroscopy. Local variations in scaffolds impedance due to 
graphene particles were also demonstrated confirming that the presence of local 
conductive sites formed by graphene particles disseminate the signal throughout the 
scaffold.  
 
3.3.3 Characterization of mES-CM on Random PCL and PCL+G Scaffolds 
A purified population of cardiomyocytes derived from mouse embryonic stem cells was 
seeded onto both PCL and PCL+G scaffolds with random fiber orientation. Cells adhered 
well and spread out within the first 24 hours. SEM images further demonstrated the 
adhesion and interaction of mES-CM with graphene-decorated fibers as shown in Figure 
3.4A and 3.4B. 
 Spontaneous beating of the cells was detected as early as 48 hours after seeding 
and continued throughout the culture resulting in synchronous contraction of the scaffold, 
which can be detected macroscopically after 4-5 days of culture. Cells exhibited similar 
spontaneous beating frequency and maintained their phenotype on both PCL and PCL+G 
scaffolds as evidenced by expression of cardiac-specific cardiac troponin T (cTnT) 
visualized through cardiac troponinT-eGFP tagged cells (Figures 3.5A and 3.5B, 
respectively). The expression of cTnT continued to increase with longer time in culture as 
monitored up to 14 days. MES-CM also exhibited well-registered sarcomeres,  
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demonstrated by F-actin staining on day 6 (Figure 3.5C and 3.5D) and day 14 (Figure 
3.5E and 3.5F). Western blotting analysis confirmed the expression of cardiac specific 
markers including cTnT, myosin heavy chain (MHC) and connexin43 (Cx43) by cells on 
both scaffolds after 6 and 14 days of culture (Figure 3.6A). However, mES-CM on 
PCL+G scaffolds exhibited up-regulation of cTnT expression compared to mES-CM on 
PCL scaffolds after 2 weeks of culture. In addition, only mES-CM cultured on PCL+G 
scaffolds had a significantly lower frequency on day 14 compared to day 6 (p*<0.05, 
Figure 3.6B). 
To compare the functional behavior of mES-CM cultured on these scaffolds, 
calcium-handling properties of the cells were examined using a single cell setup. For 
single cell analysis, mES-CM were digested after 6 days and re-plated onto a glass  
bottom cell culture dish. MES-CM cultured in 2D, on PCL scaffolds and on PCL+G  
Figure 3.4 Representative SEM images of mES-CM cultured on random PCL+G 
scaffolds (A) demonstrated infiltration of the cells into the scaffold and wrapping of 
cell projections around scaffold fibers, and (B) forming close interactions with 
scaffold fibers after 14 days of culture. Scale bars = 3 µm.  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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Figure 3.5 High expression of cTnT-eGFP by mES-CM cultured on random (A) 
PCL or (B) PCL+G was seen on day 6 of culture (green, scale bars = 100 µm). F-
actin staining with rhodamin-conjugated phalloidin (red) demonstrated well-
registered sarcomeres by mES-CM cultured on random (C, E) PCL and (D, F) 
PCL+G scaffolds, respectively on day 6 and day 14. Scale bars = 10 µm.  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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scaffolds were processed using the same protocol for direct comparison among the 
groups. Digested cells not only spontaneously contracted, but also responded to electrical 
pacing at varying frequencies of 0.5 - 2 Hz, as previously reported (Figure 3.7A and 
3.7B, respectively) 146.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 (A) Western analysis revealed similar expression of MHC, cTnT, and 
Cx43 among all the groups on day 6 of culture. However, up-regulation of cTnT 
expression in mES-CM on random PCL+G scaffolds on day 14 was demonstrated.  
(B) Average beating frequency for mES-CM cultured on random PCL+G scaffolds 
trended higher than those in 2D and on PCL scaffolds on day 6. However, the 
average beating frequency was significantly lower on day 14 in mES-CM cultured 
on PCL+G scaffolds when compared to day 6 (p* = 0.045).  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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MES-CM from all the groups demonstrated a positive response to β-adrenergic 
stimulation upon treatment with 1 µM isoproterenol as shown in Figure 3.7C. Cells also 
responded to treatment with caffeine (Figure 4d), which lowers the luminal Ca2+ 
threshold for opening of the ryanodine receptor. This allowed for the quantification of the 
total Ca2+ content in the sarcoplasmic reticulum, which can be measured from the largest 
Figure 3.7 Representative traces of (A) spontaneous beating and (B) electrically 
paced beating at 0.5 Hz on PCL+G scaffolds. Representative traces of mES-CM in 
response to (C) 1 µM isoproterenol and (D) 10 mM caffeine. (E) MES-CM cultured 
on PCL+G scaffolds exhibited significantly higher fractional release (p* = 0.005) 
compared to 2D control. (F) MES-CM cultured on PCL+G scaffolds also exhibited a 
significantly shorter (p* = 0.001) caffeine induced transient T50 compared to 2D 
control. Mean denoted by −, R: random fiber orientation. 
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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peak. The initial peaks represent the amount of Ca2+ released per paced beat (Figure 
3.7D). Cells cultured on PCL+G scaffolds demonstrated significantly higher paced Ca2+ 
transient amplitude compared to that of a 2D control. The ratio of Ca2+ released per beat 
to the total sarcoplasmic reticulum stores, known as fractional release, was also 
significantly higher in cells cultured on PCL+G scaffolds compared to that of a 2D 
control (p*<0.01, Figure 3.7E). In addition, cells on PCL+G scaffolds exhibited sharper 
and narrower caffeine induced transient peaks compared to 2D controls, as demonstrated 
by significantly shorter caffeine induced T50 (p*<0.005), a representative measurement of 
transient length (Figure 3.7F).  
 
3.3.4 Characterization of mES-CM on Aligned PCL and PCL+G Scaffolds 
Similar to randomly oriented scaffolds, mES-CM adhered well and spread out within the 
first 24 hours on aligned PCL and PCL+G scaffolds. Viability of mES-CM after 7 days 
of culture was analyzed using a Live/Dead staining kit as demonstrated in Figure 3.8A. 
Cells remained mostly viable, shown in green, with a minimal number of dead cells in 
red color. MES-CM seeded onto aligned PCL and PCL+G scaffolds exhibited strong 
eGFP-cTnT expression as shown in Figures 3.8B and 3.8C, respectively. As anticipated, 
mES-CM aligned along the major fiber axis and exhibited well-registered sarcomeres 
(Figure 3.8D and 3.8E).  
Moreover, western blotting assay revealed that mES-CM cultured on PCL+G 
exhibited higher expression of MHC and cTnT compared to PCL scaffolds after 6 days of 
culture (Figure 3.9A). Cx43 expression was also greatly up-regulated on aligned 
graphene containing scaffolds compared to PCL scaffolds and the difference became 
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Figure 3.8 (A) Live/Dead analysis demonstrated high cell viability on day 7 (live: 
green, dead: red). High expression of cTnT-eGFP by mES-CM cultured on aligned 
(B) PCL or (C) PCL+G scaffolds was seen on day 6 of culture. (green, scale bars = 
100 µm). F-actin staining with Rhodamine-conjugated phalloidin (red) demonstrated 
well-registered sarcomeres that were well aligned along the major fiber axis of the 
scaffolds in aligned (D) PCL and (E) PCL+G scaffolds. Scale bars = 10 µm.  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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more evident after longer culture of 14 days. MES-CM on both PCL and PCL+G 
scaffolds spontaneously contracted nearly twice as fast as the 2D control group 
demonstrating a significant increase in spontaneous beating frequency on aligned 3D 
scaffolds vs. 2D culture (p<0.001, Figure 3.9B).  
 Functional calcium-handling properties were assessed as described previously. 
Cells cultured on aligned scaffolds, as those on randomly oriented fibers, retained their 
ability  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 (A) Increased expression of MHC, Cx43 and cTnT was demonstrated in 
mES-CM cultured on PCL+G scaffolds compared to PCL at both 6 and 14 days.  (B) 
Significantly higher average beating frequency was shown by mES-CM cultured on 
PCL and PCL+G scaffolds compared to 2D at day 6 of culture (p * <0.001, R: 
random fiber orientation, A: aligned fiber orientation).  
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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to be electrically paced and stimulated by an inotropic agent and caffeine. Total 
sarcoplasmic reticulum Ca2+ stores were similar among all groups. However, mES-CM 
cultured on aligned PCL and PCL+G scaffolds exhibited significantly higher fractional 
release compared to that of 2D controls (p<0.02, Figure 3.10A). Similar to randomly 
oriented scaffolds, the presence of graphene promoted a sharper and narrower caffeine 
induced transient peak compared to 2D controls, as demonstrated by a significantly 
shorter caffeine induced T50. Specifically, the time required for Ca2+ to efflux out of the 
cytoplasm after release from the SR, known as caffeine induced transient decay, was also 
significantly shorter in mES-CM on PCL+G scaffolds compared to 2D controls (p<0.01, 
Figure 3.10B). 
 
  
Figure 3.10 (A) Fractional release of mES-CM cultured on aligned PCL and 
PCL+G scaffolds was significantly higher compared to 2D control (p* = 0.003). (B) 
Caffeine induced transient decay was significantly shorter in mES-CM cultured on 
aligned PCL+G scaffolds compared to 2D controls (p* = 0.007).  
Mean denoted by −. 
Source: Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106 2923-2933, (2018). 
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3.4 Discussion 
Conductive nanomaterials, including graphene and CNTs have emerged as highly 
promising candidate biomaterials 183,184 owing to their unique electrical and mechanical 
properties. Since cardiomyocytes exist in a highly complex and dynamic 
microenvironment in vivo, the unique features of graphene are especially attractive for 
cardiomyocyte culture. Previous studies have examined the biocompatibility and 
differentiation specificity of human pluripotent stem cells 128,197, and mesenchymal stem 
cells 130 on 2D graphene films. However, the effects of a 3D graphene scaffolds on 
cardiac cells are not yet known. In this study, 3D graphene-containing electroactive 
nanocomposite scaffolds providing local conductive sites was examined for the first time 
with stem cell derived cardiomyocytes for cardiac tissue engineering applications.  
Despite the difficulties in properly processing 3D electroconductive scaffolds as 
conductive nanoparticles tend to agglomerate, a 3D electroactive nanocomposite scaffold 
was successfully fabricated by electrospinning graphene dispersed PCL solutions 200. The 
addition of up to 0.05% conductive graphene into an insulative PCL polymer matrix 
resulted in an even distribution of graphene particles within the 3D PCL matrix which 
increased volume conductivity due to the percolation effect 201,202.  
  Since it has been shown that electrical stimulation can enhance cardiomyocyte 
function and differentiation capacity 115,203, the possibility of applying external electrical 
stimulation to PCL+G scaffolds was also examined. As the conductive graphene particles 
provided local conductive sites within insulative PCL matrix, conventional field 
stimulation using a conductive solution was not appropriate for these scaffolds. Instead, a 
point electrical stimulation device was built to provide localized electrical stimulation to 
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examine signal propagation through PCL+G scaffolds. Since electrical signals in the 
heart begin in the sinoatrial (SA) node with pacemaker cells and then propagates 
throughout the myocardium via cell-cell interactions for synchronous contraction 204,  
localized point stimulation more closely mimics this mechanism by initiating contraction 
in the cells in contact with the stimulating electrode. Our results demonstrating signal 
propagation through PCL+G scaffolds containing as low as 0.01% graphene confirms the 
feasibility of incorporating additional electrical stimulation to these tissues. 
To assess the cytocompatibility of PCL+G with stem cell derived cardiomyocytes, 
scaffolds with 0.01% graphene were chosen to determine whether minimum graphene 
content is enough to provide functional benefits while maximizing the biocompatibility. 
Our results demonstrated that 3D PCL+G scaffolds independent of the fiber organization 
are biocompatible with stem cell derived cardiomyocytes, as demonstrated by their high 
cellular viability and adherence to the scaffolds 129,205,206. MES-CM spontaneously 
contracted, exhibited a positive response to an inotropic agent and expressed classical 
cardiac specific markers confirming phenotypic characteristics of native cardiomyocytes 
on graphene scaffolds.  
Functional assessment demonstrated similar paced Ca2+ transient morphology in 
mES-CM cultured in all culture conditions.  Similar SERCA expression and activity 
indicated by similar paced transient T50 was also demonstrated by all culture conditions.  
However, caffeine induced transient morphology was significantly altered in the presence 
of graphene. Specifically, caffeine induced transient T50 was significantly decreased in 
mES-CM cultured on PCL+G scaffolds. This suggests involvement of Ca2+ efflux 
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mechanisms other than sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), which 
controls up to 90% of Ca2+ efflux in mice under normal physiological conditions 207.  
The other possible efflux mechanism is the sarcolemnal Na+/Ca2+ exchanger 
(NCX), which is driven by both Na+ and Ca2+ concentrations. During caffeine treatment, 
intracellular Ca2+ concentration is at its peak, driving NCX forward to expel Ca2+ out of 
the cell 208. Significantly shorter caffeine induced transient T50 and decay time of mES-
CM cultured on PCL+G scaffolds with both random and aligned fibers compared to 2D 
control suggest that graphene plays a role in the expression and organization of NCX in 
mES-CM, enabling significantly faster free Ca2+ expulsion from the cytoplasm 169,209. 
This further suggests that more efficient Ca2+ homeostasis of mES-CM can be achieved 
on PCL+G scaffolds. The resulting Ca2+ homeostasis mechanism may also explain the 
significant decrease in spontaneous beating frequency with longer time in culture on 
PCL+G scaffolds as the gradual decrease in spontaneous beating of stem cell-derived 
cardiomyocytes indicates further differentiation 165.  
 Furthermore, culture on PCL+G scaffolds promoted a significantly higher 
fractional release of approximately 40% compared to that of mES-CM cultured in 2D 
(approximately 26%). Fractional release is an indicator of excitation-contraction coupling 
efficiency and the fractional release of mature rat is approximately 60% 173.  A higher 
fractional release further suggests that calcium-handling function of mES-CM is 
enhanced with culture on 3D graphene containing scaffolds.  
 The greatest enhancement in cardiac specific protein expression and contractile 
behavior was demonstrated by mES-CM cultured on aligned PCL+G scaffold suggesting 
a synergistic effect from the combination of fiber alignment and incorporation of 
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graphene into the scaffold.  Specifically, up-regulation of Cx43 expression by mES-CM 
on aligned PCL+G scaffolds suggests enhanced cell-cell coupling 125,197,210, which is 
likely due to signal propagation facilitated by graphene providing local conductive sites, 
as suggested in studies performed with carbon nanotubes 183.  Aligned PCL+G scaffolds 
also stimulated the highest fractional release of all conditions as well as the highest 
spontaneous beating frequency at day 6 of culture. Cardiomyocyte organization and 
alignment has been shown to affect electrical function 88 and to optimize force generation 
while electrical stimulation promotes cardiomyocyte elongation and alignment 116,211. 
Hence, the benefits of combining alignment and the presence of graphene would only be 
further enhanced through the addition of local electrical stimulation.  
In summary, this chapter highlights the potential of an electroactive graphene-
containing scaffold as a candidate material for engineered cardiac tissue engineering 
application. The addition of a miniscule amount of graphene nanoparticles does not affect 
the biocompatibility of 3D scaffolds, yet provided beneficial effects to cardiomyocyte 
function specifically in calcium-handling behavior. Unlike the scaffolds formed entirely 
with conductive materials, these scaffolds have local conductive sites provided by graphene 
nanoparticles within a biocompatible PCL matrix. The changes in cardiomyocyte function on 
these scaffolds are likely due to local conductive pathways formed by cardiomyocytes that 
facilitated signal propagation and interaction between them 185,197. With the development 
of the point electrical stimulation device, further studies can be performed to investigate 
whether the combination of graphene and the external electrical stimulation can provide 
further synergistic effects on mES-CM function. Additionally, cell seeded scaffolds could 
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be transplanted into a mouse MI-model to evaluate integration into the host as 
electroconductive scaffold may aid in electrical integration.  
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CHAPTER 4 
MYOCARDIAL INFLAMMATION MODELS 
 
4.1 Introduction 
After myocardial infarction (MI), the temporal response includes the initial inflammation 
phase followed by remodeling during the proliferative and maturation phases 13. 
Macrophages are one of the key cell types activated in the initial inflammatory response 
after injury with CCL2/CCR2 signaling initiating monocyte recruitment and 
differentiation in the infarct 212.  
Macrophage phenotypes can be generally described as more pro-inflammatory in 
days 1-3, commonly referred to as M1 type, and more anti-inflammatory or pro-healing 
for days 5-7, described generally as M2 type 142,213-215. It is recognized that there is a 
complex spectrum of macrophage phenotypes in the post-MI microenvironment that 
shifts over time. Various phenotypes, including M2a or M2c, can be characterized by 
cytokine secretion and cell surface receptor expression 14,216. It is, however, not known 
exactly what dictates the shift between macrophage phenotypes. One theory is that M1 
and M2 macrophages originated from varying monocyte cell sources 217. The 
microenvironment has also been shown to influence macrophage phenotype, indicating 
plasticity of macrophages 218.  
Although macrophages are usually associated with injury, it has been 
demonstrated that resident cardiac macrophages contribute to cardiac function in the 
healthy, and steady state condition. Resident cardiac macrophages exhibit an M2-type, 
pro-healing phenotype, with population expressing various levels of major 
	65	
histocompatibility complex class 2, CCR2 and Ly6C 218. Hulsmans et al. demonstrated 
that resident cardiac macrophages also facilitate electrical signal propagation in the AV 
node through intricate interactions with cardiomyocytes via connexin43 gap junctions 5. 
In fact, they follow the pattern of action potentials of the cardiomyocytes in which they 
interact. Nevertheless, resident cardiac macrophages are not involved in the immediate 
inflammatory response post-MI, as they die along with the other cells that populate the 
infarct. Rather, infiltrating monocytes from the blood differentiate into the macrophages 
that dictate the initial immune response 219.  
Macrophage phagocytic function is known as one regulator of inflammation 
through clearing of the numerous apoptotic cells such as neutrophils, promoting a shift in 
macrophages towards anti-inflammatory mediator expression such as IL-10 and TGF-β 
220. Extracellular matrix fragments may also be involved in the promotion of macrophage 
infiltration and elicitation of a pro-inflammatory microenvironment 221. It is critical to 
better understand how macrophages influence the inflammatory response post-MI, as the 
prolonging of inflammation post-MI is associated with detrimental remodeling and 
function of the heart 14. Very recently, inhibition of the innate immune response via 
treatment with a potent antioxidant called 3-bromo-4,5-dihydroxybenzaldehyde or BDB 
caused a noticeable improvement in cardiac function, survivability and infarct size due to 
inhibition of macrophage infiltration and pro-inflammatory cytokine production 222. 
Another recent study by Tokutome et al. used nanoparticles (NPs) loaded with an anti-
inflammatory drug named Pioglitazone, which targeted monocytes and macrophages. 
NPs inhibited monocyte recruitment and inflammatory gene expression in macrophages. 
Instead, NPs promoted a more M2 type macrophage phenotype. These NPs lessened 
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ischemia-reperfusion injury and significantly reduced mouse mortality 223. Despite these 
recent studies, details regarding macrophage subpopulations and their effect on resident 
surviving cardiomyocytes or on other cell types administered during cell-based therapy 
remain unclear.  
 Both the pro- and anti-inflammatory macrophage subsets secrete an array of 
cytokines that contribute to the post-MI microenvironment. One class of proteins secreted 
by macrophages after injury is matricellular proteins 224. Matricellular proteins are 
nonstructural extracellular matrix proteins, however not much detail is known about their 
effect on different cell types, including cardiomyocytes. One matricellular protein of 
interest in the post-MI microenvironment is thrombospondin-1 (TSP-1). TSP-1 is known 
to be up-regulated at sites of inflammation, including post-MI. TSP-1 is expressed and 
secreted by infiltrating macrophages and has been shown to be isolated in the infarct 
border zone 225. TSP-1 null mice exhibit an exaggerated inflammatory response, with a 
higher density of infiltrating and activated macrophages and fibroblasts, which causes 
expansion of the infarct. Because of this, TSP-1 is suggested to form a barrier around the 
infarct to protect the healthy tissue. TSP-1 is also a strong binder of Ca2+ ions, containing 
over 30 Ca2+ binding sites 226. Ca2+ binding of TSP-1 affects its reactivity and interaction 
at other binding sites 227. Specifically, the calcium-handling mechanism associated with 
TSP-1 is store operated Ca2+ entry, or SOCE. SOCE has historically been associated with 
non-electroactive cell types. However, more recently SOCE has been identified in 
cardiomyocytes during the embryonic and neonatal phase of development 228 as well as in 
embryonic stem cell derived cardiomyocytes 229.  While healthy adult cardiomyocytes do 
not exhibit SOCE, stress induces the expression of stromal interaction molecule 1 
	67	
(Stim1), which is the Ca2+ sensing protein in the sarcoplasmic reticulum, in adult 
cardiomyocytes and therefore initiates SOCE in adult cells under stress 228. Since TSP-1 
is known to bind Stim1 in non-excitable cells, TSP-1 may be a regulator of SOCE in the 
post-MI microenvironment 230,231. 
Another matricellular protein of interest, which was originally identified as a bone 
matrix protein but is now known to be involved with inflammation through constitutive 
expression and secretion by macrophages, is osteopontin (OPN) 232,233. It is highly up-
regulated at the infarct border zone post-MI 233 and has also been associated with the 
development of cardiac disease, specifically cardiac hypertrophy and heart failure 234-238. 
This year, Shirakawa et al. demonstrated the relationship between galectin-3 and OPN, 
which contributes to cardiac repair by involvement in mediating phagocytosis and 
fibrosis 239. However, the extent of OPN involvement in the post-MI microenvironment 
and how OPN is linked to cardiac disease post-MI is not understood. Because cardiac 
hypertrophy is associated with dysfunction of calcium-handling properties in 
cardiomyocytes 240, specifically SOCE 228,241-243, OPN could affect cardiomyocyte SOCE 
response post-MI, and therefore, elicit  changes in cardiomyocyte function and further 
development of cardiac hypertrophy.  
 In this chapter, two in vitro myocardial inflammation models were created using a 
glass bottom dish. The first is a direct co-culture model in which polarized macrophage 
subsets are co-cultured with pluripotent stem cell derived cardiomyocytes. The second 
used macrophage phenotype specific conditioned-media to culture pluripotent stem cell 
derived cardiomyocytes. These models permit detailed characterization of gene 
expression by macrophage and cardiomyocyte, expression of matricellular proteins, and 
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secretion of cytokines. More importantly, the effects macrophages or macrophage-
derived factors have on the calcium-handling properties of pluripotent stem cell derived 
cardiomyocytes were examined. A potential pathway involved in SOCE response of 
cardiomyocytes with macrophage derived OPN was demonstrated. The results from this 
in vitro study provide insights to better understand the cellular interactions in the post-MI 
microenvironment, which is otherwise difficult to examine in vivo.  
 
4.2 Methods 
4.2.1   Mouse Embryonic Stem (mES) Cell Culture and Differentiation 
A stable cardiac troponinT-eGFP mES cell line (generous gift from Dr. Yibing Qyang at 
Yale University) was used. MES cells were cultured on a mouse embryonic fibroblast 
(Global Stem, MD) feeder layer for 2 days in a DMEM medium supplemented with 15% 
knockout serum replacement, 1% NEAA, sodium-pyruvate, penicillin/streptomycin 
(Gibco, NY), 2-mercaptoethanol (Sigma Aldrich, MO) and leukemia inhibiting factor 
(LIF, 5ng/mL). To differentiate mES cells into cardiomyocytes, mES cells were 
transferred to and cultured in a feeder-free condition with IMDM medium supplemented 
with 15% knockout serum replacement, 1% penicillin/streptomycin (GIBCO, NY), 1-
Thioglycerol (Sigma Aldrich, MO) and LIF (5ng/mL) for 2 days. Embryoid bodies (EBs) 
were then formed by a hanging drop method, as described previously 68. After 2 days, 
EBs were collected in a differentiation medium containing IMDM medium supplemented 
with 15% fetal bovine serum, L-glutamine (GIBCO, NY), ascorbic acid and thioglycerol 
(Sigma Aldrich, MO) and cultured for 8-9 additional days. Spontaneously contracting 
and GFP positive cells were yielded starting as early as differentiation day 6-7. MES-CM 
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were purified on day 10-11 of differentiation using a discontinuous Percoll (GE 
Healthcare) separation technique 57,156,157.  
 
4.2.2   Macrophage Culture  
A RAW 264.7 macrophage cell line was used (generous gift from Dr. Dominic Del Re at 
Rutgers New Jersey Medical School). Macrophages were maintained in an un-polarized 
state in RPMI medium (GIBCO, NY) supplemented with 10% fetal bovine serum and 1% 
penicillin/streptomycin (GIBCO, NY).  
 
4.2.3   Macrophage Polarization 
Cultured macrophages were serum starved for 24 hours followed by either 
lipopolysaccharides (LPS, Sigma Aldrich, 100 ng/mL) or IL-4 (Biolegend, 20 ng/mL) 
supplementation for 24 hours to be activated into a pro-inflammatory or anti-
inflammatory phenotype, respectively 244.  
 
4.2.4   2D Myocardial Inflammation Models 
4.2.4.1   Indirect Co-culture Model. A schematic of the indirect co-culture model 
can be seen in Figure 4.1A. MES-CM (2500,000 cells) were seeded on the glass center of 
the glass bottom culture dish (MatTek). Macrophages were cultured in a 6-well plate 
(40,000 cells/well), serum starved and polarized for 24 hours as described above. 
Conditioned-media from macrophage cultures was then centrifuged (3 minutes, 10,000 
RPM) to remove any debris or cells.  It was then added to mES-CM in 1:1 ratio with 
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cardiomyocyte differentiation media for 72 hours to examine the effects of macrophage 
secreted proteins on cardiomyocyte function. 
 
4.2.4.2   Direct Co-culture Model. A schematic of the direct co-culture model can be 
seen in Figure 4.1B. Initially, 20,000 macrophages are seeded in the outer edges of a 
glass bottom dish (MatTek) in 0.5 mL of RPMI supplemented media while 250,000 
mES-CM are seeded in the glass center region of the dish in 300uL of differentiation 
media. The use of glass bottom dish allowed for ease of functional analysis. The 
Figure 4.1 Schematic of (A) indirect and (B) direct co-culture of macrophages and 
cardiomyocytes. 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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following day, macrophage media is replaced with serum free media for 24 hours. Media 
is replaced again with either serum containing media or LPS or IL-4 supplemented 
polarization media for another 24 hours. After 24 hours of macrophage polarization, 
macrophage and cardiomyocyte media is mixed in a 1:1 ratio to initiate co-culture. 
Samples are then analyzed either 24 or 72 hours later.  
 
4.2.5   Immunofluorescence Imaging 
The use of a stable cardiac troponinT-eGFP mES cell line allowed examination of cardiac 
troponin T expression by mES-CM during culture. GFP expression of mES-CM was 
visualized using a confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, 
NJ).  
 
4.2.6   F-actin Imaging 
Macrophages in monoculture were fixed overnight using 4% formaldehyde (Sigma 
Aldrich, MO) after 24 hours of activation.  Samples were stained for F-actin using  
Rhodamine-conjugated phalloidin (1:20, Life Technologies, NY) for 2 hours at room 
temperature and were counter-stained with DAPI to visualize nuclei before imaging with 
a confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, NJ).  
 
4.2.7   RT-PCR 
Total RNA was extracted and purified from mES-CM and macrophages using the 
GenElute Mammalian Total RNA Miniprep Kit following the manufacturers instruction. 
cDNA was created with 200ng of RNA and the High-Capacity cDNA Reverse 
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Transcription Kit (Applied Biosystems, Grand Island, NY) in the T100 Thermal Cycler 
(Bio-rad, Hercules, CA) using the following program: 10 min at 25°C, 120 min at 37°C, 
5 min at 85°C and then 4°C indefinitely. RT-PCR reactions were then prepared with the 
SSo Advanced SYBRgreen Mastermix (Bio-rad, Hercules, CA). The primers used in the 
study are listed in Table A1 (IDT, Coralville, Iowa).245,246 The qPCR reaction was then 
run in a CFX Connect Real Time System (Bio-rad, Hercules, CA) for up to 50 cycles. 
Samples that saw no expression after 50 cycles were considered to have no expression. 
Changes in expression were represented using the Comparative CT method as described 
previously.247  
 
4.2.8   Cytokine Secretion  
A cytokine array (R&D Systems, Minneapolis, MN) was used to examine inflammatory 
cytokine secretion in culture medium.  Samples examined were from both monoculture 
polarized macrophages and cardiomyocyte or co-culture media after 72 hours following 
manufactures instructions. Media was collected and centrifuge (3 min, 10,000 RPM) to 
remove floating cells and debris. After blocking for 1 hour, nitrocellulose membranes 
containing 40 different capture antibodies for inflammatory cytokines were incubated 
with media samples overnight at 4°C. Membranes were then washed and incubated with 
Streptavidin-HRP. HRP was then activated via a Chemi Reagent before imaging with 
Chemidoc XRS (Bio-Rad, CA). OPN secretion in monoculture macrophages and 
conditioned-media environments after 24 or 72 hours of culture, respectively, was 
quantified using a Mouse/Rat osteopontin Quantikine ELISA (R&D Systems, 
Minneapolis, MN). 
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4.2.9   Western Blot Analysis 
Cell lysates of macrophages and cardiomyocytes were prepared using a lysis buffer 
containing RIPA buffer, 1% Triton X100 (Boston BioProducts, MA) and 1% protease 
inhibitor (Sigma Aldrich, MO). Samples were then diluted 1:1 in Laemmli SDS buffer 
(Bio-rad, CA) with 5% 2-mercaptoethanol (Sigma Aldrich, MO). Primary antibodies 
used were rabbit anti-ERK1/2, rabbit anti-phospho-ERK1/2 (1:1000, Cell Signal, 
Danvers, MA), and rabbit anti-Stim1 (1:1000, Cell Signal). Secondary antibodies used 
were sheep anti-mouse-HRP and donkey anti-rabbit-HRP (1:1000, GE Healthcare). A 
minimum of three independent blots was performed for each protein of interest. Protein 
bands were normalized to the b-actin (1:1000, Sigma Aldrich) loading control and 
analyzed via densitometry (ImageJ). 
 
4.2.10   Evaluation of Calcium-Handling Properties 
After 3 days of co-culture, mES-CM were incubated at room temperature with Rhod-
2AM (4 µM) for 30 minutes, followed by a 20 minutes washout (for AM cleavage) in 
normal Tyrode’s solution (NT). Samples were then placed in a heated chamber (35˚C) 
with a fluorescent inverted microscope (Nikon Eclipse TE200) with an Andor Ixon 
Charge-Coupled device (CCD) camera (Andor Technology, at 50 frames/s, 512 x 180 
pixels) as previously described 160,161. The intensity of fluorescence was recorded and 
normalized to the basal diastolic fluorescence levels. Cells were electrically stimulated to 
examine their response to electrical pacing at 0.5, 1 and 2 Hz frequencies (4.5 ms 
duration, 150 V, Grass S48 Stimulator, Grass Medical Instruments, West Warwick, RI). 
Cells were treated with 10 mM caffeine, a ryanodine receptor agonist, to investigate 
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sarcoplasmic reticulum Ca2+ content and fractional Ca2+ release. Additionally, for the 
exploration of store operated Ca2+ entry (SOCE), mES-CM were challenged with 10 mM 
caffeine along with 10 µM cyclopiazonic acid (CPA), a potent sarco/endoplasmic 
reticulum ATPase inhibitor 248. The protocol was as follows: 10 sec 1 mM Ca2+ NT, 10 
sec 0 mM Ca2+ NT, 10 sec 1 mM Ca2+ NT, 10 sec 0 mM Ca2+ NT, 10 sec 0 mM Ca2+ NT 
+ 10 µM CPA + 10 mM Caffeine, 10 sec 0 mM Ca2+ NT, 10 sec 1 mM Ca2+ NT + 10 µM 
CPA 10 mM Caffeine, 10 sec 0 mM Ca2+ NT. 
 
4.2.11   Osteopontin (OPN) Inhibition  
OPN was neutralized through the addition of an OPN specific antibody (OPN Ab) (R&D, 
6 µg/mL) at the initiation of indirect co-culture.  Briefly, conditioned media was collected 
from polarized macrophages and centrifuged (3 min, 10,000 RPM) to removed cells and 
floating debris. Macrophage conditioned media was then mixed 1:1 with mES-CM 
differentiation media before adding OPN Ab (100 µg/mL) to make a final concentration 
of 6 µg/mL.  
 
4.2.12   OPN Addition 
Recombinant mouse OPN (R & D) was added to mES-CM in monoculture by mixing 
mES-CM differentiation media with 200 µg/mL solution of OPN in 0.1% bovine serum 
albumin (Sigma Aldrich) to yield a final working concentration of 5 µg/mL. 
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4.2.13   Statistical Analysis 
Results are presented as mean ± standard deviation or as individual data points and an 
average. Statistical analysis was performed in SPSS (Version 24, IBM) or Prism 7 
(GraphPad) using a two-tailed independent samples t-test, one-way ANOVA or their 
nonparametric counterpart, followed by Tukey or Games-Howell post hoc tests, where 
appropriate. Statistical significance was accepted for p*<0.05.  
 
4.3  Results 
4.3.1   Macrophage Phenotype Characterization 
RAW 264.7 macrophages (Figure 4.2A,D) were successfully polarized into either a pro-
inflammatory phenotype with treatment of LPS and an anti-inflammatory phenotype with 
IL-4. LPS treated macrophages demonstrated a more spread out morphology with 
numerous projections (Figure 4.2B,E). Macrophages treated with IL-4 retained a smaller, 
rounded morphology (Figure 4.2C,F), similar to untreated controls.  
Treatment with LPS for 3 days induced the secretion of pro-inflammatory 
cytokines including granulocyte colony-stimulating factor (G-CSF), granulocyte-
macrophage colony-stimulating factor (GM-CSF), interleukin-1 receptor agonist (IL-1ra), 
intrleukin-6 (IL-6), regulated on activation normal T cell expressed and secreted 
(RANTES) and tumor necrosis factor alpha (TNF-α) (Figure 4.3A). Conversely, IL-4 
treatment induced secretion of IL-4 and diminished secretion of pro-inflammatory 
cytokines such as interferon gamma-induced protein (IP-10), RANTES, TNF-α, G-CSF, 
GM-CSF, IL-1ra and IL-6 (Figure 4.3A). 	
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Figure 4.2 (A) Raw264.7 macrophages were polarized towards (B) a pro-inflammatory phenotype with LPS or (C) an 
anti-inflammatory phenotype with IL-4 (scale bars = 50 µm). F-actin staining with rhodamine-conjugated phalloidin 
(red) demonstrates the unique morphological features of (D) untreated, (E) LPS treated or (F) IL-4 treated macrophages 
(scale bars = 10 µm).  
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via Matricellular Protein Secretion. (In 
preparation, 2018). 
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Gene analysis via RT-PCR also confirmed the expression of genes that are 
characteristic of either pro- and anti-inflammatory macrophage phenotypes. LPS treated 
macrophages demonstrated significantly higher expression of pro-inflammatory genes 
such as TNF-α, IL-1β, Cox2 and Nos2 compared to IL-4 treated macrophages (*p<0.05, 
Figure 4.3B). On the other hand, IL-4 treated macrophages expressed significantly higher 
levels of anti-inflammatory genes such as YM1 and ARG1 compared to LPS treated 
macrophages (*p<0.05, Figure 4.3B).   	
Figure 4.3 (A) Cytokine secretion screen by untreated, LPS and IL-4 treated 
macrophages after 3 days of  monoculture (n=1). (B)  Gene expression profiles of LPS 
and IL-4 treated macrophages after 24 hours of activation relative to untreated 
macrophages (n≥6, * p<0.05). 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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4.3.2   Indirect Myocardial Inflammation Model 
4.3.2.1   mES-CM Characterization. Figure 4.4A-F displays representative 
images of mES-CM in culture exhibiting cTNT-eGFP expression in all experimental 
groups after 3 days. RT-PCR results demonstrated a significant down regulation of cTnT 
(Figure 4.4G) and Serca2 (Figure 4.4H) in mES-CM cultured in LPS-treated 
macrophage-conditioned media compared to mES-CM cultured in either untreated or IL-
4-treated macrophage-conditioned media (*p<0.05). However, no significant differences 
were found in the ratio of Myh6/7 with culture in macrophage-conditioned media (Figure 
4.4I). The ratio of Bax/BCL-2, which is a classical apoptosis marker, also remained 
unchanged in mES-CM cultured in macrophage-conditioned media (Figure 4.4J).  
Calcium-handling properties of mES-CM were also explored after 72 hours. 
MES-CM cultured in LPS-treated macrophage-conditioned media exhibited significantly 
lower paced and caffeine-induced transient amplitude compared to mES-CM in IL-4-
treated macrophage-conditioned media (#p<0.05, Table 4.1) and significantly lower paced 
transient amplitude compared to mES-CM in untreated macrophage-conditioned media 
(**p<0.05, Table 4.1). LPS-treated macrophage-conditioned media also induced 
significantly longer caffeine-induced transient T50 compared to that of mES-CM in 
monoculture (*p<0.05, Table 4.1). Although paced and caffeine-induced transient 
morphology differed among groups, fractional release, which is the measure of calcium-
handling efficiency remained similar among mES-CM in all culture conditions (Figure 
4.5A).    
MES-CM cultured in IL-4-treated macrophage-conditioned media exhibited 
significantly higher baseline Ca2+ entry compared to mES-CM in monoculture (*p<0.05, 
	79	
	
Figure 4.4 Expression of cTnT-eGFP (green) after 72 hours by mES-CM in (A) 
standard culture, (B) with LPS added, (C) with IL-4 added or in conditioned media 
culture with (D) untreated, (E) LPS treated or (F) IL-4 treated macrophages (scale bars 
= 50 µm).  RT-PCR of cardiac specific markers such as (G) cTnT and (H) Serca2 as 
well as the ratio of (I) My6/My7 and apoptosis markers (J) BAX and BCL-2. (n≥5 and 
*p<0.05) 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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Figure 4.5 (A) Fractional release was calculated as the ratio between paced and 
caffeine induced transient amplitudes (n≥31) and (B) store operated Ca2+ entry 
(SOCE) was measured after treatment with caffeine and CPA (n≥70).  
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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Table 4.1). MES-CM in untreated macrophage-conditioned media culture exhibited 
significantly lower total sarcoplasmic reticulum Ca2+ stores compared to mES-CM in 
monoculture and IL-4-treated macrophage- conditioned media culture (*,#p<0.05, Table 
4.1). However, no significant differences in SOCE were found between mES-CM in 
conditioned media culture (Figure 4.5B). 
Table 4.1 Calcium-Handling Properties of mES-CM in Conditioned Media Culture  
n, cell number; Amp, Paced Transient Amplitude; T50, Paced Transient T50; CI Amp, Caffeine Induced 
Transient Amplitude; CI T50, Caffeine Induced Transient T50; Baseline, Baseline Ca2+ Entry; SR Stores, 
Sarcoplasmic Reticulum Ca2+ Stores. 
*p<0.05 vs. monoculture mES-CM; **p<0.05 vs. mES-CM in untreated conditioned media; #p<0.05 vs. 
mES-CM in IL-4 treated conditioned media  
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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Figure 4.6 (A) Secretion of OPN in mES-CM monoculture and conditioned media cultures were measured after 3 
days (n>4, *p<0.05, **p<0.01). (B) Representative blot demonstrating Stim1 expression of mES-CM in 
monoculture and conditioned media cultures after 3 days, with graphs demonstrating the average of 4 independent 
trials. (C) Activation of ERK1/2 in mES-CM in monoculture and conditioned media cultures was calculated as the 
ratio of phosphorylation, included is a representative blot as well as a graph demonstrating the average of 4 
independent trials. 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via Matricellular Protein Secretion. (In 
preparation, 2018). 
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4.3.2.2   Matricellular Protein Expression and Action. In macrophage-conditioned 
media culture, significantly higher levels of OPN were present compared to mES-CM in 
monoculture after 3 days (*p<0.05, **p<0.01, Figure 4.6A). However, similar expression 
of Stim1, which is the Ca2+ sensor and regulator of SOCE, were found in mES-CM in all 
groups (Figure 4.6B). ERK1/2 phosphorylation was also found to be similar among all 
groups (Figure 4.6C). 
When OPN was neutralized using OPN specific antibody, significant differences 
were found in SOCE response of mES-CM. Specifically, mES-CM cultured in IL-4-
treated macrophage-conditioned media exhibited the lowest SOCE response with OPN 
inhibition, significantly lower than that of mES-CM in all other conditions without OPN 
inhibition (p<0.05, Figure 4.7A). MES-CM cultured in LPS-treated macrophage-
conditioned media with OPN inhibition also exhibited significantly lower SOCE than 
mES-CM in monoculture as well as in untreated and IL-4-treated macrophage-
conditioned media without OPN inhibition (p<0.05, Figure 4.7A). ERK1/2 
phosphorylation was statistically similar among all groups, regardless of OPN inhibition. 
Although, ERK1/2 phosphorylation was the lowest in mES-CM in IL-4 treated 
conditioned media with OPN inhibition (Figure 4.7B). Additionally, when 5 µg/mL of 
recombinant OPN was added to mES-CM in monoculture, SOCE was significantly 
increased (*p<0.05, Figure 4.7C).  
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Figure 4.7 (A) Changes in SOCE in mES-CM in conditioned media culture due to 
OPN inhibition through the addition of an OPN antibody (Ab) were measured after 3 
days (n≥38, p<0.05). Similar Greek letters indicate no significant difference between 
groups. (B) Representative blot of ERK1/2 activation, as well as a graph representing 
the average of 4 or more independent trials, of mES-CM in conditioned media culture 
with or without OPN inhibition after 3 days. (C) Changes in SOCE in mES-CM due to 
the addition of recombinant OPN after 3 days (n≥36, *p<0.05). 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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4.3.3   Direct Myocardial Inflammation Model 
4.3.3.1   Macrophage Characterization. In the direct co-culture of macrophages and 
mES-CM, macrophages were initially seeded in isolation in the outer edge of the dishes. 
Due to their highly proliferative nature, some macrophages migrated towards mES-CM in 
the center of the dish to form direct cell-cell interactions with mES-CM. Over the course 
of 6 days, from initial seeding to day 3 of co-culture, their cell number increased 332.0 ± 
65.1 times for untreated, 33.0 ± 4.6 times for LPS treated and 177.8 ± 9.8 times for IL-4 
treated macrophages in co-culture. Even in co-culture with mES-CM, macrophages 
retained similar morphology as compared to those in monoculture after 3 days (Figure 
4.8). Both untreated (Figure 4.8A) and IL-4-treated (Figure 4.8C) macrophages remained 
rounded, while LPS-treated macrophages (Figure 4.8B) were more spread out with 
projections.  
The expression of classical pro-inflammatory genes such as IL-1β and Nos2 was 
up-regulated in LPS-treated macrophages in co-culture with mES-CM. Similarly, up-
regulation of anti-inflammatory genes, such as YM1 and Arg1 were present in IL-4-
treated macrophages in co-culture with mES-CM up to 3 days (Figure 4.8D). Pro-
inflammatory cytokines, such as G-CSF, IL-1ra, IP-10, Rantes, MIP-2 and TNF-α were 
present in co-culture of mES-CM and LPS-treated macrophages after 3 days (Figure 
4.9A). However, down regulation of pro-inflammatory cytokine secretion as well as up-
regulation of IL-4 secretion was seen in co-culture of mES-CM and IL-4-treated 
macrophages by day 3 (Figure 4.9A).  Expression of MCP-1, MIP-1α, MIP-1β, stromal 
derived factor 1 (SDF-1) and tissue inhibitor of metalloproteinase 1 (TIMP-1) was similar 
in all groups (Figure 4.9A). Interestingly, mES-CM in monoculture also exhibited low 
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levels of secretion of pro-inflammatory cytokines such as IP-10 and M-CSF. MES-CM 
also express high levels of stromal derived factor-1 (SDF-1), tissue inhibitor of 
metalloproteinase-1 (TIMP-1), macrophage chemotactic protein-1 (MCP-1) and thymus 
and activation regulated chemokine (TARC) (Figure 4.9B). 
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Figure 4.8 (A) Untreated, (B) LPS treated and (C) IL-4 treated macrophages in co-culture with mES-CM 
(scale bars = 50 µm). (D) Gene expression profiles of LPS and IL-4 treated macrophages in co-culture with 
mES-CM (n≥3).  
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via Matricellular Protein 
Secretion. (In preparation, 2018). 
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Figure 4.9 Cytokine secretion screen in (A) all direct co-culture conditions and (B) 
mES-CM in monoculture (n=1).  
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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4.3.3.2   mES-CM Characterization. During 3 days of co-culture with 
macrophages, similar cTnT-eGFP expression was observed in mES-CM independent of 
macrophage phenotype (Figure 4.10A-D). However, even after only 24 hours of co-
culture with macrophage subsets, significant changes in calcium-handling behavior were 
observed. After 24 hours, mES-CM co-cultured with IL-4-treated macrophages exhibited 
significantly higher paced transient amplitude compared to mES-CM cultured in all the 
other conditions (*,**,##p<0.05, Table 4.2) and significantly higher caffeine-induced 
transient amplitude compared to mES-CM in monoculture or untreated macrophage co-
culture (*,**p<0.05, Table 4.2). No significant differences in paced or caffeine-induced 
transient T50 were found. 
 After 3 days, mES-CM co-cultured with IL-4-treated macrophages exhibited 
significantly higher paced transient amplitude compared to mES-CM in LPS-treated 
macrophage co-culture (##p<0.05, Table 4.2). MES-CM co-cultured with untreated 
macrophages also exhibited significantly higher paced transient amplitude than mES-CM 
in all other conditions (*,**p<0.05, Table 4.2) and significantly longer paced transient 
T50 compared to co-culture with LPS-treated macrophages (**p<0.05, Table 4.2). 
However, mES-CM in co-culture with untreated macrophages also exhibited significantly 
shorter caffeine-induced transient T50 compared to mES-CM in monoculture and co-
culture with LPS-treated macrophages (*,**p<0.05, Table 4.2).  
 Additionally, mES-CM co-cultured with untreated and IL-4-treated macrophages 
exhibited significantly higher fractional release compared to mES-CM in monoculture or 
LPS-treated macrophage co-culture after 24 hours (**p<0.05,#,##p<0.005, Figure 4.10E).  
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Figure 4.10 Expression of cTnT-eGFP in mES-CM in (A) monoculture and (B) 
untreated, (C) LPS treated or (D) IL-4 treated macrophage co-culture (scale bars = 50 
µm). (E,G) Ca2+ fractional release (n≥16) and (F,H) SOCE (n≥11) in mES-CM in 
monoculture or direct co-culture after 24 or 72 hours, respectively. (*,#,## p<0.005, 
**p<0.05) 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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MES-CM co-cultured with untreated macrophages maintained significantly higher 
fractional release compared to mES-CM in monoculture and LPS-treated macrophage co-
culture up to 3 days (**p<0.05,#p<0.005, Figure 4.10G).  
SOCE related properties were also measured in mES-CM in co-culture with 
macrophage subsets (Table 4.3). After 24 hours, mES-CM co-cultured with LPS-treated 
macrophages exhibited significantly higher baseline Ca2+ entry than mES-CM in co-
culture with untreated macrophages (**p<0.05) and significantly higher sarcoplasmic 
reticulum Ca2+ stores than all other groups (*,**,#p<0.05). After 3 days, no significant 
differences in baseline Ca2+ entry were found but mES-CM co-culture with untreated 
macrophages exhibited significantly lower sarcoplasmic reticulum Ca2+ stores compared  
Table 4.2 Calcium-Handling Properties of mES-CM in Co-culture  
n, cell number; Amp, Paced Transient Amplitude; T50, Paced Transient T50; CI Amp, Caffeine Induced 
Transient Amplitude; CI T50, Caffeine Induced Transient T50. 
*p<0.05 vs. monoculture mES-CM; **p<0.05 vs. mES-CM in untreated conditioned media; ##p<0.05 
vs. mES-CM in LPS treated conditioned media 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
 
	92	
 
to monoculture (*p<0.05). While no changes in SOCE were observed after the first 24 
hours of co-culture (Figure 4.10F), significantly depressed SOCE response was 
demonstrated after 3 days of co-culture with macrophages independent of their subtypes 
(*p<0.005,**p<0.05, Figure 4.10H).   
 
4.3.3.3   Matricellular Protein Expression.  Gene expression of TSP-1 and OPN 
were examined in macrophages and mES-CM in monoculture as well as in co-culture 
conditions. TSP-1 expression was over 5 orders of magnitude higher in co-culture 
macrophages and was significantly increased in IL-4 treated co-culture macrophages 
compared to monoculture macrophages (*p<0.05, Figure 4.11A).  However, TSP-1 
expression was similar in mES-CM regardless of culture condition (Figure 4.11C). OPN 
expression was similar in macrophages regardless of co-culture condition and was higher  
Table 4.3 Calcium-Handling Properties Related to SOCE of mES-CM in Co-culture  
n, cell number; Baseline, Baseline Ca2+ Entry; SR Stores, Sarcoplasmic Reticulum Ca2+ Stores. 
*p<0.05 vs. monoculture mES-CM; **p<0.05 vs. mES-CM in untreated conditioned media; #p<0.05 vs. 
mES-CM in IL-4 treated conditioned media 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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Figure 4.11 Gene expression of (A) TSP-1 and (B) OPN by macrophages in 
monoculture and direct co-culture with mES-CM after 72 hours. Gene expression of 
(C) TSP-1 and (D) OPN by mES-CM in monoculture and direct co-culture with 
macrophages after 72 hours (n≥3, *p<0.05). 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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Figure 4.12 OPN secretion in monoculture (A) macrophages and (B) mES-CM. (C) 
OPN secretion in direct co-culture conditioned compared to corresponding 
conditioned media groups. (n≥3, *p<0.05, **p<0.001) 
Source: Hitscherich, P. et al. Macrophages Affect Cardiomyocyte Calcium-Handling Function Via 
Matricellular Protein Secretion. (In preparation, 2018). 
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than TSP-1 expression (Figure 4.11B). MES-CM expressed over four times as much 
OPN when in co-culture regardless of macrophage phenotype (Figure 4.11D). 
All monoculture macrophage populations secreted over 200 ng/mL OPN after 24 
hours (Figure 4.12A), while mES-CM groups secreted less than 3 ng/mL over 3 days 
(Figure 4.12B). Additionally, all co-culture conditions contained over 1800 ng/mL of 
OPN, significantly higher than the corresponding conditioned media groups 
(*p<0.05,**p<0.001, Figure 4.12C). 
 
4.4   Discussion 
Each year, millions of people suffer from MI in the United States. Even those patients 
who survive MI are left with irreversible damage to the heart and changes in ventricle 
geometry that result in decreased cardiac performance 249,250. Despite the immense 
significance, little is known about the specific roles of key cell types involved in post-MI 
myocardial survival, remodeling and function.  Macrophages are one of the key cell types 
involved post-MI during the inflammation phase 212.  Very recently, a microfluidic device 
was created to examine the effect of inflammation on the survival of rat H9c2 cells when 
in co-culture with LPS treated, pro-inflammatory macrophages 145. Ai et al. found that 
pro-inflammatory macrophages increased myocyte apoptosis via mitochondrial damage 
but did not examine any other phenotypic or functional changes 145. They only examined 
the pro-inflammatory microenvironment and therefore were unable to address the 
influence of temporally changing macrophage phenotypes present in the post-MI 
microenvironment. In this study, both a indirect and direct myocardial inflammation 
model was created, to simulate the post-MI microenvironment and to better understand 
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how distinct macrophage subsets affect pluripotent stem cell derived cardiomyocyte 
phenotype and function. This study specifically focuses on the effect of macrophages on 
calcium-handling function of cardiomyocytes to identify a potential mechanism through 
which macrophages and cardiomyocytes interact after injury.  
Macrophages of two different subsets were successfully derived as confirmed by 
their gene expression and cytokine secretion. Polarized macrophage subsets exhibited 
distinct morphologies with the pro-inflammatory subset exhibiting a more round, spread 
out morphology consistent with previously described work using bone marrow derived 
macrophages 251. LPS treated macrophages expressed known sets of pro-inflammatory 
makers such as TNF-α, IL-1β, Nos2 and Cox2 244. IL-4 treated macrophages, however, 
expressed significantly higher levels of characteristic anti-inflammatory markers, 
including YM1 and ARG1 244, with significantly lower levels of pro-inflammatory 
markers as expected. LPS treatment up-regulated pro-inflammatory cytokine secretion 
after 24 hours consistent with a previously described studies using bone marrow derived 
macrophages and RAW264.7 cells 145,216,252,253. LPS treated macrophage secretion of pro-
inflammatory cytokines such as MCP-1, MIP-1α and RANTES match with the cytokines 
found in serum of patients up to 7 days post-MI 254, suggesting the translational potential 
of the model. Alternately, IL-4 treatment induced the down-regulation of pro-
inflammatory cytokine secretion as well as up-regulation of IL-4 secretion 255. 
To explore the effects of macrophage derived factors on cardiomyocyte function, 
conditioned media from polarized macrophage subsets was first used to culture mES-CM. 
Our results suggest that differentiation and maturation of mES-CM is not affected by 
macrophage-secreted factors as evidenced by similar expression of Myh6/7 ratio in all 
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conditioned media groups. Moreover, similar BAX and BCL-2 expression suggested that 
macrophage-derived factors do not affect mES-CM apoptosis in contrast to a recent study 
that reported increased cardiomyocyte apoptosis when in indirect co-culture with pro-
inflammatory macrophages 145.However, cardiomyocyte culture with pro-inflammatory 
macrophage-conditioned media  led to a significant down-regulation of Serca2, which is 
the principle regulator of cytoplasmic Ca2+ efflux 256. Down regulation of Serca2 was 
correlated to the significant changes in sarcoplasmic reticulum calcium-handling, namely 
caffeine-induced transient T50. This change in Serca2 expression suggests that a 
prolonged or exaggerated pro-inflammatory environment could contribute to Serca2 
down-regulation, which can progress into the development of heart failure post-MI 257. 
Moreover, as Serca2 up-regulation post-MI may aid in preservation of ventricular 
function 258, our results suggest that timely resolution of inflammation may improve 
ventricular function through increased Serca2 expression. 
Another calcium-handling mechanism known to be up-regulated in response to 
stress or inflammation is SOCE243,259,260. Traditionally found in non-electroactive cell 
types, SOCE is associated with changes in sarcoplasmic reticulum Ca2+ stores. While 
there exists some debate over whether SOCE is present in healthy adult cardiac tissue, it 
has been identified in cardiomyocytes during the embryonic and neonatal phase of 
development 228 as well as in embryonic stem cell derived cardiomyocytes 229. In our 
macrophage-conditioned media treated mES-CM group, no significant SOCE differences 
were detected.  Because stem cell derived cardiomyocytes were used in our study, it is 
plausible that the innate presence of SOCE in these cells did not allow for the 
demonstration of macrophage-derived factors’ effect on SOCE response.  
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One of the proteins known to be up-regulated in response to inflammation is OPN 
261. OPN is secreted by macrophages 233,235-237 and while knockout studies suggest that 
OPN plays a crucial role in the healing process immediately after MI 238, it is also 
associated with the development of cardiac hypertrophy and the regulation of Ca2+ 
homeostasis 233,235-237. OPN is a matricellular protein, which is a non-structural protein 
that localizes at the infarct border zone 233,234,262. Matricellular proteins can act as cell-
matrix interaction mediators or as cytokines to initiate cellular processes 263. OPN is 
known as a promiscuous cytokine, interacting with multiple types of integrins as well as 
other cell surface receptor like CD44, which are implicated in the cardiac inflammatory 
response 221,264-266. OPN binding initiates multiple mitogen-activated protein kinase 
(MAPK) pathways within the cells ultimately regulating ERK1/2 activation 235,264,266. 
ERK1/2 is also known to regulate SOCE by regulating the phosphorylation of stromal 
interaction molecule 1 (Stim1), the calcium sensor on the SR that regulates SOCE 267,268. 
Because of this it was hypothesized that SOCE could be regulated by OPN via ERK1/2 
however, the link between OPN and SOCE has not previously been demonstrated in 
cardiomyocytes.  
 In this study, the effect of OPN on mES-CM calcium-handling behavior was 
explored. Results confirmed that OPN was mostly secreted by macrophages independent 
of their phenotype with negligible secretion by mES-CM. The concentration of OPN in 
all macrophage-conditioned media groups, although significantly higher than 
monoculture mES-CM, was within a normal range of serum OPN concentration seen in 
patients 269, which may be below the concentration threshold for causing significant 
changes in our experimental groups. However, OPN inhibition elicited significant 
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changes in mES-CM SOCE response, especially with culture in LPS- and IL-4-treated 
macrophage-conditioned media, suggesting OPN promotes SOCE response in mES-CM. 
Furthermore, the addition of recombinant OPN at a concentration similar to plasma OPN 
concentrations in patients from day 3 to day 7 post-MI with successful reperfusion 269, 
induced significant up-regulation of SOCE in mES-CM. These results demonstrate for 
the first time that macrophage secreted OPN is sufficient to elicit increases in 
cardiomyocyte SOCE response.  
Since macrophages are now known to connect with cardiomyocytes via gap 
junctions 5 contributing to steady state cardiac function, co-culture of macrophages and 
mES-CM was also performed to determine the effects of direct cell-cell interaction on 
cardiomyocyte calcium-handling function. Maintenance of macrophage subset phenotype 
in co-culture was first confirmed by morphology and gene expression, which remained 
similar to macrophages in monoculture. Interestingly in direct co-culture condition, the 
secretion of TIMP-1 and SDF-1 were detected.  Since the secretion of TIMP-1 and SDF-
1 was demonstrated by mES-CM in monoculture and not by macrophages in 
monoculture, it is likely that mES-CM are the main source of TIMP-1 and SDF-1 in the 
co-culture conditions. SDF-1 is secreted by cardiomyocytes post-MI exhibiting a 
paradoxical role by both promoting cardiomyocyte apoptosis and being considered 
cardioprotective 270-272. TIMP-1 expression in our mES-CM cultures could be from 
nonmyocytes, e.g. cardiac fibroblast-like cells, as TIMP-1 is known to be secreted by 
macrophages and fibroblasts in the post-MI microenvironment 273. It is demonstrated that 
TIMP-1 is involved with left ventricular remodeling as well as cell signaling 273. A high 
level of TARC secretion was also demonstrated by mES-CM in monoculture. Although 
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TARC is known to be associated with inflammation and may be involved with coronary 
artery disease, it is not known whether or not cardiomyocytes secrete TARC 274.  
The initial seeding density ratio of mES-CM to macrophages was 10:1 but after 3 
days of co-culture, the resulting densities change dependent on macrophage phenotype. 
Based on quantification data of macrophage infiltration in a mouse MI model by 
Vandervelde et al., macrophage density changes can be estimated as 180 million/cm3 to 
400 million/cm3 to 320 million/cm3 on day 3 to 4 to 7, respectively 275. Taking into 
account the healthy, normal cardiomyocyte density of an adult heart at about 28 million 
cells/cm3,18 the ratio of cardiomyocytes to macrophages present in the infarct border zone 
could be estimated at 1:6, 1:14 and 1:11 from day 3 to 4 to 7, respectively. In our direct 
co-culture model, the LPS treated condition exhibited a cardiomyocyte to macrophage 
ratio of about 1:4, similar to day 3 post-MI, when pro-inflammatory macrophages are 
known to inhabit the infarcted myocardium. Additionally, direct co-culture with IL-4 
treated macrophages demonstrated a cardiomyocyte to macrophage ratio of about 1:18 at 
day 3 of co-culture, similar to post-MI day 4 and 7, when the shift towards a pro-healing 
and anti-inflammatory phenotype of macrophages is present in the infarct. This suggests 
relevant cell-cell ratios between cardiomyocytes and macrophages in our direct co-culture 
model. 
It was demonstrated that the expression of cTnT by mES-CM is not affected by 
the presence of macrophages independent of their phenotype in co-culture. Conversely, 
Ca2+ fractional release in mES-CM was significantly affected by the presence of 
macrophages after only 24 hours of co-culture. Specifically, co-culture with anti-
inflammatory macrophages, either untreated or IL-4 treated, elicited enhanced Ca2+ 
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cycling efficiency, as demonstrated by a significantly higher fractional release 173.  
Increased fractional release was maintained in those culture conditions for up to 72 hours. 
Further investigation of SOCE response demonstrated no change after 24 hours, but 
direct co-culture with all macrophage subsets led to significant down-regulation of SOCE 
after 3 days of culture. These results suggest that direct cell-cell interaction between 
activated macrophages and cardiomyocytes was necessary to significantly affect 
cardiomyocyte calcium-handling function. 
 Again, because matricellular proteins TSP-1 and OPN are up-regulated post-MI 
and are associated with regulation of Ca2+ homeostasis 225,231,233,235, their expression was 
examined in co-culture.  However, very low TSP-1 expression in all conditions and 
inconsistent up-regulation in all co-culture conditions, suggests that it is less likely to be 
directly involved in cardiomyocyte calcium-handling behavior. However, despite 
significantly elevated levels of OPN, the promotion of SOCE was completely reversed 
when direct contact between mES-CM and macrophages was present. This suggests that 
while macrophage secreted OPN may promote SOCE, direct contact with macrophages 
significantly suppresses SOCE in mES-CM. 
OPN has been explored as a potential biomarker for the prediction of adverse 
events and outcomes related to vascular conditions 276 as well as prediction of death in 
patients suffering chronic heart failure 277. Our results further support the use of OPN as a 
marker of cardiac diseases and suggests macrophage secreted OPN could play an 
important role in the disruption of Ca2+ homeostasis through the promotion of SOCE 
leading to long-term pathological hypertrophy development if not regulated properly. 
Further exploration of the complicated crosstalk between activated macrophages and 
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mES-CM, as well as the effects on adult myocytes or human derived cell types would be 
interesting. These model can also be expanded to include additional features of the post-
MI microenvironment, namely hypoxia or reactive oxygen species, in order to better 
recapitulate the native post-MI microenvironment. Nevertheless, this study demonstrated 
for the first time, novel in vitro myocardial inflammation models dedicated to 
understanding the effects of activated macrophage subsets on cardiomyocyte calcium-
handling function and its relationship to macrophage secreted matricellular proteins.   
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
The objective of this dissertation was to present insights into cardiac regenerative 
medicine gleaned through the exploration of in vitro models of healthy and diseased 
cardiac tissues. To accomplish this goal, the study was divided into two separate aims. 
 Aim 1 was to develop functional in vitro cardiac tissues. This was accomplished 
through the use of two types of electroactive biomaterials, which were electrospun into 
highly aligned and anisotropic scaffolds, mimicking the native myocardial tissue 
architecture. The first was PVDF-TrFE, a piezoelectric material, which is known to 
generate electrical charge via mechanical deformation. It was hypothesized that the 
contraction of mES-CM cultured on the scaffold could deform the scaffold enough to 
generate changes in electrical charge. This would in turn, stimulate the seeded 
cardiomyocytes, promote differentiation and enhance function. When mES-CM were 
cultured on PVDF-TrFE, not only did they attach and express cardiac specific markers, 
but also followed the topographical cues and formed highly aligned and anisotropic 
tissues that spontaneously contracted. MES-CM cultured on PVDF-TrFE scaffolds could 
also be electrically paced, responded to ryanodine receptor and β-adrenergic stimulation. 
Additionally, mES-EC, a vascular cell type, were cultured on PVDF-TrFE scaffolds. Not 
only did mES-EC remain viable when cultured on PVDF-TrFE scaffold but also were 
able to maintain their mature phenotype including the ability to uptake LDL and 
expressed EC specific markers. Taken together, results indicate that PVDF-TrFE offers a 
promising base for cardiac tissue engineering applications.  
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 The second electroactive material was a novel, conductive graphene composite 
scaffold. PCL+G scaffolds exhibited even distribution of graphene particles forming local 
conductive networks, which increased the overall conductivity of the scaffold with as 
little as 0.005% graphene content. When mES-CM were seeded on PCL+G scaffolds, 
they not only attached, but grew into the scaffolds. They exhibited classical cardiac 
specific markers, well-registered sarcomeres and spontaneously contracted for up to two 
weeks in culture. The combination of graphene and highly aligned fiber orientation 
elicited the most efficient calcium-handling properties in mES-CM, with an average 
fractional release of over 40% and significantly shortened caffeine induced transient 
decay. Taken together, results confirm the biocompatibility of conductive PCL+G 
scaffold and its potential to promote the enhanced function of in vitro cardiac tissues.  
It is, however, important to note the limitations associated with the 
aforementioned tissue models. First, functional analysis was also performed on a single 
cell basis, requiring dissociation of mES-CM from scaffold-based tissues for 
examination.  Although dissociation treatments were kept consistent across all sample 
groups, it would be beneficial to examine functional properties in intact tissues. 
Additional functional measures, such as twitch force, could also be explored for further 
characterization of mES-CM derived cardiac tissues.  
Future studies that could be explored for Aim1 include the addition of external 
stimulation. For PVDF-TrFE, the addition of mechanical stretching could enhance the 
piezoelectric activity of the material. For PCL+G based tissues, further exploration of the 
novel point electrical stimulation device could elucidate the benefits of cardiomyocyte 
culture on scaffolds with electroactive networks. Future studies also include a transition 
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to in vivo mouse MI models. It is important to examine the functional integration of 
electroactive biomaterials in vivo for clinical applications. It is yet to be determined 
whether electroactive biomaterials elicit any arrhythmia or changes in electrical activity 
of the cells upon implantation.  
The limitation for PVDF-TrFE scaffolds is their non-biodegradability. It would be 
interesting to explore whether that plays a role in the regulation of inflammation post-MI 
through a graft-versus-host reaction. It would be necessary to explore biodegradable 
piezoelectric biomaterials in the future. In addition, long-term in vivo studies examining 
the effects of graphene particles and whether they are retained on the scaffolds awaits 
further investigation. 
 In Aim 2 an in vitro myocardial inflammation model was developed in order to 
better understand the post-MI microenvironment. First, it was confirmed that activated 
subpopulations of macrophages could be generated. Macrophages were successfully 
polarized towards either a pro- or anti-inflammatory phenotype as evidenced by gene 
expression and cytokine secretion. Secreted factors from macrophage subpopulations 
were then used to culture mES-CM in an indirect co-culture model. Some significant 
changes were seen in the pro-inflammatory conditioned media group, including 
decreased cTnT and Serca2 expression. However, calcium-handling properties such as 
fractional release and SOCE were unchanged despite significantly higher levels of OPN, 
a matricellular protein hypothesized to cause significant changes in mES-CM calcium-
handling function. Inhibition of OPN significantly decreased SOCE in LPS and IL-4 
treated conditioned media groups and reduced ERK1/2 activation in those conditions. 
Furthermore, the addition of recombinant OPN at a concentration similar to plasma OPN 
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concentrations in patients’ post-MI induced significant up-regulation of SOCE in mES-
CM. Together, these data suggest for the first time a possible connection between OPN 
and SOCE in cardiomyocytes potentially through the regulation of ERK1/2.  
To determine the effects of direct cell-cell interaction on mES-CM calcium-
handling function a direct co-culture model was created with polarized macrophage 
subpopulations. Direct co-culture demonstrated that macrophage subsets had distinct 
effects on mES-CM calcium-handling function that changed over time. Specifically, 
mES-CM co-cultured with untreated and IL-4 treated macrophages exhibited 
significantly higher fractional release after 24 hours. However, only mES-CM co-
cultured with untreated macrophages kept the significantly increased fractional release by 
day 3. Additionally, SOCE response was unchanged after 24 hours but after 3 days, all 
co-culture conditions induced a significant depression of SOCE in mES-CM despite the 
significant up-regulation of OPN secretion in all co-culture conditions. This suggests that 
while macrophage secreted OPN may promote SOCE, direct contact with macrophages 
significantly suppresses SOCE in mES-CM.  
In summary, Aim 2 demonstrated direct cell-cell interaction with macrophages 
was necessary to elicit significant changes in mES-CM calcium-handling function. 
Additionally, it revealed a novel pathway involved in calcium-handling function of 
cardiomyocytes in the post-MI microenvironment. OPN has been explored clinically as a 
marker for myocardial injury and as a potential therapeutic target for post-MI 
remodeling. Results from Aim 2 further confirm OPN as an important regulator of 
cardiomyocyte calcium-handling function. Furthermore, OPN, if not regulated properly 
post-MI, could play an important role in the disruption of Ca2+ homeostasis, through 
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regulation of SOCE, leading to long-term pathological development and ultimately heart 
failure.  
While RAW264.7 cells were used in this study, further studies can be extended 
using other macrophages including primary bone marrow derived macrophages to better 
recapitulates the native microenvironment within the heart post-MI. The use of mouse 
derived cells limits the translation of the research and it would be necessary to repeat the 
studies with human derived cells to examine species dependency. Additionally, for Aim 
2, because stem cell derived cardiomyocytes do remain immature post-differentiation, it 
would be interesting to study the effects of activated macrophage subsets on adult 
cardiomyocytes to explore changes in their calcium-handling behavior as well.  
 Future studies for Aim 2 include further investigation of OPN and its effect on 
cardiomyocyte function and the development of maladaptive cardiac dysfunction and 
disease in an in vivo MI animal model. Because OPN is present in numerous tissues in 
the body and knock-out mice have demonstrated detrimental post-MI healing, methods 
for temporal and spatial regulation of OPN should be explored. One potential option is 
the use of an injectable hydrogel exhibiting release of an OPN inhibitor or exhibiting a 
mimic for OPN antibody. Additionally, the in vitro model could be enhanced through the 
addition of other characteristic of the post-MI microenvironment, such as induction of 
reactive oxygen species or mimicking the hypoxic environment of the infarct.  
 In conclusion, the presented results expand the current state of research in cardiac 
regenerative medicine by 1) demonstrating the potential of two electroactive biomaterials 
for the formation of functional cardiac tissues and by 2) creating a simplified in vitro 
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inflammation model of the highly complex post-MI microenvironment which could 
illuminate novel targets for the enhancement of post-MI remodeling and healing.  
  
	109 
APPENDIX A 
 
RT-PCR PRIMERS 
 
 
Table A.1 contains the forward and reverse primer sequences for all genes analyzed via 
RT-PCR.  245,246,278-285 
 
   
Table A.1 List of RT-PCR Primers 
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APPENDIX B 
 
SELF ASSEMBLING PEPTIDE HYDROGELS 
 
 
In Appendix B, mouse embryonic stem (mES) cells will be characterized in a self-
assembling peptide hydrogel (SAPH) 107.    
 
B.1 Introduction 
Embryonic stem cells (ESCs) can be successfully differentiated into cells of all three 
germ layers and have unlimited proliferation potential, making them an ideal cell source 
for regenerative medicinal applications 245. However, most early and current clinical trials 
related to regenerative cell injection or transplantation utilize adult autologous stem cells. 
As a result, these studies have failed to demonstrate complete tissue regeneration due to 
the inability of adult stem cells to differentiate into cells of interest, such as 
cardiomyocytes 86. Currently, The U.S. National Library of Medicine’s ClinicalTrials.gov 
website lists only 17 clinical trials involving embryonic stem cells or cells derived from 
their progenitors. In fact, the first clinical trial involving pluripotent stem cells or cells 
derived from them was completed less than a decade ago 286. This lack of approved trials 
is due to the safety concerns associated with pluripotent stem cell derived cells 286. For 
this reason, it is critical to develop a niche in which these cells can be matured into 
homogeneous somatic cell populations that maintain their mature phenotype post-
implantation.  
It has been also demonstrated that even if there were success in vitro with 
differentiating a mature population of somatic cells from pluripotent stem cell sources, 
there are still issues associated with the delivery including massive cell death after 
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injection 287 and limited retention or homing of the cells to the site of injury, limiting the 
potential benefits of these therapies 288. Because of this, researchers have begun to 
explore different materials, such as hydrogels, to address some of these hurdles.  
Self-assembling peptide hydrogels (SAPHs) are thixotropic —they liquefy under 
shear force and reassemble when the force is removed 108,109,289. This property allows 
them to flow during injection and then be reconstituted at the site of injection. This 
property may also protect the cells suspended in the 3D hydrogel during injection, 
promoting cell survival.  They can also be tailored to include specific sequences, such as 
a cell adhesion sequence like RGD. This could potentially increase retention of cells at 
the site of injury. In this study, ESCs are cultured in SAPH to examine spatiotemporally 
directed differentiation. Such cell-hydrogel combinations have great potential for site-
directed delivery via transcatheter implantation or direct injection into the desired site. 
 
B.2 Methods 
B.2.1 Peptide Synthesis 
Peptides were synthesized using solid-phase peptide synthesis with acetyl N-terminal and 
amide C-terminal protective groups, using methods described elsewhere 111,289 having a 
sequence of K-SLSLSL-RG-SLSLSL-K-G-RGDS, termed SLac. Peptide was the 
lyophilized before dissolution in 298 mM sucrose in water (Sigma Aldrich).  
 
B.2.2 mES Cell Seeding in SAPH 
MES were trypsinized (Gibco, Grand Island, NY) and then resuspended in LIF and 
serum-free mES cell medium at a density of 2 x 106 cells/mL. Cell solution was then 
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mixed with equal volume of 1% SLac peptide generating a 0.5% SLac SAPH with a 
density of 1 x 106 cells/mL. SAPH+mES were incubated for 15 minutes at 37 °C before 
LIF free mES cell medium was added. SAPH+mES were maintained for up to 28 days.   
 
B.2.3 SAPH+mES Characterization 
B.2.3.1 Cluster Measurement. Cell clusters within SAPH+mES were imaged in 
phase contrast using confocal fluorescence microscope (IX81 DSU, Olympus, Somerset, 
NJ) and cluster diameters were measured using ImageJ software. 
 
B.2.3.2 Cell Viability. A LIVE/DEAD Viability/Cytotoxicity kit (Life 
Technologies, NY) was used to determine viability of cells on scaffolds after 3 and 6 
days of culture. Briefly, scaffolds were rinsed with warm PBS and then stained with 0.2 
M ethidium homodimer and 0.005 M calcein for 30 minutes at 37 °C. Immunofluorescent 
images were obtained using a confocal fluorescence microscope (IX81 DSU, Olympus, 
Somerset, NJ) and the ratio of live/dead cells to the total number of cells was analyzed 
using ImageJ software. 
 
B.2.3.3 RT-PCR. Total RNA was extracted from SAPH+mES using TRIzol 
(Invitrogen, Carlsbad, CA) as previously described 290. Briefly, frozen tissues were 
thawed and homogenized in 1mL of TRIzol using a 20-G needle and syringe until totally 
dissolved, then incubated at room temperature for 5 minutes. Chloroform, 200 uL, was 
then added to mixture before shaking vigorously for 25 seconds followed by 2-minute 
incubation at room temperature. Samples are then centrifuged for 15 minutes at 12,000 
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RPM to generate a dual phase solution. The top phase is collected and then purified using 
the GenElute Mammalian Total RNA Miniprep Kit following manufacturers instruction. 
CDNA was created with 500ng of RNA and the High-Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Grand Island, NY) in the T100 Thermal Cycler 
(Bio-rad, Hercules, CA). RT-PCR reactions were then prepared with the SSo Advanced 
SYBRgreen Mastermix (Bio-rad, Hercules, CA) and the primers listed in Table A1 (IDT, 
Coralville, Iowa).245,246 The qPCR reaction was then run in a CFX Connect Real Time 
System (Bio-rad, Hercules, CA). Fold change increases in expression over mES cells in 
standard culture were calculated using the Comparative CT method as described 
previously.247  
 
B.2.4 Statistical Analysis 
Results are presented as mean ± standard deviation. Statistical analysis for gene 
expression was performed using a one-way ANOVA followed by Tukey post-hoc tests 
where appropriate. Statistical analysis for cluster diameter was performed using a two-
tailed independent samples t-test or its no- parametric equivalent Mann Whitney U test. 
Statistical significance was accepted for p<0.05. 
 
B.3 Results and Discussion 
MES were distributed in SLac and cultured for up to 28 days in LIF free media, allowing 
for stem cell differentiation. MES cells, which were initially distributed in the peptide, 
demonstrated high cellular viability (Figure B.1A).  Interestingly, by 7 days, mES cells 
start to form clusters and large viable mES cell clusters are apparent in the peptide 
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(Figure B.1B,F). Cluster size significantly increased at each time point (Figure B.2) and 
demonstrated high cellular viability for up to 4 weeks (Figure B.1D,H).  
 Gene expression profiles of mES cells cultured in SLac peptide were also 
examined up to 28 days in culture. Expression of classical pluripotency markers such as 
Nanog, Oct3/4, and Sox2 were examined.245 Expression of Oct3/4 was highest at 7 days 
while expression was significantly lower by day 28. Sox2 peaked at 14 days of culture 
with expression being significantly lower again at 4 weeks while Nanog expression 
remained similar throughout the 4 weeks of culture (Figure B.2A). This demonstrates that 
over the course of culture, mES cells began to differentiate, losing their pluripotent gene 
expression profile by day 28. All mesoderm markers analyzed remained statistically 
similar throughout the culture time; however, there was an increasing trend for Brachyury 
and Twist2 (Figure B.2B).245 Similarly, endoderm markers were up-regulated. However, 
Figure B.1 mES cell viability in SLac peptide hydrogels was assessed via Live/Dead 
assay (Live (green), dead (red)) at (a) day 0, (b) day 7, (c) day 14 and (d) day 28. 
Clusters within SLac SAPH were imaged after (e) 3, (f) 7, (g) 14 and (h) 28 days of 
culture. Scale bars = 50 µm. 
Source: Hitscherich, P. et al. Injectable Self-Assembling Peptide Hydrogels for Tissue Writing and 
Embryonic Stem Cell Culture. J. Biomed. Nanotech. 14, 802-807, (2018).	
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expression of PDX1, Sox17, and Pax4 did not change significantly over the culture 
period (Figure B.2C).246 Finally, ectoderm markers, including Fgf5 and Sox1, remained 
statistically similar with an increasing trend for up to 4 weeks while Otx2 was 
significantly down-regulated from day 3 to day 28 (Figure B.2D).245 These results 
demonstrate differentiation of mES cells into cells of all 3 germ layers, opening up the 
possibility of SAPH to be used as a platform for pluripotent stem cell differentiation. 
SAPH versatility also allows for the tailoring of peptide sequences to tissue or cell 
specific sequences, including pro-angiogenic functionality 111. 
 	
	
Figure B.2 Diameter of mES cell clusters in SAPH cultured for up to 28 days. (*,#,**, 
p<0.005) 
Source: Hitscherich, P. et al. Injectable Self-Assembling Peptide Hydrogels for Tissue Writing and 
Embryonic Stem Cell Culture. J. Biomed. Nanotech. 14, 802-807, (2018).		
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Figure B.3 Gene expression profiles of mES cells cultured in SAPH were analyzed up 
to 28 days using characteristic (a) pluripotent, (b) mesoderm, (c) endoderm and (d) 
ectoderm markers. N=3 for all groups. Similar Greek letters indicate no significant 
difference between days. (*p<0.05) 
Source: Hitscherich, P. et al. Injectable Self-Assembling Peptide Hydrogels for Tissue Writing and 
Embryonic Stem Cell Culture. J. Biomed. Nanotech. 14, 802-807, (2018).		
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APPENDIX C 
CELL CULTURE MEDIUM RECIPES 
 
This appendix includes the culture medium recipes for all of the presented studies.  
 
C.1 Mouse Embryonic Fibroblast (mEF) Culture Medium 
1. 500mL, DMEM, high glucose (GIBCO 11965-084) 
2. 58mL, FBS (Atlanta Biologicals S11550)  
3. 5.8mL, 100 x Penicillin/streptomycin (GIBCO 15140)  
4. 5.8mL, 100 x NEAA (GIBCO 11140)  
5. 5.8mL, 100 x Na-pyruvate (GIBCO 11360)  
 
C.2 Mouse Embryonic Stem (mES) Cell Culture Medium 
1. 500mL DMEM, High Glucose (GIBCO 11965-084)  
2. 90mL KN Serum Replacement (GIBCO 10828)  
3. 6.25mL 100x Penicillin/streptomycin (GIBCO 15140)  
4. 6.25mL 100x NEAA (GIBCO 11140)  
5. 6.25mL 100x Na-Pyruvate (GIBCO 11360)  
6. 4.4uL 2-Mercaptoethanol (Sigma M6250) 
7. LIF final Concentration is 5ng/mL in 50 mL aliquot (R&D 8878-LF) 
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C.3 mES Adaptation Culture Medium 
1. 500 mL IMDM (GIBCO 12440-053)  
2. 90 ml, KO Serum Replacement (GIBCO 10828)  
3. 6 mL, 100 x Penicillin/streptomycin (GIBCO 15140)  
4. 4.7 uL, 1-Thioglycerol (Sigma M6145) 
5. LIF final Concentration is 5ng/mL in 50 mL aliquot (R&D 8878-LF) 
 
C.4 mES Differentiation Culture Medium 
1. 85 mL, IMDM (GIBCO 12440-053)  
2. 15 mL, FBS (Atlanta Biologicals S11550) 
3. 1 mL, 100 x Penicillin/streptomycin (GIBCO 15140)   
4. 5 mg, L-Ascorbic acid: Final concentration is 5 µg/ml (Sigma Aldrich A4544) 
5. 0.78 uL 1-Thioglycerol (Sigma M6145)  
 
C.5 Serum Free Macrophage Culture Medium 
1. 50 mL, RPMI (Gibco 31800-022) 
2. 0.5 mL, 100x Penicillin/streptomycin (GIBCO 15140)  
 
C.6 Complete Macrophage Culture Medium 
1. 178 mL, RPMI (Gibco 31800-022) 
2. 20 mL, FBS (Atlanta Biologicals S11550) 
3. 2 mL, 100x Penicillin/streptomycin (GIBCO 15140) 
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APPENDIX D 
DETAILED MOUSE EMBRYONIC STEM CELL CULTURE AND 
DIFFERENTIATION 
 
This appendix describes the detailed protocol for mouse embryonic stem (mES) cell 
culture and differentiation into cardiomyocytes. 
 
D.1 Mouse Embryonic Fibroblast (mEF) Plating 
1. Coat 6 well plate with 0.1% gelatin (Sigma Aldrich G9391) for 1 hour in the 
incubator. 
2. Thaw a mEF vial (ThermoFisher Scientific A34959) in hands, transfer to 
clean 15 mL tube and add double volume of mEF medium.  
3. Centrifuge at 1000 rpm for 5 minutes and then decant old medium. 
4. Remove excess gelatin from plate and add 1 mL of mEF medium to each well. 
5. Suspend mEF in 6 mL of mEF medium and distribute 1 mL of cell suspension 
in each plate well. 
6. Bring plate to incubator and move the plate 7 times up and 7 times to the side 
in order to evenly distribute cells. 
7. Make sure to change medium every other day and to use wells and plates by 
day 14. 
 
D.2 Mouse Embryonic Stem (mES) Cell Passage 
1. Trypsinize with 500 uL of 0.05% (Gibco 25300-054) and 500 uL of .25% 
trypsin (Gibco 25200-056) for about 3 minutes.   
2. Rinse well with trypsin solution and then transfer to clean 15 mL tube.  
3. Add 1 mL of fresh mES-LIF medium directly to the cells in the tube and then 
use another 1 mL of fresh medium to rinse the dish again.  
4. Centrifuge at 1000 rpm for 5 minutes.  
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5. Decant off old medium and suspend in 2 mL of mES-LIF medium. 
6. After counting, take 0.04 million cells and plate in a new mEF-covered well 
with 3 mL of mES+LIF medium. 
 
D.3 mES Adaptation 
1. Coat tissue culture treated p35 dishes with 0.1% gelatin for 1 hour in the 
incubator. 
2. Pre-plate mES in tissue culture treated p35 uncoated dish for 30 minutes in 
incubator.  
3. Remove excess gelatin and seed 0.15 million pre-plated mES into each gelatin 
coated dishes with 2mL of Adaptation+LIF medium.  
4. Place in incubator and move in “figure 8” shape in order to evenly distribute 
the cells within the plate. 
 
D.4 Embryoid Body (EB) Formation 
1. Trypsinize as described for mES using differentiation medium.   
2. Count cells to determine how many differentiation plates can be made.  
a. Each drop is 15uL and must contain 1000 cells. 
b. Must use the multi pipette with 10 filtered 100uL tips. 
c. Must make 20 – 25 rows of hanging drops/dish. 
d. Calculate amount of suspension needed 
i. 15uL/drop * #rows * 10drops/row = ______ uL/plate 
ii. ____ uL/plate * # of plates = ______ uL suspension 
e. Calculate number of cells needed 
i. 1000cells/drop*10drops/row*# rows = ______ cells/plate 
ii. ____ cells/plate * # of plates = ______ cells 
3. Suspend the correct amount of cells in the correct amount of medium to create 
the suspension and make sure to mix very well. 
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4. Add 10-12 mL of 0.01% gelatin in the bottom surface of the 150 mm 
untreated culture dish to keep the hanging drops hydrated. 
5. Pour the suspension into a reagent reservoir. Be sure to not disturb the 
reservoir once the suspension is poured. 
6. Flip the lid of the 150 mm untreated culture dish and distribute the suspension 
in drops on the lid one row at a time.  Be careful to allow enough room 
between drops to keep them from merging.  
7. Invert the lid carefully and replace on the gelatin-coated bottom. 
8. Culture for 2 days. 
 
D.5 EB Collection 
1. Can only use a total of 5mL of differentiation medium per 150 mm plate.  
This includes the hanging drops themselves. 
a. 15uL/drop * #rows * 10drops/row = ______ uL 
b. Use the remaining amount of medium to collect EBs and wash the 
plate. 
2. Collect EBs from three 150 mm dishes into one 100 mm tissue culture dish. 
3. Allow the cells to differentiate for up to 10 days without medium change for 
mES-CM differentiation. 
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APPENDIX E 
MOUSE EMBRYONIC STEM CELL DERIVED CARDIOMYOCYTE 
PURIFICATION 
 
This appendix includes the recipes of all solutions necessary for as well as a detailed 
protocol of mouse embryonic stem cell-derived cardiomyocyte (mES-CM) purification. 
 
E.1 Reagent Recipes 
E.1.1 Collagenase I/II Solution  
1. 30 mg Collagenase I (Worthington Chemical LS004196) 
2. 30 mg Collagenase II (Worthington Chemical LS004176) 
3. 0.6 mL HBSS (Sigma Aldrich H1387)  
 
E.1.2 DNAse1 Solution 
1. 30 mg DNAse1 (Roche 10-104-159-001)  
2. 3 mL MilliQ water 
 
E.1.3 10X Clear ADS Buffer  
1. 500 mL of MilliQ water 
2. 34 g NaCl (Sigma Aldrich S5886) 
3. 23.8 g HEPES (Sigma H4034) 
4. 0.69 g NaH2PO4 (Sigma Aldrich S9638) 
5. 3 g Glucose (Sigma Aldrich G7528) 
6. 2 g KCl (J.T. Baker 3040-01) 
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7. 1.025 g MgSO4-7H2O (Sigma Aldrich 63138) 
8. Adjust pH to 7.4 
 
E.1.4 Percoll Stock Solution 
1. 5 mL 10X Clear ADS Buffer  
2. 45 mL Percoll Solution (Sigma Aldrich P4937) 
 
E.1.5 1X Red ADS Buffer 
1. 5 mL 10X clear ADS 
2. 45 mL Sterile MilliQ water 
3. Phenyl Red powder (Sigma Aldrich P5530) 
 
E.1.6 Top Gradient 
1. 22.5mL Percoll Stock Solution  
2. 27.5mL 1X Clear ADS Buffer  
 
E.1.7 Bottom Gradient 
1. 25mL Percoll Stock Solution  
2. 14mL 1X Red ADS Buffer 
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E.2 mES-CM Purification 
E.2.1 Embryoid Body (EB) Digestion Protocol 
1. Prepare digestion solution as follows: 
a. 100 µl Collagenase I 
b. 100 µl Collagenase II 
c. 325 µl Differentiation Medium  
2. Add DNAse1 to solution at 10 µl per 1ml digestion solution. 
3. Aspirate medium out of a 100 mm differentiation dish and pipette about 500 uL of 
digestion solution into the dish, and gently scrape cells off with a cell scrapper. 
Note: cells will come off in sheets. 
4. Transfer cells from the dish into a 15 mL tube using a 5 mL pipette. 
5. Repeat for all 100 mm dishes. 
6. Mix digestion solution and cells 10 times with 5 mL pipette to begin breaking up 
cell clusters. 
7. Incubate at 37°C in the water bath for 70 minutes in 20, 15, 15, 20 minute 
intervals. Gently dissociate the cells with a 5mL pipette about 10 times. 
8. Spin cells at 1000 rpm for 5 minutes and discard the supernatant. 
9. Suspend cells in 5 mL Differentiation Medium and count the cells, “initial cell 
count”.  
10. Spin cells again at 1000 rpm for 5 minutes and discard supernatant. 
11. Suspend in 2 mL of 1X Red ADS buffer per tube for Percoll separation. 
 
E.2.2 Percoll Separation Protocol 
1. Add 4 ml of top gradient to a 15 ml tube. 
2. Gently add 3 ml of bottom gradient underneath the top gradient by very slowly 
pipetting to maintain a clear interface between top and bottom gradients. 
3. Gently pipette 2 ml of the cells suspended in 1x red ADS to the top of the top 
gradient. 
This	amount	per		100mm	dish	
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4. And image of the gradients can be seen below: 
  
5. Spin at 4000 rpm for 30 min with NO deceleration. 
6. Cardiomyocytes will be located in the bottom portion. The top contains other cell 
types: 
 
7. Remove the top half portion and discard.  
8. Add 10 ml PBS to the bottom half in the tube and spin at 2000 rpm for 5 min to 
remove the Percoll gradient and discard supernatant. 
9. Suspend in differentiation media and count cells. 
10. Use as needed. 
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APPENDIX F 
SINGLE CELL CALCIUM-HANDLING ANALYSIS 
 
This appendix describes the recipes of all solutions necessary for as well as a detailed 
protocol of single cell calcium-handling analysis. 
 
F.1 Reagent Recipes 
F.1.1 Normal Tyrode’s (NT) Solution 
1. 15.896 g NaCL (136mM, Sigma Aldrich S5886)    
2. 0.805 g KCl (5.4mM, J.T. Baker 3040-01) 
3. 0.091 g NaH2PO4 (0.33mM, Sigma Aldrich S9638)    
4. 0.407 g MgCl2 (1mM, Sigma Aldrich M4880)          
5. 4.766 g HEPES (10mM, Sigma Aldrich H4034)      
6. 2 L MilliQ water 
7. Adjust pH to 7.4  
 
F.1.2 Modified NT Solution (Mod NT) 
1. 1 L NT 
2. 1.8 g glucose (Sigma Aldrich G7528) 
3. 1 mL of 1 M CaCl2 (Sigma Aldrich C5080) 
 
F.1.3 Calcium Free Mod NT (CF-Mod NT) Solution 
1. 1 L NT 
2. 1.8 g glucose (Sigma Aldrich G7528) 
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F.1.4 Caffeine (Caff) Solution  
1. 50 mL NT  
2. 97 mg caffeine (10 mM, Sigma Aldrich C-8960) 
3. Sonicate until dissolved 
 
F.1.5 Isoproterenol (Iso) Solution  
1. 5 uL of 10 mM stock solution (Sigma Aldrich I6504) 
2. 50 mL of Mod NT solution (1 uM)  
 
F.1.6 Store Operated Calcium Entry (SOCE) Solution 
1. 50 mL calcium free Mod NT 
2. 50 uL 10 mM stock cyclopiazonic acid (CPA) solution (Sigma Aldrich C1530) 
3. 97 mg caffeine (10 mM, Sigma Aldrich C-8960) 
F.1.7 Calcium Free SOCE (CF-SOCE) Solution 
1. 50 mL Mod NT 
2. 50 uL 10 mM stock cyclopiazonic acid (CPA) solution (Sigma Aldrich C1530) 
3. 97 mg caffeine (10 mM, Sigma Aldrich C-8960) 
F.2 Calcium-Handling Analysis 
F.2.1 Normal Calcium-Handling Analysis  
1. Incubate mES-CM with Rhod-2AM (4 µM, Invitrogen R1245MP) for 30 minutes. 
2. Replace solution with Mod NT for 20 minutes for AM cleavage. 
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3. Under constant perfusion with Mod NT, stimulate cells at 0.5, 1 and 2 Hz 
frequencies (4.5 ms duration, 150 V, Grass S48 Stimulator, Grass Medical 
Instruments) for 30 seconds. 
4. Stop stimulation for a minimum of 5 seconds. 
5. Switch perfusion solution to Caff solution for a minimum of 5 seconds.  
6. Switch perfusion solution back to Mod NT for 10 seconds. 
 
F.2.2 Iso Challenge 
1. Incubate mES-CM with Rhod-2AM (4 µM, Invitrogen R1245MP) for 30 minutes. 
2. Replace solution with Mod NT for 20 minutes for AM cleavage. 
3. Under constant perfusion with Mod NT, spontaneously contracting cells were 
recorded for at least 60 seconds. 
4. Switch perfusion solution to Iso solution for at east 60 seconds until frequency 
increase plateaus. 
 
F.2.3 SOCE 
1. Incubate mES-CM with Rhod-2AM (4 µM, Invitrogen R1245MP) for 30 minutes. 
2. Replace solution with Mod NT for 20 minutes for AM cleavage. 
3. Under constant perfusion with Mod NT, stimulate cells at 0.5 Hz frequency (4.5 
ms duration, 150 V, Grass S48 Stimulator, Grass Medical Instruments) in order to 
choose cells to examine. 
4. Perfuse cells with Mod NT solution for 10 seconds. 
5. Perfuse cells with CF-Mod NT solution for 10 seconds. 
6. Perfuse cells with Mod NT solution for 10 seconds. 
7. Perfuse cells with CF-Mod NT solution for 10 seconds. 
8. Perfuse cells with CF-SOCE solution for 10 seconds. 
9. Perfuse cells with CF-Mod NT solution for 10 seconds. 
10. Perfuse cells with SOCE solution for 10 seconds. 
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APPENDIX G 
DETAILED RT-PCR PROTOCOL 
 
This appendix describes the detailed protocol for RNA extraction, cDNA creation and 
RT-PCR. 
 
G.1 Reagents 
1. Β-mercaptoethanol (Sigma Aldrich M6250) 
2. RNA Isolation Kit (Sigma Aldrich RTN350) 
a. Lysis Buffer (L8285) 
b. Wash Buffer I (W3136) 
c. Wash Buffer II (W3261) 
d. Elution Solution (E8024) 
3. Nuclease Free Water (Invitrogen 10977-015) 
4. Ethanol (Fisher S25309) 
5. cDNA Kit (Applied Biosystems 4368814) 
a. 10X RT Buffer 
b. 25X dNTP Mix 
c. 10X RT Random Primers 
d. Multiscribe RT 
6. Sybrgreen Supermix (Applied Biosystems A25743) 
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G.2 Protocols 
G.2.1 Sample Preparation 
1. Determine approximate number of cells and make enough Lysis Buffer for all 
samples 
a. Up to 5 x 106 cells – 250 µL Lysis Buffer 
b. Over 5 x 106 cells – 500 µL Lysis Buffer 
2. Completely aspirate culture medium. 
3. Add appropriate amount of Lysis buffer to the dish. 
4. Collect the lysate using a cell scraper. 
5. Pipette the lysate into a micro-centrifuge tube. 
6. Vortex to mix and ensure that no visible clumps are present for at least 1 minute. 
7. Lysates can be used directly for RNA extraction or stored at -80 °C at this point. 
 
G.2.2 RNA Extraction 
1. Add 1:1 volume of 70% Ethanol to the homogenized lysate and mix well by 
pipetting.  
2. Transfer up to 700 µL including any precipitates into the RNA filter column.  
3. Centrifuge for 30 sec at >8000 g (10,000 rpm). Discard the flow through by 
decanting into waste beaker. 
4. If the sample exceeds 700 µL, centrifuge successive aliquots in the same RNA 
filter column. Discard the flow through. 
5. Add 500 uL of Wash Buffer I to the RNA filter column. Close the lid, centrifuge 
for 30 sec at >8000 g (10,000 rpm). Discard the flow through and collection tube. 
6. Move RNA filter column to new collection tube. 
7. Add 500 uL of Wash Buffer II to the RNA filter column. Close the lid, centrifuge 
for 30 sec at >8000 g (10,000 rpm) to wash the spin column membrane. Discard 
the flow through. 
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8. Add 500 uL of Wash Buffer II to the RNA filter column. Close the lid, centrifuge 
for 2 min at >8000 g (10,000 rpm) to wash the spin column membrane. Discard 
the flow through. 
9. Close the lid and centrifuge for 1 min at full speed (14,000 RPM) to dry the 
column. 
10. Place the RNA filter column in a new collection/recovery tube. 
11. Add 35 uL of Nuclease Free water directly on top of the membrane.  
12. The lid will not close at this point. Centrifuge for 1 to 1.5 min at 10,000 rpm to 
elute the RNA. 
13. If expected RNA yield is >30 µg, then repeat with additional 30-50 uL of water. 
14. Discard the column, put the cap back on the collection tube and save the sample 
over ice for use within 2hrs. For long term use save at -80 °C. 
 
G.2.3 RNA Quantification 
G.2.3.1 Method I 
1. Use NanoDrop in ICPH lab. Blank with Nuclease Free water and then measure 
“RNA-40” for each sample. Record 260/280, 260/230 and concentration. 
2. Dilute sample with Nuclease Free Water in order to generate a concentration that 
would have 200 ug in each cDNA reaction. 
 
G.2.3.2 Method II 1. Open	the	InfinitePro	software	and	go	the	Applications	bar	using	the	Tecan	16	Flat	Black	plate.	2. Set	to	needed	type	(RNA)		3. Add	2ul	drops	of	nuclease	free	water	to	each	well	for	blanking.	Close	the	lid.	Open	the	machine	(Infinite	M200	Pro)	and	put	in	the	plate.		4. After	blanking	is	done,	the	plate	will	come	out	5. Use	Kim	Wipe	to	clean	both	sides.	
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6. Add	2ul	of	your	sample	to	one	of	the	wells.	Highlight	on	the	software	the	wells	that	will	be	used.	7. Load	the	plate	into	the	machine	and	press	the	start	button	in	the	top	left	corner	(blue	play	button).		8. A	window	of	Microsoft	Excel	will	open	containing	both	purity	and	concentration	for	each	sample.	9. Use	the	concentration	data	to	dilute sample with Nuclease Free Water in order 
to generate a concentration that would have 200 ug in each cDNA reaction.	
 
G.2.4 cDNA Synthesis 
 
1. Allow the kit components to thaw on ice (Applied Biosystems 4368814). 
2. Prepare 2X RT master mix. This amount is required per reaction. For every 7 
reactions make one extra.  
a. 10X RT Buffer                           2 uL 
b. 25X dNTP Mix (100 mM)      0.8 uL 
c. 10X RT Random primers          2 uL 
d. Multiscribe RT                          1 uL   
e. Nuclease free water                4.2 uL 
TOTAL                       10 uL 
3. Place the 2X RT master mix on ice and mix gently by flicking the tube with your 
finger.  
4. Pipette 10 uL of 2X RT master mix into each well of a 96 well plate. 
5. Pipette 10 uL of RNA sample into their respective well and pipette up and down 
2-3 times gently to mix. 
6. Seal the plates with clear adhesive tape.  
7. Keep the tubes on ice till you are ready to load on the thermal cycler. 
8. Program the thermal cycler as follows: 
a. Step 1 – 10 minutes at 25°C 
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b. Step 2 – 120 minutes at 37°C 
c. Step 3 – 5 minutes at 85°C 
d. Step 4 – Infinity at 4°C 
9. Load the reactions into the T100 Thermal Cycler (Bio-rad).  
10. Set the reaction volume to 20 uL. 
11. Start the reverse transcription run.  
12. After the run is over, dilute each reaction 1:4 with Nuclease Free water, making 
the final volume 80uL. 
13. Aliquot samples here into 1, 2 or 3 gene aliquots (19uL/gene) according to the 
expected usage as cDNA is good for only one freeze and thaw cycle. 
14. Store samples at 4-6 °C for short-term use (24 hrs) or in -80 °C for long-term 
storage (up to a year).  
 
G.2.5 RT-PCR Protocol 
 
1. Make a layout of the plate. 
2. Thaw all components over ice. 
3. Run all samples in triplicates and always include a control on every plate, for 
every gene for comparison. 
4. Set up the reaction Master Mix as follows: This is determined with each 
individual kit but an example of one recipe is listed below: 
a. SYBRgreen Supermix (Applied Biosystems A25743)     10 uL 
b. Forward primer (10 uM)                                    2 uL 
c. Reverse primer (10 uM)                                  2 uL 
5. Make master mix for each gene, adding one extra reaction to account for loss with 
pipetting.  
6. The volume/reaction is 20 uL. 
7. Add 14ul of the appropriate Master Mix by pipetting carefully along the wall of 
the well. 
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8. Add 6ul of the appropriate cDNA samples to each well, pipetting up and down 3-
4 times to mix components. 
9. Open Bio-rad CFX Manager software and load the plate on the CFX Connect RT 
System (Bio-rad).  
10. Start a new protocol.  
11. This is determined by the Sybrgreen mix (Applied Biosystems A25743) as 
follows:  
a. 2 minutes @ 50°C 
b. 2 minutes @ 95°C 
c. 15 seconds @ 95°C 
d. 15 seconds @ 57°C 
e. 1 minute @ 72°C 
i. Cycle c, d and e for 50 cycles 
12. Read the Ct values on the software and export the data in an excel file. 
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APPENDIX H 
DENSITOMETRY PROTOCOL 
 
1. Save western blot images as .tif files. 
2. Open each blot in ImageJ software. 
3. Draw a rectangular box around lane 1 of the blot and press the #1. This should 
make a little “1” appear inside the rectangle you drew on the image. 
4. Using the keyboard arrows, move the rectangle to the right to now surround lane 
2 of the blot and press the #2. This should make a little “2” appear in the box 
surrounding lane 2. 
5. Repeat this process for all lanes, pressing #2 for all until the last lane when you 
would press #3. 
6. After pressing #3, a new window will appear containing a box for each lane with 
a peak inside. This represents the band in on the blot so they will differ depending 
on the size and darkness of the band. Hence, no peak will be present if there is no 
band in that lane. 
7. Then using the line tool, draw a line to close the bottom of the peaks at their 
minimums on either side. 
8. Then using the wand tool, highlight the now closed peaks and a third window will 
pop up with values representing the size and darkness of the bands.  
9. Repeat this for the loading control and use the values to make the protein of 
interest relative to the loading control. 
	136 
REFERENCES 
 
1  Streeter, D. D., Jr., Spotnitz, H. M., Patel, D. P., Ross, J., Jr. & Sonnenblick, E. H. 
Fiber Orientation in the Canine Left Ventricle During Diastole and Systole. Circ. 
Res. 24, 339-347, (1969). 
2  Pinto, A. R. et al. Revisiting Cardiac Cellular Composition. Circ. Res. 118, 400-409, 
(2016). 
3  Brutsaert, D. L. Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac 
Growth, Contractile Performance, and Rhythmicity. Physiol. Rev. 83, 59-115, 
(2003). 
4  Shah, A. M. et al. The Cardiac Endothelium: Cardioactive Mediators. Prog. 
Cardiovasc. Dis. 39, 263-284, (1996). 
5  Hulsmans, M. et al. Macrophages Facilitate Electrical Conduction in the Heart. Cell 
169, 510-522.e520, (2017). 
6  Benjamin, E. J. et al. Heart Disease and Stroke Statistics—2017 Update: A Report 
from the American Heart Association. Circulation, (2017). 
7  Heart Attack: What Is Your Risk? Am. Fam. Physician 82, 275, (2010). 
8  Mignone, J. L., Kreutziger, K. L., Paige, S. & Murry, C. E. Cardiogenesis from Human 
Embryonic Stem Cells: Mechanisms and Applications. Circ. J. 74, 2517-2526, 
(2010). 
9  Buikema, J. W., Van Der Meer, P., Sluijter, J. P. G. & Domian, I. J. Engineering 
Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue 
Engineering Technology. Stem Cells 31, 2587-2598, (2013). 
10 Tompkins, B. A., Natsumeda, M., Balkan, W. & Hare, J. M. What Is the Future of 
Cell-Based Therapy for Acute Myocardial Infarction. Circ. Res. 120, 252-255, 
(2017). 
11 Quyyumi, A. A. et al. Preserve-Ami: A Randomized, Double-Blind, Placebo-
Controlled Clinical Trial of Intracoronary Administration of Autologous Cd34+ 
	137 
Cells in Patients with Left Ventricular Dysfunction Post Stemi. Circ. Res. 120, 
324-331, (2017). 
12 Quyyumi, A. A. et al. Cd34(+) Cell Infusion after St Elevation Myocardial Infarction 
Is Associated with Improved Perfusion and Is Dose Dependent. Am. Heart J. 161, 
98-105, (2011). 
13 Frangogiannis, N. G. The Inflammatory Response in Myocardial Injury, Repair and 
Remodeling. Nat. Rev. Cardiol. 11, 255-265, (2014). 
14 Frangogiannis, N. G. Regulation of the Inflammatory Response in Cardiac Repair. 
Circ. Res. 110, 159-173, (2012). 
15 Lee, E. J. & Hitscherich, P. Cardiac Tissue Engineering. Vol. 2 (Hoboken, NJ): Wiley 
(2017). 
16 Laflamme, M. A. & Murry, C. E. Heart Regeneration. Nature 473, 326-335, (2011). 
17 Murry, C. E., Reinecke, H. & Pabon, L. M. Regeneration Gaps: Observations on Stem 
Cells and Cardiac Repair. J. Am. Coll. Cardiol. 47, 1777-1785, (2006). 
18 Bergmann, O. et al. Dynamics of Cell Generation and Turnover in the Human Heart. 
Cell 161, 1566-1575, (2015). 
19 Pope, J. H. et al. Missed Diagnoses of Acute Cardiac Ischemia in the Emergency 
Department. N. Engl. J. Med. 342, 1163-1170, (2000). 
20 Suter, R. E. The Risk of Missed Diagnosis of Acute Myocardial Infarction Associated 
with Emergency Department Volume. Ann. Emerg. Med. 50, 203; author reply 
203-204, (2007). 
21 Mccarthy, B. D., Beshansky, J. R., D'agostino, R. B. & Selker, H. P. Missed 
Diagnoses of Acute Myocardial Infarction in the Emergency Department: Results 
from a Multicenter Study. Ann. Emerg. Med. 22, 579-582, (1993). 
22 Eschenhagen, T. et al. Cardiomyocyte Regeneration: A Consensus Statement. 
Circulation 136, 680-686, (2017). 
	138 
23 Cambria, E. et al. Translational Cardiac Stem Cell Therapy: Advancing from First-
Generation to Next-Generation Cell Types. NPJ Regen. Med. 2, 17, (2017). 
24 Dixit, P. & Katare, R. Challenges in Identifying the Best Source of Stem Cells for 
Cardiac Regeneration Therapy. Stem Cell. Res. Ther. 6, 1-12, (2015). 
25 Ellison, G. M. et al. Cardiac Stem and Progenitor Cell Identification: Different 
Markers for the Same Cell? Front. Biosci. 2, 641-652, (2010). 
26 Li, T.-S. et al. Direct Comparison of Different Stem Cell Types and Subpopulations 
Reveals Superior Paracrine Potency and Myocardial Repair Efficacy with 
Cardiosphere-Derived Cells. J. Am. Coll. Cardiol. 59, 942-953, (2012). 
27 Chugh, A. R. et al. Administration of Cardiac Stem Cells in Patients with Ischemic 
Cardiomyopathy: The Scipio Trial: Surgical Aspects and Interim Analysis of 
Myocardial Function and Viability by Magnetic Resonance. Circulation 126, 
S54-64, (2012). 
28 Bolli, R. et al. Cardiac Stem Cells in Patients with Ischaemic Cardiomyopathy 
(Scipio): Initial Results of a Randomised Phase 1 Trial. Lancet 378, 1847-1857, 
(2011). 
29 Makkar, R. R. et al. Intracoronary Cardiosphere-Derived Cells for Heart Regeneration 
after Myocardial Infarction (Caduceus): A Prospective, Randomised Phase 1 
Trial. Lancet 379, 895-904, (2012). 
30 Pittenger, M. F. et al. Multilineage Potential of Adult Human Mesenchymal Stem 
Cells. Science 284, 143-147, (1999). 
31 De Ugarte, D. A. et al. Comparison of Multi-Lineage Cells from Human Adipose 
Tissue and Bone Marrow. Cells Tissues Organs 174, 101-109, (2003). 
32 Song, L. & Tuan, R. S. Transdifferentiation Potential of Human Mesenchymal Stem 
Cells Derived from Bone Marrow. FASEB J. 18, 980-982, (2004). 
33 Jiang, Y. et al. Pluripotency of Mesenchymal Stem Cells Derived from Adult Marrow. 
Nature 418, 41-49, (2002). 
	139 
34 Toma, C., Pittenger, M. F., Cahill, K. S., Byrne, B. J. & Kessler, P. D. Human 
Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the 
Adult Murine Heart. Circulation 105, 93-98, (2002). 
35 Barry, F. P., Murphy, J. M., English, K. & Mahon, B. P. Immunogenicity of Adult 
Mesenchymal Stem Cells: Lessons from the Fetal Allograft. Stem Cells Dev 14, 
252-265, (2005). 
36 Ankrum, J. A., Ong, J. F. & Karp, J. M. Mesenchymal Stem Cells: Immune Evasive, 
Not Immune Privileged. Nat. Biotechnol. 32, 252-260, (2014). 
37 Martens, T. P. et al. Mesenchymal Lineage Precursor Cells Induce Vascular Network 
Formation in Ischemic Myocardium. Nat. Clin. Pract. Cardiovasc. Med. 3 Suppl 
1, S18-22, (2006). 
38 Hoffmann, J. et al. Angiogenic Effects Despite Limited Cell Survival of Bone 
Marrow-Derived Mesenchymal Stem Cells under Ischemia. Thorac. Cardiovasc. 
Surg. 58, 136-142, (2010). 
39 Rennert, R. C., Sorkin, M., Garg, R. K. & Gurtner, G. C. Stem Cell Recruitment after 
Injury: Lessons for Regenerative Medicine. Regen. Med. 7, 833-850, (2012). 
40 Tomita, S. et al. Autologous Transplantation of Bone Marrow Cells Improves 
Damaged Heart Function. Circulation 100, II247-256, (1999). 
41 Jiang, W. et al. Intravenous Transplantation of Mesenchymal Stem Cells Improves 
Cardiac Performance after Acute Myocardial Ischemia in Female Rats. Transpl. 
Int. 19, 570-580, (2006). 
42 Berry, M. F. et al. Mesenchymal Stem Cell Injection after Myocardial Infarction 
Improves Myocardial Compliance. Am. J. Physiol. Heart Circ. Physiol. 290, 
H2196-2203, (2006). 
43 Quevedo, H. C. et al. Allogeneic Mesenchymal Stem Cells Restore Cardiac Function 
in Chronic Ischemic Cardiomyopathy Via Trilineage Differentiating Capacity. 
Proc. Natl. Acad. Sci. U. S. A. 106, 14022-14027, (2009). 
	140 
44 Williams, A. R. et al. Intramyocardial Stem Cell Injection in Patients with Ischemic 
Cardiomyopathy: Functional Recovery and Reverse Remodeling. Circ. Res. 108, 
792-796, (2011). 
45 Li, Y., Yao, Y., Sheng, Z., Yang, Y. & Ma, G. Dual-Modal Tracking of Transplanted 
Mesenchymal Stem Cells after Myocardial Infarction. Int. J. Nanomedicine 6, 
815-823, (2011). 
46 Hare, J. M. et al. A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation 
Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) after 
Acute Myocardial Infarction. J. Am. Coll. Cardiol. 54, 2277-2286, (2009). 
47 Chen, S. L. et al. Effect on Left Ventricular Function of Intracoronary Transplantation 
of Autologous Bone Marrow Mesenchymal Stem Cell in Patients with Acute 
Myocardial Infarction. Am. J. Cardiol. 94, 92-95, (2004). 
48 Assmus, B. et al. Transplantation of Progenitor Cells and Regeneration Enhancement 
in Acute Myocardial Infarction (Topcare-Ami). Circulation 106, 3009-3017, 
(2002). 
49 Strauer, B. E. et al. Repair of Infarcted Myocardium by Autologous Intracoronary 
Mononuclear Bone Marrow Cell Transplantation in Humans. Circulation 106, 
1913-1918, (2002). 
50 Gaebel, R. et al. Cell Origin of Human Mesenchymal Stem Cells Determines a 
Different Healing Performance in Cardiac Regeneration. PLoS One 6, e15652, 
(2011). 
51 Alvarez-Dolado, M. et al. Fusion of Bone-Marrow-Derived Cells with Purkinje 
Neurons, Cardiomyocytes and Hepatocytes. Nature 425, 968-973, (2003). 
52 Nygren, J. M. et al. Bone Marrow-Derived Hematopoietic Cells Generate 
Cardiomyocytes at a Low Frequency through Cell Fusion, but Not 
Transdifferentiation. Nat. Med. 10, 494-501, (2004). 
53 Kinnaird, T. et al. Marrow-Derived Stromal Cells Express Genes Encoding a Broad 
Spectrum of Arteriogenic Cytokines and Promote in Vitro and in Vivo 
Arteriogenesis through Paracrine Mechanisms. Circ. Res. 94, 678-685, (2004). 
	141 
54 Schaefer, A. et al. Long-Term Effects of Intracoronary Bone Marrow Cell Transfer on 
Diastolic Function in Patients after Acute Myocardial Infarction: 5-Year Results 
from the Randomized-Controlled Boost Trial--an Echocardiographic Study. Eur. 
J. Echocardiogr. 11, 165-171, (2010). 
55 Meyer, G. P. et al. Intracoronary Bone Marrow Cell Transfer after Myocardial 
Infarction: 5-Year Follow-up from the Randomized-Controlled Boost Trial. Eur. 
Heart J. 30, 2978-2984, (2009). 
56 Acimovic, I. et al. Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research 
and Therapeutic Tools. Biomed. Res. Int. 2014, 512831, (2014). 
57 Xu, C., Police, S., Rao, N. & Carpenter, M. K. Characterization and Enrichment of 
Cardiomyocytes Derived from Human Embryonic Stem Cells. Circ. Res. 91, 501-
508, (2002). 
58 He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A. & Kamp, T. J. Human Embryonic Stem 
Cells Develop into Multiple Types of Cardiac Myocytes: Action Potential 
Characterization. Circ. Res. 93, 32-39, (2003). 
59 Takahashi, K. et al. Induction of Pluripotent Stem Cells from Adult Human 
Fibroblasts by Defined Factors. Cell 131, 861-872, (2007). 
60 Du Pre, B. C., Doevendans, P. A. & Van Laake, L. W. Stem Cells for Cardiac Repair: 
An Introduction. J. Geriatr. Cardiol. 10, 186-197, (2013). 
61 Seki, T. & Fukuda, K. Methods of Induced Pluripotent Stem Cells for Clinical 
Application. World J. Stem Cells 7, 116-125, (2015). 
62 Pawani, H. & Bhartiya, D. Pluripotent Stem Cells for Cardiac Regeneration: Overview 
of Recent Advances & Emerging Trends. Indian J. Med. Res. 137, 270-282, 
(2013). 
63 Taranger, C. K. et al. Induction of Dedifferentiation, Genomewide Transcriptional 
Programming, and Epigenetic Reprogramming by Extracts of Carcinoma and 
Embryonic Stem Cells. Mol. Biol. Cell 16, 5719-5735, (2005). 
64 Bru, T. et al. Rapid Induction of Pluripotency Genes after Exposure of Human 
Somatic Cells to Mouse Es Cell Extracts. Exp. Cell Res. 314, 2634-2642, (2008). 
	142 
65 Carey, B. W., Markoulaki, S., Beard, C., Hanna, J. & Jaenisch, R. A Single-Gene 
Transgenic Mouse Strain for Reprogramming Adult Somatic Cells. Nat. Methods 
7, 56-59, (2010). 
66 Chen, S., Zhang, Q., Wu, X., Schultz, P. G. & Ding, S. Dedifferentiation of Lineage-
Committed Cells by a Small Molecule. J. Am. Chem. Soc. 126, 410-411, (2004). 
67 Lin, S. L. et al. Mir-302 Reprograms Human Skin Cancer Cells into a Pluripotent Es-
Cell-Like State. RNA 14, 2115-2124, (2008). 
68 Lee, M. Y. et al. High Density Cultures of Embryoid Bodies Enhanced Cardiac 
Differentiation of Murine Embryonic Stem Cells. Biochem. Biophys. Res. 
Commun. 416, 51-57, (2011). 
69 Ungrin, M. D., Joshi, C., Nica, A., Bauwens, C. & Zandstra, P. W. Reproducible, 
Ultra High-Throughput Formation of Multicellular Organization from Single Cell 
Suspension-Derived Human Embryonic Stem Cell Aggregates. PLoS One 3, 
e1565, (2008). 
70 Bauwens, C. L. et al. Control of Human Embryonic Stem Cell Colony and Aggregate 
Size Heterogeneity Influences Differentiation Trajectories. Stem Cells 26, 2300-
2310, (2008). 
71 Mummery, C. L. et al. Differentiation of Human Es and Ips Cells to Cardiomyocytes: 
A Methods Overview. Circ. Res. 111, 344-358, (2012). 
72 Laflamme, M. A. et al. Cardiomyocytes Derived from Human Embryonic Stem Cells 
in Pro-Survival Factors Enhance Function of Infarcted Rat Hearts. Nat. Biotech. 
25, 1015-1024, (2007). 
73 Zhang, J. et al. Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation 
of Human Pluripotent Stem Cells: The Matrix Sandwich Method. Circ. Res. 111, 
1125-1136, (2012). 
74 Mummery, C. et al. Cardiomyocyte Differentiation of Mouse and Human Embryonic 
Stem Cells. J. Anat. 200, 233-242, (2002). 
75 Narazaki, G. et al. Directed and Systematic Differentiation of Cardiovascular Cells 
from Mouse Induced Pluripotent Stem Cells. Circulation 118, 498-506, (2008). 
	143 
76 Singla, D. K., Long, X., Glass, C., Singla, R. D. & Yan, B. Induced Pluripotent Stem 
(Ips) Cells Repair and Regenerate Infarcted Myocardium. Mol. Pharm. 8, 1573-
1581, (2011). 
77 Lepperhof, V. et al. Bioluminescent Imaging of Genetically Selected Induced 
Pluripotent Stem Cell-Derived Cardiomyocytes after Transplantation into 
Infarcted Heart of Syngeneic Recipients. PLoS One 9, e107363, (2014). 
78 Van Laake, L. W. et al. Human Embryonic Stem Cell-Derived Cardiomyocytes 
Survive and Mature in the Mouse Heart and Transiently Improve Function after 
Myocardial Infarction. Stem Cell Res. 1, 9-24, (2007). 
79 Shiba, Y. et al. Hesc-Derived Cardiomyocytes Electrically Couple and Suppress 
Arrhythmias in Injured Hearts. Nature 489, 322-325, (2012). 
80 Dai, W. et al. Survival and Maturation of Human Embryonic Stem Cell-Derived 
Cardiomyocytes in Rat Hearts. J. Mol. Cell. Cardiol. 43, 504-516, (2007). 
81 Caspi, O. et al. Transplantation of Human Embryonic Stem Cell-Derived 
Cardiomyocytes Improves Myocardial Performance in Infarcted Rat Hearts. J. 
Am. Coll. Cardiol. 50, 1884-1893, (2007). 
82 Fernandes, S. et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Engraft 
but Do Not Alter Cardiac Remodeling after Chronic Infarction in Rats. J. Mol. 
Cell. Cardiol. 49, 941-949, (2010). 
83 Chong, J. J. H. et al. Human Embryonic Stem Cell-Derived Cardiomyocytes 
Regenerate Non-Human Primate Hearts. Nature 510, 273-277, (2014). 
84 Laflamme, M. A. et al. Formation of Human Myocardium in the Rat Heart from 
Human Embryonic Stem Cells. Am. J. Pathol. 167, 663-671, (2005). 
85 Yang, X., Pabon, L. & Murry, C. E. Engineering Adolescence: Maturation of Human 
Pluripotent Stem Cell-Derived Cardiomyocytes. Circ. Res. 114, 511-523, (2014). 
86 Haraguchi, Y., Shimizu, T., Yamato, M. & Okano, T. Concise Review: Cell Therapy 
and Tissue Engineering for Cardiovascular Disease. Stem Cells Transl Med 1, 
136-141, (2012). 
	144 
87 Schmid, P. et al. Ventricular Myocardial Architecture as Visualised in Postmortem 
Swine Hearts Using Magnetic Resonance Diffusion Tensor Imaging. Eur. J. 
Cardiothorac. Surg. 27, 468-472, (2005). 
88 Chung, C. Y., Bien, H. & Entcheva, E. The Role of Cardiac Tissue Alignment in 
Modulating Electrical Function. J. Cardiovasc. Electrophysiol. 18, 1323-1329, 
(2007). 
89 Slaughter, B. V., Khurshid, S. S., Fisher, O. Z., Khademhosseini, A. & Peppas, N. A. 
Hydrogels in Regenerative Medicine. Adv. Mater. 21, 3307-3329, (2009). 
90 Eschenhagen, T. et al. Three-Dimensional Reconstitution of Embryonic 
Cardiomyocytes in a Collagen Matrix: A New Heart Muscle Model System. 
FASEB J. 11, 683-694, (1997). 
91 Barocas, V. H., Girton, T. S. & Tranquillo, R. T. Engineered Alignment in Media 
Equivalents: Magnetic Prealignment and Mandrel Compaction. J. Biomech. Eng. 
120, 660-666, (1998). 
92 Kolodney, M. S. & Wysolmerski, R. B. Isometric Contraction by Fibroblasts and 
Endothelial Cells in Tissue Culture: A Quantitative Study. J. Cell Biol. 117, 73-
82, (1992). 
93 Costa, K. D., Lee, E. J. & Holmes, J. W. Creating Alignment and Anisotropy in 
Engineered Heart Tissue: Role of Boundary Conditions in a Model Three-
Dimensional Culture System. Tissue Eng. 9, 567-577, (2003). 
94 Zimmermann, W. H. et al. Tissue Engineering of a Differentiated Cardiac Muscle 
Construct. Circ. Res. 90, 223-230, (2002). 
95 Lee, E. J., Kim Do, E., Azeloglu, E. U. & Costa, K. D. Engineered Cardiac Organoid 
Chambers: Toward a Functional Biological Model Ventricle. Tissue Eng. Part A 
14, 215-225, (2008). 
96 Black, L. D., 3rd, Meyers, J. D., Weinbaum, J. S., Shvelidze, Y. A. & Tranquillo, R. 
T. Cell-Induced Alignment Augments Twitch Force in Fibrin Gel-Based 
Engineered Myocardium Via Gap Junction Modification. Tissue Eng. Part A 15, 
3099-3108, (2009). 
	145 
97  Birla, R. K. et al. Methodology for the Formation of Functional, Cell-Based Cardiac 
Pressure Generation Constructs in Vitro. In Vitro Cell. Dev. Biol. Anim. 44, 340-
350, (2008). 
98  Zhang, D. et al. Tissue-Engineered Cardiac Patch for Advanced Functional 
Maturation of Human Esc-Derived Cardiomyocytes. Biomaterials 34, 5813-5820, 
(2013). 
99  Zimmermann, W. H. et al. Engineered Heart Tissue Grafts Improve Systolic and 
Diastolic Function in Infarcted Rat Hearts. Nat. Med. 12, 452-458, (2006). 
100 Zimmermann, W. H. & Eschenhagen, T. Cardiac Tissue Engineering for 
Replacement Therapy. Heart Fail. Rev. 8, 259-269, (2003). 
101 Wendel, J. S., Ye, L., Zhang, P., Tranquillo, R. T. & Zhang, J. J. Functional 
Consequences of a Tissue-Engineered Myocardial Patch for Cardiac Repair in a 
Rat Infarct Model. Tissue Eng. Part A 20, 1325-1335, (2014). 
102 Young, J. L. & Engler, A. J. Hydrogels with Time-Dependent Material Properties 
Enhance Cardiomyocyte Differentiation in Vitro. Biomaterials 32, 1002-1009, 
(2011). 
103 Bearzi, C. et al. Plgf-Mmp9-Engineered Ips Cells Supported on a Peg-Fibrinogen 
Hydrogel Scaffold Possess an Enhanced Capacity to Repair Damaged 
Myocardium. Cell Death Dis. 5, e1053, (2014). 
104 Johnson, T. D. & Christman, K. L. Injectable Hydrogel Therapies and Their Delivery 
Strategies for Treating Myocardial Infarction. Expert Opin. Drug Deliv. 10, 59-
72, (2013). 
105 Ravichandran, R., Venugopal, J. R., Sundarrajan, S., Mukherjee, S. & Ramakrishna, 
S. Minimally Invasive Cell-Seeded Biomaterial Systems for Injectable/Epicardial 
Implantation in Ischemic Heart Disease. Int. J. Nanomedicine 7, 5969-5994, 
(2012). 
106 Fujimoto, K. L. et al. Synthesis, Characterization and Therapeutic Efficacy of a 
Biodegradable, Thermoresponsive Hydrogel Designed for Application in Chronic 
Infarcted Myocardium. Biomaterials 30, 4357-4368, (2009). 
	146 
107 Hitscherich, P. et al. Injectable Self-Assembling Peptide Hydrogels for Tissue 
Writing and Embryonic Stem Cell Culture. J. Biomed. Nanotech. 14, 802-807, 
(2018). 
108 Galler, K. M., Aulisa, L., Regan, K. R., D'souza, R. N. & Hartgerink, J. D. Self-
Assembling Multidomain Peptide Hydrogels: Designed Susceptibility to 
Enzymatic Cleavage Allows Enhanced Cell Migration and Spreading. J. Am. 
Chem. Soc. 132, 3217-3223, (2010). 
109 Kumar, V. A. et al. Self-Assembling Multidomain Peptides Tailor Biological 
Responses through Biphasic Release. Biomaterials 52, 71-78, (2015). 
110 Kumar, V. A. et al. Treatment of Hind Limb Ischemia Using Angiogenic Peptide 
Nanofibers. Biomaterials 98, 113-119, (2016). 
111 Kumar, V. A. et al. Highly Angiogenic Peptide Nanofibers. ACS nano 9, 860-868, 
(2015). 
112 Gonnerman, E. A., Kelkhoff, D. O., Mcgregor, L. M. & Harley, B. A. The Promotion 
of Hl-1 Cardiomyocyte Beating Using Anisotropic Collagen-Gag Scaffolds. 
Biomaterials 33, 8812-8821, (2012). 
113 Kai, D., Prabhakaran, M. P., Jin, G. & Ramakrishna, S. Guided Orientation of 
Cardiomyocytes on Electrospun Aligned Nanofibers for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. B Appl. Biomater. 98, 379-386, (2011). 
114 Pok, S. et al. Biocompatible Carbon Nanotube-Chitosan Scaffold Matching the 
Electrical Conductivity of the Heart. ACS Nano 8, 9822-9832, (2014). 
115 Nunes, S. S. et al. Biowire: A New Platform for Maturation of Human Pluripotent 
Stem Cell Derived Cardiomyocytes. Nat. Methods 10, 781-787, (2013). 
116 Radisic, M. et al. Functional Assembly of Engineered Myocardium by Electrical 
Stimulation of Cardiac Myocytes Cultured on Scaffolds. Proc. Natl. Acad. Sci. U. 
S. A. 101, 18129-18134, (2004). 
117 Weber, N., Lee, Y. S., Shanmugasundaram, S., Jaffe, M. & Arinzeh, T. L. 
Characterization and in Vitro Cytocompatibility of Piezoelectric Electrospun 
Scaffolds. Acta Biomater. 6, 3550-3556, (2010). 
	147 
118 Damaraju, S. M., Wu, S., Jaffe, M. & Arinzeh, T. L. Structural Changes in Pvdf 
Fibers Due to Electrospinning and Its Effect on Biological Function. Biomed. 
Mater. 8, 045007, (2013). 
119 Lee, Y. S. & Arinzeh, T. L. The Influence of Piezoelectric Scaffolds on Neural 
Differentiation of Human Neural Stem/Progenitor Cells. Tissue Eng. Part A 18, 
2063-2072, (2012). 
120 Martins, P. M. et al. Effect of Poling State and Morphology of Piezoelectric 
Poly(Vinylidene Fluoride) Membranes for Skeletal Muscle Tissue Engineering. 
RSC Advances 3, 17938-17944, (2013). 
121 Kotwal, A. & Schmidt, C. E. Electrical Stimulation Alters Protein Adsorption and 
Nerve Cell Interactions with Electrically Conducting Biomaterials. Biomaterials 
22, 1055-1064, (2001). 
122 Xu, Y., Takai, M. & Ishihara, K. Protein Adsorption and Cell Adhesion on Cationic, 
Neutral, and Anionic 2-Methacryloyloxyethyl Phosphorylcholine Copolymer 
Surfaces. Biomaterials 30, 4930-4938, (2009). 
123 Yang, X. L., Gu, J. W. & Zhu, H. S. Preparation of Bioelectret Collagen and Its 
Influence on Cell Culture in Vitro. J. Mater. Sci. Mater. Med. 17, 767-771, 
(2006). 
124 Hsiao, C. W. et al. Electrical Coupling of Isolated Cardiomyocyte Clusters Grown on 
Aligned Conductive Nanofibrous Meshes for Their Synchronized Beating. 
Biomaterials 34, 1063-1072, (2013). 
125 You, J. O., Rafat, M., Ye, G. J. & Auguste, D. T. Nanoengineering the Heart: 
Conductive Scaffolds Enhance Connexin 43 Expression. Nano Lett. 11, 3643-
3648, (2011). 
126 Martins, A. M. et al. Electrically Conductive Chitosan/Carbon Scaffolds for Cardiac 
Tissue Engineering. Biomacromolecules 15, 635-643, (2014). 
127 Zhou, J. et al. Engineering the Heart: Evaluation of Conductive Nanomaterials for 
Improving Implant Integration and Cardiac Function. Sci. Rep. 4, (2014). 
	148 
128 Lee, T. J. et al. Graphene Enhances the Cardiomyogenic Differentiation of Human 
Embryonic Stem Cells. Biochem. Biophys. Res. Commun. 452, 174-180, (2014). 
129 Kim, T., Kahng, Y. H., Lee, T., Lee, K. & Kim Do, H. Graphene Films Show Stable 
Cell Attachment and Biocompatibility with Electrogenic Primary Cardiac Cells. 
Mol. Cells 36, 577-582, (2013). 
130 Park, J. et al. Graphene‒Regulated Cardiomyogenic Differentiation Process of 
Mesenchymal Stem Cells by Enhancing the Expression of Extracellular Matrix 
Proteins and Cell Signaling Molecules. Adv. Healthcare Mat. 3, 176-181, (2014). 
131 Sayyar, S. et al. Covalently Linked Biocompatible Graphene/Polycaprolactone 
Composites for Tissue Engineering. Carbon 52, 296-304, (2013). 
132 Fan, H. et al. Fabrication, Mechanical Properties, and Biocompatibility of Graphene-
Reinforced Chitosan Composites. Biomacromolecules 11, 2345-2351, (2010). 
133 Shin, S. R. et al. Cell-Laden Microengineered and Mechanically Tunable Hybrid 
Hydrogels of Gelatin and Graphene Oxide. Adv. Mater. 25, 6385-6391, (2013). 
134 Wan, C. & Chen, B. Poly(Epsilon-Caprolactone)/Graphene Oxide Biocomposites: 
Mechanical Properties and Bioactivity. Biomed. Mater. 6, 055010, (2011). 
135 Pinto, A. M., Gonçalves, I. C. & Magalhães, F. D. Graphene-Based Materials 
Biocompatibility: A Review. Colloids Surf. B. Biointerfaces 111, 188-202, 
(2013). 
136 Goenka, S., Sant, V. & Sant, S. Graphene-Based Nanomaterials for Drug Delivery 
and Tissue Engineering. J. Control. Release 173, 75-88, (2014). 
137 Zhang, Y., Nayak, T. R., Hong, H. & Cai, W. Graphene: A Versatile Nanoplatform 
for Biomedical Applications. Nanoscale 4, 3833-3842, (2012). 
138 Marchant, D. J. et al. Inflammation in Myocardial Diseases. Circ. Res. 110, 126-144, 
(2012). 
139 Swirski, F. K. & Nahrendorf, M. Leukocyte Behavior in Atherosclerosis, Myocardial 
Infarction, and Heart Failure. Science 339, 161-166, (2013). 
	149 
140 Frangogiannis, N. G. Emerging Roles for Macrophages in Cardiac Injury: 
Cytoprotection, Repair, and Regeneration. J. Clin. Invest. 125, 2927-2930, (2015). 
141 Nathan, C. & Ding, A. Nonresolving Inflammation. Cell 140, 871-882, (2010). 
142 Troidl, C. et al. Classically and Alternatively Activated Macrophages Contribute to 
Tissue Remodelling after Myocardial Infarction. J. Cell. Mol. Med. 13, 3485-
3496, (2009). 
143 Heinemann, J. C. et al. Cb2 Receptor-Mediated Effects of Pro-Inflammatory 
Macrophages Influence Survival of Cardiomyocytes. Life Sci. 138, 18-28, (2015). 
144 Trial, J., Rossen, R. D., Rubio, J. & Knowlton, A. A. Inflammation and Ischemia: 
Macrophages Activated by Fibronectin Fragments Enhance the Survival of 
Injured Cardiac Myocytes. Exp. Biol. Med. 229, 538-545, (2004). 
145 Ai, X. et al. Microfluidic Coculture Device for Monitoring of Inflammation-Induced 
Myocardial Injury Dynamics. Anal. Chem. 90, 4485-4494, (2018). 
146 Hitscherich, P. et al. The Effect of Pvdf-Trfe Scaffolds on Stem Cell Derived 
Cardiovascular Cells. Biotechnol. Bioeng. 113, 1577-1585, (2016). 
147 Robertson, C., Tran, D. D. & George, S. C. Concise Review: Maturation Phases of 
Human Pluripotent Stem Cell-Derived Cardiomyocytes. Stem Cells 31, 
10.1002/stem.1331, (2013). 
148 Hitscherich, P. et al. Electroactive Graphene Composite Scaffolds for Cardiac Tissue 
Engineering. J. Biomed. Mater. Res. A 106, 2923-2933, (2018). 
149 Go, A. S. et al. Heart Disease and Stroke Statistics--2014 Update: A Report from the 
American Heart Association. Circulation 129, e28-e292, (2014). 
150 Zimmermann, W. H. et al. Three-Dimensional Engineered Heart Tissue from 
Neonatal Rat Cardiac Myocytes. Biotechnol. Bioeng. 68, 106-114, (2000). 
151 Akins, R. E., Schroedl, N. A., Gonda, S. R. & Hartzell, C. R. Neonatal Rat Heart 
Cells Cultured in Simulated Microgravity. In Vitro Cell. Dev. Biol. Anim. 33, 337-
343, (1997). 
	150 
152 Freed, L. E. & Vunjak-Novakovic, G. Microgravity Tissue Engineering. In Vitro 
Cell. Dev. Biol. Anim. 33, 381-385, (1997). 
153 Wainwright, J. M. et al. Preparation of Cardiac Extracellular Matrix from an Intact 
Porcine Heart. Tissue Eng. Part C Methods 16, 525-532, (2010). 
154 Sarig, U. et al. Thick Acellular Heart Extracellular Matrix with Inherent Vasculature: 
A Potential Platform for Myocardial Tissue Regeneration. Tissue Eng. Part A 18, 
2125-2137, (2012). 
155 Zhang, J. et al. Functional Cardiomyocytes Derived from Human Induced 
Pluripotent Stem Cells. Circ. Res. 104, e30-e41, (2009). 
156 E, L. L. et al. Enrichment of Cardiomyocytes Derived from Mouse Embryonic Stem 
Cells. J. Heart Lung Transplant. 25, 664-674, (2006). 
157 Muller, M. et al. Selection of Ventricular-Like Cardiomyocytes from Es Cells in 
Vitro. FASEB J. 14, 2540-2548, (2000). 
158 Jain, N. & Lee, E. J. Islet Endothelial Cells Derived from Mouse Embryonic Stem 
Cells. Cell Transplant., (2015). 
159 Lee, Y. S., Collins, G. & Arinzeh, T. L. Neurite Extension of Primary Neurons on 
Electrospun Piezoelectric Scaffolds. Acta Biomater. 7, 3877-3886, (2011). 
160 Zhao, Z. et al. Modulation of Intracellular Calcium Waves and Triggered Activities 
by Mitochondrial Ca Flux in Mouse Cardiomyocytes. PLoS One 8, e80574, 
(2013). 
161 Zhao, Z. et al. Revisiting the Ionic Mechanisms of Early Afterdepolarizations in 
Cardiomyocytes: Predominant by Ca Waves or Ca Currents? Am. J. Physiol. 
Heart Circ. Physiol. 302, H1636-1644, (2012). 
162 Worsdorfer, P. et al. Connexin Expression and Functional Analysis of Gap 
Junctional Communication in Mouse Embryonic Stem Cells. Stem Cells 26, 431-
439, (2008). 
	151 
163 Tandon, N. et al. Electrical Stimulation Systems for Cardiac Tissue Engineering. 
Nat. Protoc. 4, 155-173, (2009). 
164 Arshi, A. et al. Rigid Microenvironments Promote Cardiac Differentiation of Mouse 
and Human Embryonic Stem Cells. Sci. Technol. Adv. Mater. 14, (2013). 
165 Yang, H.-T. et al. The Ryanodine Receptor Modulates the Spontaneous Beating Rate 
of Cardiomyocytes During Development. Proc. Natl. Acad. Sci. U. S. A. 99, 9225-
9230, (2002). 
166 Fujiwara, M. et al. Induction and Enhancement of Cardiac Cell Differentiation from 
Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A. PLoS 
One 6, e16734, (2011). 
167 Van Kempen, M. J., Fromaget, C., Gros, D., Moorman, A. F. & Lamers, W. H. 
Spatial Distribution of Connexin43, the Major Cardiac Gap Junction Protein, in 
the Developing and Adult Rat Heart. Circ. Res. 68, 1638-1651, (1991). 
168 Boheler, K. R. et al. Differentiation of Pluripotent Embryonic Stem Cells into 
Cardiomyocytes. Circ. Res. 91, 189-201, (2002). 
169 Liu, J., Fu, J. D., Siu, C. W. & Li, R. A. Functional Sarcoplasmic Reticulum for 
Calcium Handling of Human Embryonic Stem Cell-Derived Cardiomyocytes: 
Insights for Driven Maturation. Stem Cells 25, 3038-3044, (2007). 
170 Marks, A. R. Intracellular Calcium-Release Channels: Regulators of Cell Life and 
Death. Am. J. Physiol. 272, H597-605, (1997). 
171 Hu, P. et al. Salbutamol and Chronic Low-Frequency Stimulation of Canine Skeletal 
Muscle. J. Physiol. 496, 221-227, (1996). 
172 Satin, J. et al. Calcium Handling in Human Embryonic Stem Cell-Derived 
Cardiomyocytes. Stem Cells 26, 1961-1972, (2008). 
173 Bassani, R. A., Ricardo, R. A. & Bassani, J. W. Estimation of the Fractional 
Sarcoplasmic Reticulum Ca2+ Release in Intact Cardiomyocytes Using Integrated 
Ca2+ Fluxes. Gen. Physiol. Biophys. 31, 401-408, (2012). 
	152 
174 Palchesko, R. N., Lathrop, K. L., Funderburgh, J. L. & Feinberg, A. W. In Vitro 
Expansion of Corneal Endothelial Cells on Biomimetic Substrates. Sci. Rep. 5, 
7955, (2015). 
175 Atkins, G. B., Jain, M. K. & Hamik, A. Endothelial Differentiation: Molecular 
Mechanisms of Specification and Heterogeneity. Arterioscler. Thromb. Vasc. 
Biol. 31, 1476-1484, (2011). 
176 Hofmann, J. J. & Iruela-Arispe, M. L. Notch Signaling in Blood Vessels: Who Is 
Talking to Whom About What? Circ. Res. 100, 1556-1568, (2007). 
177 Im, S. H., Kim, C. Y., Jung, Y., Jang, Y. & Kim, S. H. Biodegradable Vascular 
Stents with High Tensile and Compressive Strength: A Novel Strategy for 
Applying Monofilaments Via Solid-State Drawing and Shaped-Annealing 
Processes. Biomater. Sci. 5, 422-431, (2017). 
178 Radisic, M. et al. Biomimetic Approach to Cardiac Tissue Engineering: Oxygen 
Carriers and Channeled Scaffolds. Tissue Eng. 12, 2077-2091, (2006). 
179 Neal, R. A. et al. Three-Dimensional Elastomeric Scaffolds Designed with Cardiac-
Mimetic Structural and Mechanical Features. Tissue Eng. Part A 19, 793-807, 
(2013). 
180 Yeong, W. Y. et al. Porous Polycaprolactone Scaffold for Cardiac Tissue 
Engineering Fabricated by Selective Laser Sintering. Acta Biomater. 6, 2028-
2034, (2010). 
181 Ku, S. H., Lee, M. & Park, C. B. Carbon-Based Nanomaterials for Tissue 
Engineering. Adv. Healthc. Mater. 2, 244-260, (2013). 
182 Cong, H.-P., Chen, J.-F. & Yu, S.-H. Graphene-Based Macroscopic Assemblies and 
Architectures: An Emerging Material System. Chem. Soc. Rev. 43, 7295-7325, 
(2014). 
183 Shin, S. R. et al. Carbon-Nanotube-Embedded Hydrogel Sheets for Engineering 
Cardiac Constructs and Bioactuators. ACS Nano 7, 2369-2380, (2013). 
	153 
184 Chan, V., Raman, R., Cvetkovic, C. & Bashir, R. Enabling Microscale and 
Nanoscale Approaches for Bioengineered Cardiac Tissue. ACS Nano 7, 1830-
1837, (2013). 
185 Martinelli, V. et al. Improving Cardiac Myocytes Performance by Carbon Nanotubes 
Platforms. Front. Physiol. 4, 239, (2013). 
186 Martinelli, V. et al. Carbon Nanotubes Promote Growth and Spontaneous Electrical 
Activity in Cultured Cardiac Myocytes. Nano Lett. 12, 1831-1838, (2012). 
187 Martinelli, V. et al. Carbon Nanotubes Instruct Physiological Growth and 
Functionally Mature Syncytia: Nongenetic Engineering of Cardiac Myocytes. 
ACS Nano 7, 5746-5756, (2013). 
188 Ravichandran, P. et al. Induction of Apoptosis in Rat Lung Epithelial Cells by 
Multiwalled Carbon Nanotubes. J. Biochem. Mol. Toxicol. 23, 333-344, (2009). 
189 Ye, S. et al. Multi-Walled Carbon Nanotubes Induce Apoptosis in Raw 264.7 Cell-
Derived Osteoclasts through Mitochondria-Mediated Death Pathway. J. Nanosci. 
Nanotechnol. 12, 2101-2112, (2012). 
190 Andon, F. T. & Fadeel, B. Programmed Cell Death: Molecular Mechanisms and 
Implications for Safety Assessment of Nanomaterials. Acc. Chem. Res. 46, 733-
742, (2013). 
191 Wang, J., Sun, P., Bao, Y., Liu, J. & An, L. Cytotoxicity of Single-Walled Carbon 
Nanotubes on Pc12 Cells. Toxicol. In Vitro 25, 242-250, (2011). 
192 Foldvari, M. & Bagonluri, M. Carbon Nanotubes as Functional Excipients for 
Nanomedicines: Ii. Drug Delivery and Biocompatibility Issues. Nanomedicine 4, 
183-200, (2008). 
193 Yamaguchi, A. et al. Effects of Sustained Stimulation with Multi-Wall Carbon 
Nanotubes on Immune and Inflammatory Responses in Mice. J. Toxicol. Sci. 37, 
177-189, (2012). 
194 Buzea, C., Pacheco, Ii & Robbie, K. Nanomaterials and Nanoparticles: Sources and 
Toxicity. Biointerphases 2, MR17-71, (2007). 
	154 
195 Madani, S. Y., Mandel, A. & Seifalian, A. M. A Concise Review of Carbon 
Nanotube's Toxicology. Nano Reviews 4, 10.3402/nano.v3404i3400.21521, 
(2013). 
196 Zhao, J., Park, H., Han, J. & Lu, J. P. Electronic Properties of Carbon Nanotubes 
with Covalent Sidewall Functionalization. J. Phys. Chem. B 108, 4227-4230, 
(2004). 
197 Wang, J. et al. Graphene Sheet-Induced Global Maturation of Cardiomyocytes 
Derived from Human Induced Pluripotent Stem Cells. ACS Appl. Mater. 
Interfaces 9, 25929-25940, (2017). 
198 Ahadian, S. et al. Graphene Induces Spontaneous Cardiac Differentiation in 
Embryoid Bodies. Nanoscale 8, 7075-7084, (2016). 
199 Murray, E. et al. A Bio-Friendly, Green Route to Processable, Biocompatible 
Graphene/Polymer Composites. RSC Advances 5, 45284-45290, (2015). 
200 Aphale, A. N. et al. Fabrication and Experimental Analysis of Axially Oriented 
Nanofibers. J. Nanosci. Nanotechnol. 16, 2668-2676, (2016). 
201 Roy, S., Mitra, K., Desai, C., Petrova, R. & Mitra, S. Detonation Nanodiamonds and 
Carbon Nanotubes as Reinforcements in Epoxy Composites—a Comparative 
Study. J. Nanotechnol. Eng. Med. 4, 011008-011008, (2013). 
202 J.O. Aguilar, J. R. B.-Q., F. Aviles. Influence of Carbon Nanotube Clustering on the 
Electrical Conductivity of Polymer Composite Films. eXPRESS Polymer Letters 
4, 292-299, (2010). 
203 Hernandez, D. et al. Electrical Stimulation Promotes Cardiac Differentiation of 
Human Induced Pluripotent Stem Cells. Stem Cells Int 2016, 1718041, (2016). 
204 Kashou, A. H. & Kashou, H. E.      (StatPearls Publishing LLC., 2017). 
205 Spearman, B. S. et al. Conductive Interpenetrating Networks of Polypyrrole and 
Polycaprolactone Encourage Electrophysiological Development of Cardiac Cells. 
Acta Biomater. 28, 109-120, (2015). 
	155 
206 Ishii, O., Shin, M., Sueda, T. & Vacanti, J. P. In Vitro Tissue Engineering of a 
Cardiac Graft Using a Degradable Scaffold with an Extracellular Matrix–Like 
Topography. J. Thorac. Cardiovasc. Surg. 130, 1358-1363, (2005). 
207 Fearnley, C. J., Roderick, H. L. & Bootman, M. D. Calcium Signaling in Cardiac 
Myocytes. Cold Spring Harb. Perspect. Biol. 3, a004242, (2011). 
208 Barry, W. H. & Bridge, J. H. Intracellular Calcium Homeostasis in Cardiac 
Myocytes. Circulation 87, 1806-1815, (1993). 
209 Sato, D., Despa, S. & Bers, Donald m. Can the Sodium-Calcium Exchanger Initiate 
or Suppress Calcium Sparks in Cardiac Myocytes? Biophys. J. 102, L31-L33, 
(2012). 
210 Zhang, Y. et al. Connexin43 Expression Levels Influence Intercellular Coupling and 
Cell Proliferation of Native Murine Cardiac Fibroblasts. Cell Commun. Adhes. 15, 
289-303, (2008). 
211 Baumgartner, S. et al. Electrophysiological and Morphological Maturation of Murine 
Fetal Cardiomyocytes During Electrical Stimulation in Vitro. J. Cardiovasc. 
Pharmacol. Ther. 20, 104-112, (2015). 
212 Dewald, O. et al. Ccl2/Monocyte Chemoattractant Protein-1 Regulates Inflammatory 
Responses Critical to Healing Myocardial Infarcts. Circ. Res. 96, 881-889, 
(2005). 
213 Yan, X. et al. Temporal Dynamics of Cardiac Immune Cell Accumulation Following 
Acute Myocardial Infarction. J. Mol. Cell. Cardiol. 62, 24-35, (2013). 
214 Miao, L. et al. Hydrogen Sulfide Mitigates Myocardial Infarction Via Promotion of 
Mitochondrial Biogenesis-Dependent M2 Polarization of Macrophages. Antioxid. 
Redox Signal. 25, 268-281, (2016). 
215 Shiraishi, M. et al. Alternatively Activated Macrophages Determine Repair of the 
Infarcted Adult Murine Heart. J. Clin. Invest. 126, 2151-2166, (2016). 
216 Melton, D. W., Mcmanus, L. M., Gelfond, J. a. L. & Shireman, P. K. Temporal 
Phenotypic Features Distinguish Polarized Macrophages in Vitro. Autoimmunity 
48, 161-176, (2015). 
	156 
217 Nahrendorf, M. et al. The Healing Myocardium Sequentially Mobilizes Two 
Monocyte Subsets with Divergent and Complementary Functions. J. Exp. Med. 
204, 3037-3047, (2007). 
218 Ma, Y., Mouton, A. J. & Lindsey, M. L. Cardiac Macrophage Biology in the Steady-
State Heart, the Aging Heart, and Following Myocardial Infarction. Trans. Res. 
191, 15-28, (2018). 
219 Heidt, T. et al. Differential Contribution of Monocytes to Heart Macrophages in 
Steady-State and after Myocardial Infarction. Circ. Res. 115, 284-295, (2014). 
220 Huynh, M. L., Fadok, V. A. & Henson, P. M. Phosphatidylserine-Dependent 
Ingestion of Apoptotic Cells Promotes Tgf-Beta1 Secretion and the Resolution of 
Inflammation. J. Clin. Invest. 109, 41-50, (2002). 
221 Huebener, P. et al. Cd44 Is Critically Involved in Infarct Healing by Regulating the 
Inflammatory and Fibrotic Response. J. Immunol. 180, 2625, (2008). 
222 Ji, N., Lou, H., Gong, X., Fu, T. & Ni, S. Treatment with 3-Bromo-4,5-
Dihydroxybenzaldehyde Improves Cardiac Function by Inhibiting Macrophage 
Infiltration in Mice. Korean Circ. J. 48, 933-943, (2018). 
223 Tokutome, M. et al. Ppargamma-Targeting Nanomedicine Promotes Cardiac Healing 
after Acute Myocardial Infarction by Skewing Monocyte/Macrophage 
Polarization in Preclinical Animal Models. Cardiovasc. Res., (2018). 
224 Frangogiannis, N. G. Matricellular Proteins in Cardiac Adaptation and Disease. 
Physiol. Rev. 92, 635-688, (2012). 
225 Frangogiannis, N. G. et al. Critical Role of Endogenous Thrombospondin-1 in 
Preventing Expansion of Healing Myocardial Infarcts. Circulation 111, 2935-
2942, (2005). 
226 Misenheimer, T. M. & Mosher, D. F. Calcium Ion Binding to Thrombospondin 1. J. 
Biol. Chem. 270, 1729-1733, (1995). 
227 Calzada, M. J. et al. Calcium Indirectly Regulates Immunochemical Reactivity and 
Functional Activities of the N-Domain of Thrombospondin-1. Matrix Biol. 27, 
339-351, (2008). 
	157 
228 Luo, X. et al. Stim1-Dependent Store-Operated Ca(2)(+) Entry Is Required for 
Pathological Cardiac Hypertrophy. J. Mol. Cell. Cardiol. 52, 136-147, (2012). 
229 Youm, J. B. Electrophysiological Properties and Calcium Handling of Embryonic 
Stem Cell-Derived Cardiomyocytes. Integr. Med. Res. 5, 3-10, (2016). 
230 Ambily, A. et al. The Role of Plasma Membrane Stim1 and Ca(2+)Entry in Platelet 
Aggregation. Stim1 Binds to Novel Proteins in Human Platelets. Cell. Signal. 26, 
502-511, (2014). 
231 Duquette, M. et al. Members of the Thrombospondin Gene Family Bind Stromal 
Interaction Molecule 1 and Regulate Calcium Channel Activity. Matrix Biol. 37, 
15-24, (2014). 
232 De Haan, J. J., Smeets, M. B., Pasterkamp, G. & Arslan, F. Danger Signals in the 
Initiation of the Inflammatory Response after Myocardial Infarction. Mediators 
Inflamm. 2013, 206039, (2013). 
233 Murry, C. E., Giachelli, C. M., Schwartz, S. M. & Vracko, R. Macrophages Express 
Osteopontin During Repair of Myocardial Necrosis. Am. J. Pathol. 145, 1450-
1462, (1994). 
234 Waller, A. H., Sanchez-Ross, M., Kaluski, E. & Klapholz, M. Osteopontin in 
Cardiovascular Disease: A Potential Therapeutic Target. Cardiol. Rev. 18, 125-
131, (2010). 
235 Xie, Z., Singh, M. & Singh, K. Osteopontin Modulates Myocardial Hypertrophy in 
Response to Chronic Pressure Overload in Mice. Hypertension 44, 826-831, 
(2004). 
236 Stawowy, P. et al. Increased Myocardial Expression of Osteopontin in Patients with 
Advanced Heart Failure. Eur. J. Heart Fail. 4, 139-146, (2002). 
237 Graf, K. et al. Myocardial Osteopontin Expression Is Associated with Left 
Ventricular Hypertrophy. Circulation 96, 3063-3071, (1997). 
238 Trueblood, N. A. et al. Exaggerated Left Ventricular Dilation and Reduced Collagen 
Deposition after Myocardial Infarction in Mice Lacking Osteopontin. Circ. Res. 
88, 1080-1087, (2001). 
	158 
239 Shirakawa, K. et al. Il-10-Stat3-Galectin-3 Axis Is Essential for Osteopontin-
Producing Reparative Macrophage Polarization after Myocardial Infarction. 
Circulation, (2018). 
240 Lan, F. et al. Abnormal Calcium Handling Properties Underlie Familial Hypertrophic 
Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells. 
Cell Stem Cell 12, 101-113, (2013). 
241 Rosenberg, P. Socking It to Cardiac Hypertrophy: Stim1-Mediated Ca2+ Entry in the 
Cardiomyocyte. Circulation 124, 766-768, (2011). 
242 Hulot, J. S. et al. Critical Role for Stromal Interaction Molecule 1 in Cardiac 
Hypertrophy. Circulation 124, 796-805, (2011). 
243 Zheng, C. et al. Gastrodin Inhibits Store-Operated Ca(2+) Entry and Alleviates 
Cardiac Hypertrophy. Front. Pharmacol. 8, 222, (2017). 
244 Martinez, F. O. & Gordon, S. The M1 and M2 Paradigm of Macrophage Activation: 
Time for Reassessment. F1000Prime Reports 6, 13, (2014). 
245 Poh, Y. C. et al. Generation of Organized Germ Layers from a Single Mouse 
Embryonic Stem Cell. Nat. Commun. 5, 4000, (2014). 
246 Schroeder, I. S., Rolletschek, A., Blyszczuk, P., Kania, G. & Wobus, A. M. 
Differentiation of Mouse Embryonic Stem Cells to Insulin-Producing Cells. Nat. 
Protoc. 1, 495-507, (2006). 
247 Schmittgen, T. D. & Livak, K. J. Analyzing Real-Time Pcr Data by the Comparative 
C(T) Method. Nat. Protoc. 3, 1101-1108, (2008). 
248 Nakipova, O. V. et al. Store-Operated Ca(2+) Entry Supports Contractile Function in 
Hearts of Hibernators. PLoS One 12, e0177469, (2017). 
249 Mckay, R. G. et al. Left Ventricular Remodeling after Myocardial Infarction: A 
Corollary to Infarct Expansion. Circulation 74, 693-702, (1986). 
	159 
250 Pfeffer, M. A. & Braunwald, E. Ventricular Remodeling after Myocardial Infarction. 
Experimental Observations and Clinical Implications. Circulation 81, 1161-1172, 
(1990). 
251 Mcwhorter, F. Y., Wang, T., Nguyen, P., Chung, T. & Liu, W. F. Modulation of 
Macrophage Phenotype by Cell Shape. Proc. Natl. Acad. Sci. U. S. A. 110, 17253-
17258, (2013). 
252 Mosser, D. M. & Edwards, J. P. Exploring the Full Spectrum of Macrophage 
Activation. Nat. Rev. Immunol. 8, 958-969, (2008). 
253 Chung, J., Choi, M. J., Jeong, S. Y., Oh, J. S. & Kim, H. K. Chemokines Gene 
Expression of Raw 264.7 Cells by Actinobacillus Actinomycetemcomitans 
Lipopolysaccharide Using Microarray and Rt-Pcr Analysis. Mol. Cells 27, 257-
261, (2009). 
254 Kobusiak-Prokopowicz, M. et al. Kinetics of Chemokines in Acute Myocardial 
Infarction. Kardiol. Pol. 62, 301-314; discussion 315-306, (2005). 
255 Choi, P. & Reiser, H. Il-4: Role in Disease and Regulation of Production. Clin. Exp. 
Immunol. 113, 317-319, (1998). 
256 Bers, D. M. Cardiac Excitation-Contraction Coupling. Nature 415, 198-205, (2002). 
257 Currie, S. & Smith, G. L. Enhanced Phosphorylation of Phospholamban and 
Downregulation of Sarco/Endoplasmic Reticulum Ca2+ Atpase Type 2 (Serca 2) 
in Cardiac Sarcoplasmic Reticulum from Rabbits with Heart Failure. Cardiovasc. 
Res. 41, 135-146, (1999). 
258 Fernandes, A. A. et al. Serca-2a Is Involved in the Right Ventricular Function 
Following Myocardial Infarction in Rats. Life Sci. 124, 24-30, (2015). 
259 Kojima, A., Kitagawa, H., Omatsu-Kanbe, M., Matsuura, H. & Nosaka, S. Presence 
of Store-Operated Ca2+ Entry in C57bl/6j Mouse Ventricular Myocytes and Its 
Suppression by Sevoflurane. Br. J. Anaesth. 109, 352-360, (2012). 
260 Wen, H. Z., Z. ; Fefelova, N. ; Xie, Lh. Potential Arrhythmohenic Role of Trpc 
Channels and Store-Operated Calcium Entry Mechanism in Mouse Ventricular 
Myocytes. Front. Physiol. (In Press), (2018). 
	160 
261 Subraman, V., Thiyagarajan, M., Malathi, N. & Rajan, S. T. Opn -Revisited. J. Clin. 
Diagn. Res. 9, ZE10-13, (2015). 
262 Komatsubara, I. et al. Spatially and Temporally Different Expression of Osteonectin 
and Osteopontin in the Infarct Zone of Experimentally Induced Myocardial 
Infarction in Rats. Cardiovasc. Pathol. 12, 186-194, (2003). 
263 Bornstein, P. & Sage, E. H. Matricellular Proteins: Extracellular Modulators of Cell 
Function. Curr. Opin. Cell Biol. 14, 608-616, (2002). 
264 Robertson, B. W., Bonsal, L. & Chellaiah, M. A. Regulation of Erk1/2 Activation by 
Osteopontin in Pc3 Human Prostate Cancer Cells. Mol. Cancer 9, 260-260, 
(2010). 
265 Kahles, F., Findeisen, H. M. & Bruemmer, D. Osteopontin: A Novel Regulator at the 
Cross Roads of Inflammation, Obesity and Diabetes. Mol. Metab. 3, 384-393, 
(2014). 
266 Dalal, S. et al. Osteopontin Stimulates Apoptosis in Adult Cardiac Myocytes Via the 
Involvement of Cd44 Receptors, Mitochondrial Death Pathway, and Endoplasmic 
Reticulum Stress. Am. J. Physiol. Heart Circ. Physiol. 306, H1182-1191, (2014). 
267 Lopez-Guerrero, A. M., Pascual-Caro, C., Martin-Romero, F. J. & Pozo-Guisado, E. 
Store-Operated Calcium Entry Is Dispensable for the Activation of Erk1/2 
Pathway in Prostate Cancer Cells. Cell. Signal. 40, 44-52, (2017). 
268 Pozo-Guisado, E. et al. Phosphorylation of Stim1 at Erk1/2 Target Sites Modulates 
Store-Operated Calcium Entry. J. Cell Sci. 123, 3084-3093, (2010). 
269 Suezawa, C. et al. Time-Dependent Changes in Plasma Osteopontin Levels in 
Patients with Anterior-Wall Acute Myocardial Infarction after Successful 
Reperfusion: Correlation with Left-Ventricular Volume and Function. J. Lab. 
Clin. Med. 145, 33-40, (2005). 
270 Hofmann, U. & Frantz, S. Role of Stromal Cell Derived Factor-1 in Myocardial 
Healing—Novel Insights from Comparative Studies in the Fetal and Postnatal 
Myocardium. Transl. Pediatr. 7, 239-241, (2018). 
	161 
271 Saxena, A. et al. Stromal Cell-Derived Factor-1 Alpha Is Cardioprotective after 
Myocardial Infarction. Circulation 117, 2224-2231, (2008). 
272 Jarrah, A. A. et al. Sdf-1 Induces Tnf-Mediated Apoptosis in Cardiac Myocytes. 
Apoptosis 23, 79-91, (2018). 
273 Lambert, J. M., Lopez, E. F. & Lindsey, M. L. Macrophage Roles Following 
Myocardial Infarction. Int. J. Cardiol. 130, 147-158, (2008). 
274 Ye, Y. et al. Serum Chemokine Ccl17/Thymus Activation and Regulated Chemokine 
Is Correlated with Coronary Artery Diseases. Atherosclerosis 238, 365-369, 
(2015). 
275 Vandervelde, S. et al. Increased Inflammatory Response and Neovascularization in 
Reperfused Vs. Non-Reperfused Murine Myocardial Infarction. Cardiovasc. 
Pathol. 15, 83-90, (2006). 
276 Lutz, M. et al. Osteopontin Predicts Clinical Outcome in Patients after Treatment of 
Severe Aortic Stenosis with Transcatheter Aortic Valve Implantation (Tavi). 
Open Heart 4, e000633-e000633, (2017). 
277 Rosenberg, M. et al. Osteopontin, a New Prognostic Biomarker in Patients with 
Chronic Heart Failure. Circ. Heart Fail. 1, 43-49, (2008). 
278 Unni, E., Kittrell, F. S., Singh, U. & Sinha, R. Osteopontin Is a Potential Target Gene 
in Mouse Mammary Cancer Chemoprevention by Se-Methylselenocysteine. 
Breast Cancer Res. 6, R586-592, (2004). 
279 Breitkopf, K. et al. Thrombospondin 1 Acts as a Strong Promoter of Transforming 
Growth Factor Beta Effects Via Two Distinct Mechanisms in Hepatic Stellate 
Cells. Gut 54, 673-681, (2005). 
280 Nishii, K. et al. Targeted Disruption of the Cardiac Troponin T Gene Causes 
Sarcomere Disassembly and Defects in Heartbeat within the Early Mouse 
Embryo. Dev. Biol. 322, 65-73, (2008). 
281 Wuytack, F. et al. A Sarco/Endoplasmic Reticulum Ca(2+)-Atpase 3-Type Ca2+ 
Pump Is Expressed in Platelets, in Lymphoid Cells, and in Mast Cells. J. Biol. 
Chem. 269, 1410-1416, (1994). 
	162 
282 Pugach, E. K., Richmond, P. A., Azofeifa, J. G., Dowell, R. D. & Leinwand, L. A. 
Prolonged Cre Expression Driven by the Alpha-Myosin Heavy Chain Promoter 
Can Be Cardiotoxic. J. Mol. Cell. Cardiol. 86, 54-61, (2015). 
283 Oshima, Y. et al. Pivotal Role of Bcl-2 Family Proteins in the Regulation of 
Chondrocyte Apoptosis. J. Biol. Chem. 283, 26499-26508, (2008). 
284 Ni, H.-M. et al. Caspase Inhibition Prevents Tumor Necrosis Factor-Α–Induced 
Apoptosis and Promotes Necrotic Cell Death in Mouse Hepatocytes In vivo and 
In vitro. Am. J. Pathol. 186, 2623-2636, (2016). 
285 Wang, X., Spandidos, A., Wang, H. & Seed, B. Primerbank: A Pcr Primer Database 
for Quantitative Gene Expression Analysis, 2012 Update. Nucleic Acids Res. 40, 
D1144-D1149, (2012). 
286 Pereira, L. D. V. Stem Cells: Promise and Reality.  (Hackensack, NJ): World 
Scientific Publishing Company (2017). 
287 Abdelwahid, E. et al. Stem Cell Death and Survival in Heart Regeneration and 
Repair. Apoptosis 21, 252-268, (2016). 
288 Barbash, I. M. et al. Systemic Delivery of Bone Marrow–Derived Mesenchymal 
Stem Cells to the Infarcted Myocardium. Circulation 108, 863, (2003). 
289 Dong, H., Paramonov, S. E., Aulisa, L., Bakota, E. L. & Hartgerink, J. D. Self-
Assembly of Multidomain Peptides: Balancing Molecular Frustration Controls 
Conformation and Nanostructure. J. Am. Chem. Soc. 129, 12468-12472, (2007). 
290 D. Simms, P. E. C. a. P. C. Trizol: A New Reagent for Optimal Single-Step Isolation 
of Rna. Focus 15, 99-103, (1993). 
 
